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Abstract
Interactions between proteins and their ligands play crucial roles in many biological processes,
such as metabolism, signaling, transport, regulation or molecular recognition. Understanding
the molecular basis of protein-ligand interactions is thus of great interest, not only for modeling
complex biological systems but also for applications in drug discovery. However, structural
details for most of these interactions have not been characterized experimentally. Therefore,
computational methods have become increasingly important for investigating biological systems
at an atomistic level.
This work aims at a better understanding of the molecular basis of disease related viral
methyltransferases, their interactions with small molecules and the catalytic mechanism, which
may on the long perspective help to develop a treatment against neglected tropical diseases.
Furthermore, we aim to advance the current methods for the computational prediction of a
protein’s molecular function and its biological role in the cell. In addition, we aim to complement
currently available computational strategies for estimating protein ligand interaction energies.
Dengue fever is a rapidly emerging, still neglected tropical disease which causes significant
mortality and morbidity in humans. For the discovery of novel classes of compounds inhibiting
dengue virus methyltransferase, a combination of structure-based virtual screening and enzy-
matic inhibition assays is employed. From the shortlist of 263 candidates selected by virtual
screening, ten compounds are found to specifically inhibit the target enzyme with IC50 values in
the low µM range. Promising compounds are selected for further experimental characterization
and the inhibitory activity of the two most active compounds is confirmed.
For obtaining a better understanding of the molecular basis of the target enzyme’s function,
molecular dynamics simulations and mixed quantum mechanics/molecular mechanics calcula-
tions are employed to investigate the mechanisms of the enzymatically catalyzed reaction at
an atomistic level. Based on a structural model of the target protein in complex with its RNA
substrate, the impact of mutations on ligand binding, geometric arrangements and reaction
energy barriers are evaluated computationally. In addition, for a detailed characterization of
the underlying chemical reactions, ab initio electronic structure calculations are performed on
model systems approximating the biological structure.
The reliable prediction of ligand binding sites is crucial for characterizing proteins with
unknown function. Therefore, the use of computational predictions of protein function and
ligand binding sites for proteins without experimental structures are assessed in a blind and
objective way. Limitations in the current prediction methods are analyzed and suggestions for
i
a more reliable evaluation are given. Following those suggestions, an extended and fully auto-
mated assessment is implemented in the Continuous Automated Model EvaluatiOn (CAMEO)
framework.
Computational identification of protein-ligand interactions can greatly facilitate the drug
discovery process. Thus, we establish a straightforward, rapid scoring function that aims to
identify the best poses out of an ensemble of pre-docked poses, by quantifying the degree of
burial and the electrostatic interactions of the ligand in a binding site. The scoring function
is evaluated on a set of high quality protein-ligand complex structures, where the results show
promisingly high retrieval rates for selecting the best poses from a pool of decoy poses.
Finally, a novel human-computer interface device is described which facilitates the interac-
tion with the computational representation of complex biological systems by employing natural
and intuitive movements.
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Chapter 1
Introduction
1.1 Protein-Ligand Interactions
Proteins are biological macromolecules that play a central role in all living cells. They are
involved in virtually every physiological process like metabolism, catalysis, signal transduction,
cell cycle and transport and they perform structural and mechanical functions such as in the
cytosceleton and in muscles.
In most of these processes interactions between proteins and their ligands play crucial roles.
Most of these interactions are unspecific and transient in nature (e.g. interactions with water
and ions), some are persistent and may play a structural or functional role (e.g. certain metal
ions) and others might be transient but nevertheless highly specific, often resulting in essen-
tial changes of the protein or the ligand (e.g. enzyme-substrate complexes or receptor-ligand
complexes). Understanding the molecular basis of protein-ligand interactions is thus of great
interest, not only for understanding complex biological systems but also for clinical applications.
Although protein-ligand interactions are crucial for the function of a protein, in many cases
they are unknown. Despite the kind of ligands interacting with a protein is often known from bio-
chemical analyses, elucidating the structural details of these interactions requires elaborate and
time-consuming studies by X-ray crystallography or nuclear magnetic resonance spectroscopy.
Therefore, computational methods have become increasingly important to investigate biologi-
cal systems at an atomistic level. Today, as examples, in-silico approaches facilitate the func-
tional characterization of proteins,1 allow the identification of possible interactions with small
molecules based on three-dimensional protein structures2 or help to investigate the molecular
mechanism of enzymatic catalysis.3
Ultimately, the function of a protein is determined by its three-dimensional structure, which
in turn is governed by its amino acid sequence. Therefore, in cases where no experimentally
determined three-dimensional structures are available, comparative modeling techniques can
provide insights. These methods rely on the observation that the three-dimensional structure
of a protein family is robust against sequence changes.4 This allows to build structural models
based on similarity to proteins with known structure.
Studies of the interactions of small chemical molecules with the binding site of a disease
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related protein can help to develop specific inhibitors with applications both as research tools
for probing the effect of inhibition in a protein network as well as early lead compounds for
developing new drugs.
2
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1.2 Estimation of Protein-Ligand Interactions
Computational approaches have been developed for a broad variety of applications in molecular
biology, ranging from the identification of ligand binding sites, through estimation of protein-
ligand interaction energies to detailed descriptions of the electronic structure of catalyzed reac-
tions.
1.2.1 Prediction of Ligand Binding Sites
The number of protein structures with unknown biological function is steadily increasing. To
bridge this rapidly growing gap between known sequences and unknown function, numer-
ous computational and experimental techniques have been developed to help identifying the
structure-function relationship.5,1, 6
Among these methods, computational approaches for determining the precise location of
ligand binding sites and protein residues involved in ligand interaction, directly from a protein’s
sequence, is of high relevance for life science research. Various approaches for the predic-
tion of ligand-binding sites have been proposed,7 based on sequence conservation,8,9, 10,11,12,13
geometric criteria of the protein surface14,15,16,17,18 or homology transfer from known struc-
tures.19,20,21,22
Recently, methods based on homology transfer have been shown to exhibit excellent results
in a blind assessment of prediction methods.23,24,25 These methods follow a general scheme:
starting from an input sequence, a three dimensional structure is build based on homology
modeling techniques. With this model, a database of protein structures with bound ligands
is queried to identify proteins with similar structure. Superimposing these structures onto
the query structure aligns the bound ligands onto the query and allows to identify contacting
protein residues which form the binding site.22 A number of variations to this scheme have been
implemented including residue conservation,22 constrained ligand docking26 or local functional
site identification.27
Despite the good results of these methods, they are limited to cases where homologous
proteins with known ligands are detectable, which is not commonly the case. When homologue
structures are available, but their binding sites are unknown, geometric methods, trying to
identify the deepest clefts on the protein surface, yield good results. Where no homologue
structure of the query protein is detectable, only methods based on sequence conservation are
applicable.
1.2.2 Protein-Ligand Docking and Virtual Screening
Computational methods for docking small molecules into the binding sites of biological macro-
molecules and for scoring their potential interactions with the protein are widely used in drug
discovery for hit identification and lead optimization.28 They often help to identify possible
drug candidates from a large library of available chemical compounds.
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Based on the three dimensional structure of the target protein, docking programs try to
predict the best fit of a ligand into the binding pocket. For this, chemical compounds are
computationally placed into the target protein binding site and their interaction energy is esti-
mated. Current algorithms used in virtual screening make a number of approximations in order
to achieve reasonable computational speeds necessary for screening of large compound libraries.
These approximations reduce the numbers of degrees of freedom which are explicitly treated, of
which some are replaced with implicit degrees of freedom. This includes constraining of protein
motions, implicit treatment of solvent molecules or evaluation of interaction energies based on
molecular mechanics force fields or empirical scoring functions.29
In general there are two aims of docking studies: First, the accurate modeling of the binding
pose and second, the correct prediction of binding free energies.30
For the sampling of the small molecule’s conformational space, a number of algorithms are
employed, based on genetic algorithms, incremental build strategies or Monte Carlo sampling.
It has been found that most methods for virtual screening work reasonably well in reproducing
a close-to-native orientation of the ligand if properly configures and applied to well-behaved
systems. However, their ability to predict binding free energies is often very limited.31,28,30
1.2.3 Estimation of Protein-Ligand Binding Affinities
Various approaches have been developed for a more accurate estimation of protein-ligand binding
free energies. These calculations often employ molecular dynamics simulations or Monte Carlo
sampling of a full system in explicit solvent. However, such methods are very time consuming
and are thus only applicable to a small number of compounds.
Most accurate results are obtained with free energy pathway methods, like free energy
perturbation (FEP), which sample the whole path from initial to final state. However, these
methods are computationally too costly to be routinely applied in a drug discovery process.29
Therefore, numerous approaches have been developed which try to obtain similarly accurate
results at lower computational costs. Generally, those methods are end-point methods which
consider only the initial and final state. These methods include MM-PBSA / MM-GBSA32 and
linear interaction energy (LIE)33 which are nowadays commonly applied to study the interaction
of ligands with biological macromolecules.
1.2.4 Estimation of Reaction Energy Barriers
Mixed Quantum-Mechanical/Molecular-Mechanics Calculations
For describing chemical reactions, quantum-mechanical (QM) methods are often required. How-
ever, the application of such methods are limited to systems with a few hundred atoms. On
the other hand, even small biological systems, contain orders of magnitude more atoms and are
thus incompatible with a full QM treatment. Therefore, mixed quantum-mechanical/molecular-
mechanics (QM/MM) approaches have become the method of choice for modeling reactions in
biological systems.3
4
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These methods use a QM treatment of the chemically active region, whereas the surrounding
is modeled as molecular-mechanics (MM). Combining these methods allows to simulate complex
biological systems with good accuracies and reasonable computational costs. These methods
can give detailed insights into enzyme catalyzed reactions and other electronic processes, like
charge transfer or electronic excitation.34
Potential of Mean Force
The free energy changes as a function of an inter- or intramolecular coordinate is of high
relevancy for the computational investigation of physically relevant processes like chemical re-
actions, ligand migration or conformational changes. The free energy surface along a reaction
coordinate is called potential of mean force (PMF). The highest energy point on a PMF is of
particular interest, since it corresponds to the transition state of the process, from which kinetic
quantities, like rate constants, can be computed. The PMF considers not only the interaction
between the solute particles but also incorporates solvent effects if the system is in solution.
Although the PMF is of high relevancy, it is difficult to obtain for complex systems like
solvated macromolecules which have many minimum energy conformations. Unfortunately,
standard unrestrained molecular dynamics simulations do not adequately sample high energy
regions of phase space which contribute significantly to the free energy and thus, yield inaccurate
values for the PMF.
One method to overcome these sampling problems is umbrella sampling. In umbrella sam-
pling, the potential energy function is modified in order to adequately sample high energy
regions. Bias potentials are placed along a reaction coordinate in order to drive the system
from one state to another. The steps along the path are covered by subsequent umbrella win-
dows. In each window, an MD simulation is performed from which the change in free energy can
be computed. Subsequently, all windows are combined using the weighted histogram analysis
method in order to obtain the free energy profile along the reaction coordinate.35
5
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1.3 Flavivirus
Flaviviruses are small, enveloped RNA viruses, belonging to the Flaviviridae family, together
with Hepaciviruses and Pestiviruses.36 The Flavivirus genus contains numerous recognized viral
species, which are predominantly transmitted by arthropod vectors, mainly Aedes mosquitoes.
There are 40 known flaviviruses capable of causing diseases in humans.37 Of those some are
medically important pathogens causing significant mortality and morbidity in humans. This
includes all four serotypes of dengue virus (DENV1-4), Japanese encephalitis virus (JEV), tick-
borne encephalitis virus (TBEV), West Nile virus (WNV) and yellow fever virus (YFV).38 Al-
though vaccines are available for YFV, JEV and TBE, none have been developed for other
flaviviral diseases. Currently, there are no specific antiviral drug treatments available against
flaviviruses, and disease control is often limited to vector control.
1.3.1 Dengue Fever
Dengue fever (DF), which is caused by all four dengue virus serotypes, is among the most
important emerging diseases. In the last 25 years, a dramatic global expansion of DF and the
more severe and potentially lethal form of the disease, dengue haemorrhagic fever (DHF) and
dengue shock syndrome (DSS), has occurred.37 Nowadays, dengue is predominantly prevalent
in all tropical regions with annually 50-100 million cases of DF, 500’000 cases of DHF/DSS
and around 20’000 death worldwide. For dengue virus, four closely related serotypes have
been isolated, where each serotype is sufficiently different, that no cross-protection can occur.
Furthermore, sequential infection with different DENV serotypes in long intervals can produces
unusually severe disease.39
Vaccine development for DENV has been a challenge for decades, mainly due to the inability
of vaccines to protect simultaneously against all four distinct serotypes.40 In the absence of
vaccines, specific drug treatments are needed, but none were developed so far.
1.3.2 Dengue Virus
Like all flaviviruses, dengue virus is a enveloped, single stranded, positive sense RNA virus. The
genome is packaged by viral capsid protein (C) in a host-derived lipid bilayer, into which 180
copies of the envelope protein E in complex with the membrane protein (M) are embedded.
This results in a smooth and spherical virion with a diameter of 50 nm (Figure 1.1).41
The single stranded, 11 kb positive sense RNA genome has a single long open reading frame
which is flanked by 5’- and 3’-untranslated regions (UTR), which have secondary structure that
is essential for the initiation of translation and for replication. The 5’ end of the genome has a
type 1 cap, whereas the 3’ end lacks a poly-A tail.42 In the host, the viral RNA is translated
into a polyprotein which is cleaved by both host and viral proteases into three structural and
seven non-structural (NS) proteins (Figure 1.2).43
The non-structural proteins are involved in viral RNA replication. The best characterized
proteins are NS3 and NS5. NS3 has three distinct activities: serine protease in complex with
6
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Figure 1.1: Depiction of the flavivirus virion. Source: ViralZone www.expasy.org/viralzone, Swiss Institute
of Bioinformatics
Figure 1.2: Flavivirus genome (top) and polyprotein (bottom) with cleavage sites. (Source: ViralZone
www.expasy.ch/viralzone, Swiss Institute of Bioinformatics)
NS2B, required for polyprotein processing; helicase/NTPase activity, required for unwinding
double stranded replicative form of RNA; RNA triphosphatase, required for capping of nascent
viral RNA. NS5 has three enzymatic functions: S-adenosyl-L-methionine (SAM) dependent
methyltransferase (MTase)44,45 and guanylyltransferase46 required for maturation of the RNA
cap; RNA-dependent RNA polymerase (RdRp) required for RNA replication. NS1 is required
for flaviviral replication and presumably involved in negative-strand synthesis. NS2A is a trans-
membrane protein involved in membrane generation during virus assembly. NS4A is a membrane
protein involved in the formation of the viral replication complex. NS4B inhibits type I interferon
response of host cells.47
A type 1 cap structure is found at the 5’-end of both viral and cellular eukaryotic RNA.48
It is essential for viral replication, since it ensures RNA stability by protecting against RNases
and it enhances recognition by the ribosomes.49,50 The capping process results from four
chemical reactions, catalyzed by viral enzymes (Figure 1.3). Starting from the unaltered 5’-
7
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end, consisting of the final nucleotide to which a triphosphate is attached at the 5’ position, an
RNA triphosphatase (presumably NS3) removes the terminal phosphate group. In the following
step, a guanylyltransferase (NS5) transfers one molecule of guanosine monophosphate to the
5’-diphosphate RNA. Finally, the terminal guanosine moiety is methylated in the N7-position by
a methyltransferase (NS5), which leads to a cap 0 structure. In addition, a methyltransferase
(NS5) further methylates the 2’-hydroxy group of the first RNA nucleotide which leads to the
cap 1 structure.44 For all flaviviruses, a cap 1 structure with the form 7MeGpppA2′OMeG-RNA is
always present in mature viral RNA, where the first two nucleotides (A,G) are strictly conserved
among all flaviviruses.48
Figure 1.3: Schematic overview of the processes involved in RNA capping.
1.3.3 NS5 Methyltransferase
One of the viral enzymes involved in the capping process, is the NS5 methyltransferase (MTase)
which is located at the N-terminal domain of the NS5 protein. This enzyme shares a common
fold with many SAM dependent methyltransferases although sequence identity within this family
is very low (10-15%).44,51
Twelve X-ray crystal structures of the dengue MTase domain complexed with S-adenosyl-L-
homocystein (SAH), ribavirin triphosphate (RTP), as well as a variety of RNA cap analogues,
have been published. So far, no full length NS5 crystal structure, consisting of the N-terminal
MTase and the C-terminal RdRp domains, has been solved.
The enzyme has two specific binding sites where ligands have been co-crystallized: The
position of SAH indicates the binding of the methyl donor, SAM. RNA cap analogues bind to a
shallow second pocket. The two binding sites are connected by a common Y-shaped positively
charged cleft, which suggests the placement of capped RNA along the cleft, positioning the
first RNA nucleotide close to SAM, compatible with 2’O-methylation (Figure 1.4).44,52,53
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Figure 1.4: Structure of the dengue virus methyltransferase domain.
Although competitive inhibitors are known for both sites of the dengue MTase, the medicinal
chemistry of DENV is still in its very early stage.54 SAH, as well as sinefungin and dehydrosine-
fungin have been characterized as efficient sub-micromolar competitive inhibitors of the MTase.
The structural similarity to SAM strongly suggests their interaction with the SAM pocket.55 A
virtual screening campaign, identified a further inhibitor based on structural similarity to SAM,
which inhibits MTase activity in the medium-micromolar range.56 Furthermore, RTP has been
found to inhibit dengue MTase, but shows only weak activity.52 An additional inhibitor with
activity in the low micromolar range was found, which is expected to bind to the RNA cleft.57
Recently, Lim et al. have developed a small molecular inhibitor based on SAM analogs, which
selectively blocks DENV MTase.58 In addition, using high throughput screening, Stahla-Beek
et al have discovered the first inhibitor of the enzyme’s guanylyltransferase activity.59
The NS5 MTase catalyzes both the guanine N7 and the ribose 2’O methylation, generating
sequentially GpppA-RNA → 7MeGpppA-RNA → 7MeGpppA2′OMe-RNA (Figure 1.5).44,60,50
For both reactions in flaviviruses, no mechanisms at an atomistic level is known and no structure
with a short capped RNA in a conformation suitable for methyltransfer has been solved.
Sequence alignment revealed that the four residues Lys61, Asp146, Lys181 and Glu217 are
conserved among many MTases. From biochemical and mutagenesis studies, it has been shown
that those four residues are critical for the functioning of the methyltransfer reactions and
thus the replication of the virus itself. However, different dependencies on the residues within
this motive were found for the N7 and the 2’O methylation reaction, which suggests different
underlying mechanisms.60 In addition, further mutagenesis studies identified two distinct sets
of amino acids on the enzyme’s surface required for the N7 and the 2’O methylation, which
9
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Figure 1.5: Overview of the two methyltransfer reactions catalyzed by the NS5 MTase. Reactants:
unmethylated RNA (1), S-adenosyl-L-methionine (3). Products: doubly methylated RNA (2), S-adenosyl-
L-homocysteine (4).
suggests that the RNA adopts two different binding modes.61 In addition, for the N7 reaction, it
has been found that it can only take place on RNA templates comprising at least 74 nucleotides
of the viral 5’ UTR sequence.50
From the structures of vaccinia virus VP39 2’O-MTase and mutagenesis studies of RrmJ
MTase, a mechanism for the 2’O methylation has been suggested for those enzymes.62,63 It was
proposed that the methyltransfer from SAM to the 2’-hydroxy group of the RNA ribose moiety
proceeds as a nucleophilic SN2 type reaction and that it is catalyzed by the conserved residues
in the Lys61-Asp146-Lys181-Glu217 tetrade, which mediates deprotonation of the 2’-hydroxy
group.64,65 From the structure of the distantly related Ecm1 N7-MTase, an in-line mechanism
with no direct contact of the protein was suggested for the N7-methylation. There, the catalysis
seems to be achieved through close proximity of the guanosine N7-atom and the SAM methyl
group.66
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1.4 Objectives
This work aims at a better understanding of the molecular basis of disease related viral methyl-
transferases, their interactions with small molecules and the catalytic mechanism, which may on
the long perspective help to develop a treatment against neglected tropical diseases. Further-
more, we aim to advance the current methods for the computational prediction of a protein’s
molecular function and its biological role in the cell. In addition, we aim to complement currently
available computational strategies for estimating protein ligand interaction energies.
This thesis is organized as follows: First, the results from our study on the identification
of novel dengue virus methyltransferases are given, followed by a description of the further ex-
perimental characterization of the inhibitory effects of selected promising compounds. Second,
the computational and experimental analysis of the mechanism of action of the dengue virus
methyltransferase is described. Third, insights of the assessment of ligand binding site prediction
methods are presented, indicating current limitations in prediction methods and their assess-
ment. In addition, the subsequent implementation of these suggestions is described. Fourth,
the development of a rapid scoring function for identifying the correct pose of a ligand bound
to a protein is presented. Finally, a novel human-computer interface device is described.
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Chapter 2
Identification and Validation of Novel Dengue
Methyltransferase Inhibitors
The search for lead compounds which inhibit the dengue methyltransferase can be significantly
facilitated by using computational methods. We are using high-throughput structure-based
virtual screening of a library of over five million purchasable compounds to reduce the library
to a list of a few hundred candidates which are tested in vitro. Subsequently, the experimental
binding affinities can be used to increase the accuracy of our predictions and to select further
compounds for experimental verification.
The focus of our study is to obtain a better understanding of the molecular properties of
viral methyltransferase active sites and their interactions with small molecules, which will guide
our search for novel lead compounds against neglected tropical diseases.
For the discovery of novel classes of compounds inhibiting dengue MTase, a combination
of large-scale structure-based virtual screening and enzymatic inhibition assays was employed.
The virtual screening approach was based on a multi-stage docking strategy and was applied
to a library of over five million commercially available compounds. The funnel like strategy
included multiple Glide67 docking steps of selected subsets with increasing accuracy as well as
a refinement and a selection step. Promising compounds were subsequently assayed in vitro
using a scintillation proximity assay55 at the Novartis Institute for Tropical Diseases (NITD) in
Singapore.
Additionally, ligand based virtual screening methods were applied to retrieve additional
active compounds. Thus, we constructed a pharmacophore model, based on experimental
data obtained by this study and common receptor-ligand interactions predicted by our docking
calculations. This model was used to obtain further candidates from the initial compound library
which were subsequently assayed in vitro.
From the list of 263 candidates which were assayed experimentally, ten compounds were
found to specifically inhibit dengue MTase with IC50 values in the low µM range. Due to the
broad setup of the initial library, those active compounds represent a set of diverse chemotypes
and predicted binding modes, leading to a variety of different starting points for further drug
discovery efforts.
During compound screening, numerous false positive hits were encountered, which non-
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specifically inhibit the dengue MTase. Thus, we have tested computational methods to predict
non-specific inhibition due to compound aggregation. Those methods use supervised machine
learning techniques to classify specific from non-specific inhibitors based on calculated physic-
ochemical properties. While our trained classifier performs well within one dataset, misclassi-
fication rates are significantly increased when applied to a completely new set of compounds.
Our results suggest that prediction of aggregation behavior is not transferable between assay
conditions or biological targets. Thus, such classifiers cannot be used to eliminate predicted
non-specific compounds prior to in vitro assays.
To further characterize the active compounds and to validate their specific interaction with
the dengue MTase, additional experimental assays were performed. Of the ten active compounds
identified through our virtual screening approach, five promising compounds were selected for
further follow-up experimental assays to confirm their specific inhibition of the MTase and to
distinguish between inhibitory activity of the 2’O and the N7 MTase function. Thereby, the
inhibitory activity of the two most active compounds was confirmed.
In addition, we have developed an isothermal titration calorimetry (ITC) assay in order to
measure binding constants of the selected active compounds. Due to solubility issues only a
subset of three compounds was assayed in the ITC experiment, however, their binding to the
dengue MTase could not be confirmed.
For obtaining a better understanding of the important interactions governing protein-ligand
binding, for the validation of predicted binding modes as well as for future structure-based
compound optimizations, we started efforts to obtain X-ray crystal structures of the inhibitors
bound to the MTase.
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2.1. SCREENING FOR NOVEL INHIBITORS
2.1 Screening For Novel Inhibitors
In the following, a published manuscript is included:
“Novel Inhibitors of Dengue Virus Methyltransferase: Discovery by in Vitro-Driven
Virtual Screening on a Desktop Computer Grid”
My contributions to this joint work were the following:
In-depth analysis of high-throughput docking results
Development of pharmacophore hypotheses based on experimentally validated high-throughput
docking hits
Pharmacophore based screening for additional compounds and subsequent rescoring of
obtained hits
Retrospective analysis of refinement and rescoring procedures
Modeling of compound aggregation behaviour
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Dengue fever is a viral disease that affects 50-100 million people annually and is one of the most
important emerging infectious diseases in many areas of the world. Currently, neither specific drugs nor
vaccines are available. Here, we report on the discovery of new inhibitors of the viral NS5 RNA
methyltransferase, a promising flavivirus drug target. We have used a multistage molecular docking
approach to screen a library of more than 5 million commercially available compounds against the two
binding sites of this enzyme. In 263 compounds chosen for experimental verification, we found 10
inhibitors with IC50 values of <100 μM, of which four exhibited IC50 values of <10 μM in in vitro
assays. The initial hit list also contained 25 nonspecific aggregators. We discuss why this likely occurred
for this particular target. We also describe our attempts to use aggregation prediction to further guide
the study, following this finding.
Introduction
Dengue fever is a viral disease that is transmitted between
humanhosts byAedesmosquitoes, particularlyAedes aegyptii.
In 1997, 20 million cases of dengue fever were estimated to
occur annually.1,2 Partially because of increased urbanization
and failure to effectively control the spread of the insect vector,
more recent estimates suggest this number has risen to 50-100
million, and dengue fever is now seen as one of the most
important emerging infectious diseases in many areas of the
world.3-5 Mild cases of dengue fever result in severe flulike
symptoms, including fever, headache, and myalgia, but more
severe cases can progress into a hemorrhagic fever and shock
syndrome with considerable lethality.6 Current treatment
practice is nonspecific and symptomatic with a regimen of
analgesics and fluid replacement, as neither specific drugs nor
vaccines are available.1
Dengue virus is a plus-strand RNA virus belonging to the
Flavivirus genus of the Flaviviridae family. Four serotypes
have been isolated (DENV1-DENV4), and exposure to each
of the serotypes conveys only partial immunity.Moreover, the
presence of heterologous antibodies against a serotype other
than the present infection may precipitate the more severe
forms of dengue fever in patients.7 In the absence of efficient
and cost-effective vaccines, the development of inhibitors of
viral or cellular enzyme targets as antiviral therapeutic agents
is of particular interest.
The dengue genome, a single RNA strand 10.7 kb in length,
is translated into a single polyprotein and later cleavedbyviral
and cellular proteases into 10 mature proteins. Three of the
proteins have a structural role (C, prM, and E). In addition,
seven nonstructural proteins (NS1, NS2A, NS2B, NS3,
NS4A, NS4B, and NS5) are formed.8
Of the latter, NS3 andNS5 are the best understood to date,
and both enzymes exhibit multiple domains and functions.9,10
NS5 is the largest (900 amino acids) and most conserved
protein in the dengue genome (67% sequence identity among
serotypes 1-4).8 It contains the RNA methyltransferase
(MTase)a domain, as well as the RNA-dependent RNA
polymerase necessary for virus replication. In this study, we
focus on the discovery of compounds inhibiting the NS5
MTase, which has been proposed as a promising drug target
against flaviviruses by us and others.11-13
The 50 end of the dengue genome contains a type 1 cap
structure, followed by the nucleotides AG, which are conserved
in all flaviviruses.14 Appropriate capping of cellular and viral
RNA is known to increase translation efficiency aswell asRNA
half-life.15,16 Host RNA is transcribed in the nucleus and
processed by the cellular capping machinery. Dengue virus
replication, however, occurs at the membrane of the endoplas-
mic reticulum; hence, a viral MTase is required for capping of
the nascent viral RNA. Of the four steps necessary in Flavivirus
cap formation, the final twomethylation reactions are catalyzed
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61 267 15 84. E-mail: torsten.schwede@unibas.ch.
aAbbreviations: ATA, aurintricarboxylic acid; CF-I, cell-based fla-
vivirus immunodetection; Cpd, compound; DENV, dengue virus; FN,
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by NS5 MTase with S-adenosyl-L-methionine (SAM) as the
methyl donor, generating S-adenosyl-L-homocysteine (SAH)
as a byproduct.17,18 The cap guanine is methylated at the N7
position, resulting in a type 0 cap structure. Subsequently, the
first RNA base, adenosine, is methylated at the 20-OH group
of the ribose, resulting in the formation of a type 1 cap
structure.
The three-dimensional (3D) structure of the dengue NS5
MTase domain was the first FlavivirusMTase structure to be
determined by X-ray crystallography.18 Structures of the
MTase complexed with S-adenosyl-L-homocysteine (SAH),
the nonhydrolyzable GTP analogue GDPMP, ribavirin tri-
phosphate (RTP), and a variety of RNA cap analogues
(GpppA, GpppG, 7MeGpppA, 7MeGpppG, and 7MeGppp-
G20OMe) have been published.
17-20
Dengue MTase has an overall globular fold and shares a
common fold withmany SAM-dependentMTases, consisting
of a seven-stranded β-sheet enclosed by four R-helices
(subdomain 2).21 This domain is surrounded by subdomain
1, an N-terminal extension of a helix-turn-helix motif,
followed by a β-strand, an R-helix, and subdomain 3, a
C-terminal extension consisting of an R-helix and two
β-strands, spatially located between subdomain 2 and the
N-terminal extension.18 The enzyme has two specific binding
sites where ligands have been cocrystallized (cf. Figure 1). The
position of SAH indicates the binding site of the methyl
donor, SAM. RNA cap analogues bind to a shallow second
pocket formed between subdomains 1 and 2 (cf. Figure 1A).
The two binding sites are connected by a common Y-shaped
cleft, which suggests the placement of capped RNA along the
cleft, positioning the first RNA nucleotide close to SAM,
compatible with 20-O-methylation. These positions are in
accordance with observed positions of the RNA and cofactor
in a complex structure of vaccinia virus VP39 MTase.22
Here, we present the results of our efforts to find novel
classes of compounds inhibiting dengue MTase, potentially
blocking viral replication. We have used a combination of
large-scale structure-based computational analysis and en-
zyme inhibition assays. On the basis of structural analysis of
dengueMTase, separate binding sites forRTP and SAMwere
targeted. For both sites, competitive inhibitors are known:
SAH, sinefungin, and dehydrosinefungin have been charac-
terized as efficient submicromolar competitive inhibitors of
this MTase, and structural similarity to SAM strongly sug-
gests their interaction with the SAM pocket.23 Furthermore,
two inhibitors of dengue MTase were published concomitant
to this work. An inhibitor (IC50=60.5 μM) has been found by
Luzhkov et al. based on structural similarity to SAM,13 and a
docking study by Milani et al. has found aurintricarboxylic
acid (ATA) to be a low-micromolar inhibitor of dengue
MTase (IC50 = 2.3 μM).
24 On the basis of the specific
structural interactions of RTP (IC50=101 μM)
19 and nucleo-
tide or cap analogues with the RNA cap binding site, we
consider this site a valid second target for inhibitors.
Our virtual screening approach was based on initial high-
throughput docking calculations performed on a library of
more than 5 million commercially available compounds.
Using a personal computer (PC) grid to harness the idle
computing power of our university’s PCs, we were able to
perform these calculations without prior focusing of the
compound library. After the compounds had been docked,
compound poses were refined, and promising candidates were
assayed in vitro. Insights from these assays combined with
pharmacophoric searches based on the predicted binding
mode of actives were then used to select further compounds
for follow-up testing. In the following, we will discuss our
combined screening study, as well as the results obtained
computationally and in vitro.
Materials and Methods
Chemical Compounds. All compounds in the docking data-
base were associated with purchasing information, and com-
pounds selected for inhibition assays were obtained from a
variety of vendors. Compounds 1-9 (Table 1) were obtained
from the NCI DTP Open Chemical Repository (http://dtp.nci.
nih.gov) with the following compound codes: NSC12451,
NSC15765, NSC26899, NSC49419, NSC54771, NSC84407,
NSC91788, NSC14778, and NSC140047, respectively. Com-
pounds 10-12, 14, 15, 17, 18, 20, 21, 27, and 33 were obtained
from ChemBridge Corp. (San Diego, CA) (codes 5654575,
6490771, 7018889, 7936171, 7208655, 7746191, 7778100,
5219400, 7364286, 5255882, and 5917902, respectively). Com-
pounds 13, 24, 26, and 35 were from Enamine Ltd. (Kiev,
Ukraine) (codes T0520-2463, T0511-8111, T5237786, and
T5285909, respectively). Compounds 16, 19, 22, and 23 were
from InterBioScreen (Moscow, Russia) (codes STOCK1N-
55803, STOCK2S-36613, STOCK3S-13122, and STOCK5S-
06910, respectively). Compounds 25 and 28 were from Inter-
Chim (Montluc-on, France) (codes STOCK1N-17364 and UZI/
9041345, respectively). Compounds 29 and 30were fromAurora
Fine Chemicals (San Diego, CA) (codes Kenb-0135169 and
Kina-0056391, respectively). Compound 31was fromAmbinter
SARL (Paris, France) (code PHAR058572). Compound 32was
from TimTec LLC (Newark, DE) (code ST057026), and com-
pound 35 was from Life Chemicals (Burlington, ON) (code
F0777-1485).
Molecular Modeling. (i) Analysis of Dengue Methyltransfer-
ase Mutations and Structural Variability. For structural studies
and for docking, anX-ray crystallographic structure of DENV2
MTase with bound SAH andRTPwas used [Protein Data Bank
(PDB) entry 1R6A]. To assess the conservation of protein
residues, we extracted dengueMTase sequences froma database
of all dengue sequences inUniProtKB release 14.0 using a blastp
search with the sequence of PDB entry 1R6A as a query.25,26
From the retrieved set of sequences, redundant sequences were
removed, and 127 unique sequences were aligned using Clus-
talW with standard parameter settings.27 Next, identity histo-
gram values (Ip) were calculated at each position, where Ip=
(M - 1)/(N - 1), with p being the position in the alignment,M
the number of prevalent residues in row p, and N the total
number of residues in row p. Finally, residues were colored by
identity histogram values in the Chimera software package.28
To study the structural variability seen in dengue MTase
crystal structures, we obtained all available X-ray structures
from the PDB20 and optimally superposed their backbone
atoms to the reference structure (PDB entry 1R6A). The average
per-residue root-mean-square distances (rmsd) between the
1R6A structure and all other structures were calculated using
VMD version 1.8.629 and colored accordingly.
(ii) Library of Purchasable Chemical Compounds. The com-
pound library for screening was collected as follows. The all-
purchasable subset of the ZINC V5 database, comprising ∼2.7
million molecules from a variety of vendors, was obtained from
http://zinc5.docking.org/.30 To this collection were added 2.4
million nonredundant compounds from the Schr€odinger in-
house CACDBdatabase of commercially available compounds.
Ligands were prepared for docking using the LigPrep process
(Schr€odinger Suite 2007, Schr€odinger LLC, NY). Briefly, the
procedure was as follows. Ligands were desalted, neutralized,
and parametrized using the OPLS 2005 force field. Next,
tautomers and ionization states expected to occur in the pH
range of 5.0-9.0 were generated using ionizer (Schr€odinger
Suite 2007). Wherever the stereochemistry of chiral centers
Article Journal of Medicinal Chemistry, 2010, Vol. 53, No. 4 1485
Figure 1. Sequence and structural conservation ofDENV2MTase. (A-C) Sequence conservation of dengueMTase. Sequence conservation is
expressed as the identity histogram (I ) of an alignment of 127 nonredundant dengueMTase sequences retrieved fromUniProtKB. (A) Overall
structure of DENV2 MTase in complex with RTP (left) and SAH (right). Ligands are displayed as element-colored licorice sticks. Surface
gradient: from light gray (I=1) to yellow (I=0.947, i.e., 95% identical residues) to red (I=0.323, i.e., 33% identical residues). (B) RNA cap
binding site.Residues surrounding the inhibitorRTPare shownas licorice sticks, colored by degree of conservation as in panelA.RTP is shown
in element-colored sticks (only one of three phosphate groups is shown). Residues undergoing key interactions with the ligand are labeled, and
hydrogen bonds are depicted as cyan lines. (C) SAM binding site. Residues surrounding the reaction byproduct SAH are shown as licorice
sticks, colored by degree of conservation as in panel A. SAH is shown in element-colored sticks. Residues undergoing key interactions with the
ligand are labeled, and hydrogen bonds are depicted as cyan lines. (D-F) Structural variation calculated as a per-residue root-mean-square
distance (rmsd) between the displayed structure and all other available DENV2MTase crystal structures with and without bound ligands. (D)
Overall MTase structure. The average rmsd is expressed as a color gradient: from light gray (rmsd = 0.0 A˚) to yellow (rmsd = 1.0 A˚) to red
(rmsd g 2.0 A˚). (E) RNA cap binding site with residues close to the inhibitor RTP, colored as in panel D. (F) SAM binding site with residues
close to the reaction byproduct SAH, colored according to the rmsd as in panel D. Surfaces were calculated using the MSMS package.57
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was not specified, a maximum of two chiral centers was expanded
into stereoisomers. Up to two low-energy conformations were
produced for ligands with flexible ring systems. Ligand structures
were minimized in implicit solvent using bmin (Schr€odinger Suite
2007). The final library consisted of 5428096 structures.
(iii) Protein Preparation. In preparation for virtual screening,
the enzyme structure from PDB entry 1R6A was modified as
follows. All sulfate ions andwatermolecules found in the crystal
structure were removed with the exception of HOH11, a struc-
tural water molecule found close to SAH.Moreover, the pose of
the flexible Lys22 residue was replaced with an alternate rota-
mer, opening up the front of the RNA cap site to potentially
accommodate larger ligands.
(iv) Ligand Docking and Compound Selection Procedures.
Virtual screening and docking were performed using Glide
version 4.5 (Schr€odinger Suite 2007) using default docking
parameter settings. A set of docking grids was generated in-
dependently for the RNA cap site and the SAM binding site
using the default parameters. For the SAM site, the ligand’s
ability to form ahydrogen bond to the backboneNofVal132 (as
observed with SAH)was required as a docking constraint. Next,
a “funnel” strategy was employed for virtual screening. Initially,
all compounds were docked using Glide in HTVS (High-
throughput Virtual Screening) mode. After this rapid screening,
the following compounds were selected for the next round. (1)
All compounds ranked in the top 10% by GlideScore were
picked. (2) All isomers (enantiomers, tautomers, and ring con-
formers) or alternate protonation states of compounds selected
under 1 were chosen. (3) All docked poses forming a hydrogen
bond to the Val132 backbone nitrogen were selected using a
relaxed distance criterion of 3 A˚. In the next round, these
compounds were docked into the respective binding sites, using
the Glide SP (Standard Precision) protocol. From this stage,
compounds were selected as follows. (1) The top 10% of the
compounds for each binding site byGlideScore were chosen. (2)
Isomers of compounds selected in step 1 were included if found
in the top 20% of compounds. These compounds were finally
docked using the Glide XP (Extended Precision) procedure, and
the 4000 top-ranked molecules from each binding site were
selected for further refinement. Details on the number of
compounds selected in each step are given in Results.
Following docking, selected compounds were passed through
further refinement steps. (1) Additional input conformations for
each selected compound were generated by reconstructing the
geometry of each of the hit compounds and minimizing in
implicit solvent or vacuum using the OPLS-AA or MMFF94
force fields31,32 using MacroModel (Schr€odinger Suite 2007).
Alternate conformations were docked using Glide XP, and only
the best-scoring pose was retained. The rationale for this
enhanced sampling procedure was to ensure that found poses
and scores are not influenced by subtle biases in the starting
conformations of compounds induced by the force field. (2) We
next applied a correction term to the docking score to account
for internal ligand strain. The ligand strain correction term was
calculated by optimizing the docked pose of the free ligand
resulting from step 1 with torsion angle restraints and then
Table 1. Predicted Binding Pocket and Measured Inhibition of Docked Compounds
Cpd IDa
binding
pocket
IC50 ( μM)
(Hill coefficient)
IC50 (μM)
with 0.1% TX100 (μM)
(Hill coefficient)
activity
retained EC50 (μM) CC50 (μM)
1 NSC12451 SAM 29.9 (n.d.) >100 (n.d.)
2 NSC15765 SAM 14.3 (1.9) 43.4 (2.3) yes >100 >100
3 NSC26899 SAM 25.3 (3.1) >100 (n.d.)
4 NSC49419 SAM 27.59 (2.5) >100 (n.d.)
5 NSC54771 SAM 27.53 (2.9) >100 (n.d.)
6 NSC84407 SAM 31.43 (2.3) >100 (n.d.)
7 NSC91788 SAM 29.03 (1.4) >100 (n.d.)
8 NSC14778 SAM 1.52 (3.1) 9.46 (2.5) yes >100 >100
9 NSC140047 SAM 8.78 (1.9) 4.47 (2.2) yes >100 >100
10 ZINC 02911543 RNA cap 7.56 (1.5) 7.14 (1.4) yes >100 >100
11 ZINC 01174529 RNA cap 6.83 (2.9) >100 (n.d.)
12 ZINC 03461039 RNA cap 7.11 (2) >100 (n.d.)
13 ZINC 03287966 RNA cap 8.81 (2.3) >100 (n.d.)
14 ZINC 01078518 RNA cap 9.28 (2.4) 64.2 (4.4) yes 12 22.7
15 ZINC 01138375 RNA cap 11.35 (3.2) >100 (n.d.)
16 ZINC 02129857 RNA cap 11.92 (1.9) >100 (n.d.)
17 ZINC 01112283 RNA cap 13.16 (2.5) >100 (n.d.)
18 ZINC 02849675 RNA cap 17.64 (2.8) >100 (n.d.)
19 ZINC 00632055 RNA cap 20.32 (1.3) >100 (n.d.)
20 ZINC 01467812 RNA cap 37.46 (1.5) >100 (n.d.)
21 ZINC 02826899 SAM 2.91 (2.7) >25 (n.d.)
22 ZINC 01878835 SAM 4.29 (4.1) >25 (n.d.)
23 ZINC 01758620 SAM 9.62 (2.1) >100 (n.d.)
24 ZINC 00633950 SAM 12.84 (1.7) >100 (n.d.)
25 CACDB 1751080 SAM 16.87 (2.2) 79.8 (0.9) yes 10.9 30.7
26 ZINC 02642996 SAM 16.09 (1.6) >100 (n.d.)
27 ZINC 01226983 SAM 21.11 (2) >100 (n.d.)
28 ZINC 02750651 RNA cap 2.81 (1.6) 19.55 (1.3) yes >100 >100
29 CACDB964942 RNA cap 13.50 (1.7) 87.1 (2.3) yes 50.0 75.1
30 CACDB1563494 SAM 9.84 (2.1) >100 (n.d.)
31 ZINC 01832826 RNA cap 4.42 (1.8) 44.5 (4.1) yes >100 >100
32 ZINC 01078734 RNA cap 12.39 (1.8) >100 (n.d.)
33 ZINC01196449 RNA cap 7.99 (1.3) >100 (n.d.)
34 ZINC02379945 RNA cap 14.50 (1.4) >100 (n.d.)
35 ZINC03369470 RNA cap 4.80 (2.1) 4.91 (1.6) yes >100 >100
aCompound structures are depicted in Table S4 of the Supporting Information. n.d. = not determined.
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without such restraints. A portion of the difference in minimized
energies (25% of the strain energy in excess of 4 kcal/mol) was
used to calculate the correction term, which is applied to the
original Glide docking score. (3) We then applied the Prime
MM-GBSA rescoring protocol (Schr€odinger Suite 2007). This
procedure estimates the ligand binding free energy by performing
minimization of the receptor-ligand complex, or the receptor
and ligand alone. After refinement, a sorted list of the top
compounds for each binding site was generated using the best-
scoring Glide XP score of the multiple conformations, the strain-
corrected XP score, and theMM-GBSA binding free energy, and
three ranks were assigned to each compound, along with a
consensus rank, calculated as the mean of the individual ranks.
In summary, the refinement procedure first resampled ligand
conformations and then provided the Glide XP score and
two additional scores (strain-corrected Glide XP scores and
MM-GBSAbinding free energy estimates), as well as a consensus
score for the selection of ligands for experimental verification.
For retrospective analysis, initial (nondocked) conformations of
all 263 compounds tested in assays (regardless of activity) were
collected and docked into both binding sites using Glide XP. Next,
refinement and rescoring procedures as described above were ap-
plied to all resulting poses. To allow comparisons between the bin-
ding sites, all compound scores were converted into Z scores. The
better-scoring pose of the two binding sites was then used in the
generation of enrichment plots. With two exceptions, all the dif-
ferent scoring schemes employed in this process selected the same
binding pocket as predicted in our previous docking attempts. We
predicted compound 8 to dock into the SAM site, but as it does not
formtheH-bondtoVal132, itspose in theRNAcapsitewaschosen.
This bond was not required in the initial screening of the NCI
library. For compound 31, only the Prime MM-GBSA approach
favored a pose in the SAM site over the RNA cap site, which was
predicted by all other scores along with our previous predictions.
(v) Pharmacophore Searches. Pharmacophore generation
and database searching were performed using Phase version
2.5 (Schr€odinger LLC). Three different 3D pharmacophore
hypotheses were generated on the basis of (A) a cluster consist-
ing of five compounds [10, 13, 17, 20, and 32 (Table 1)],
including the confirmed hit compound 10, (B) compound 10
alone, and (C) the cocrystallizedMTase ligands ribavirin mono-
phosphate and guanosine monophosphate. Pharmacophoric
features were chosen so that they resembled the interac-
tions between the ligands and the protein predicted by docking
(A and B) or present in the cocrystallized structures33 (C).
To allow flexible pharmacophore matching, a conforma-
tional search was performed on all compounds of the library
of purchasable chemical compounds described above. For sub-
sequent filtering of the full compound library, Phase default
parameters were applied and all features defined in the pharma-
cophore hypotheses were required to match.
All compounds returned by the pharmacophore searches were
subsequently docked to the RNA cap binding site and scored
using Glide XP version 4.5 (Schr€odinger LLC). The best-scoring
pose for each compound was saved for further evaluation. As
pharmacophore (A) resulted in a large number of hits, resultswere
clustered by similarity, using MACCS structural keys finger-
prints, a Tanimotometric, and a degree of similarity of 60%using
MOE 2007.09 (Chemical Computing Group, Montreal, QC). A
diverse result set was obtained by picking the representative with
the best GlideScore from each cluster.
Aggregation Prediction. (i) Test Sets. Three test sets were
assembled to evaluate different predictors of compound aggre-
gation. Briefly, theDenV test set consists of themolecules tested
in this study, and the Med and AmpC test sets are taken from
previously published studies on aggregation behavior.34-36 See
the Supporting Information for details.
(ii) Decision Tree Aggregation Prediction. We assembled a
decision tree similar to that which Seidler et al. derived using
recursive partitioning.37 See the Supporting Information for details.
(iii) Random Forest Modeling of Aggregation Behavior. We
applied the random forest method38 to model aggregation in a
manner similar to the approach published by Feng et al.35 See
the Supporting Information for details.
Computational Infrastructure.While visual analysis of protein
and small-molecule structures, as well as analysis of physico-
chemical properties, was performed on standard Linux work-
stations, the preparation and filtering of the library for docking
were performed on a Beowulf-type Linux cluster. Still, these
resources were not sufficient to allow us to execute the planned
large-scale molecular docking campaigns against theMTase. In
the early stages of the project, we therefore built up a grid
computing infrastructure at that time consisting of approxi-
mately 300 desktop PCs running theWindows 2000 orWindows
XP operating system located in our institution’s laboratories
and classrooms, as well as some laboratory computers from
another academic institution. These computers were tasked
with docking or pharmacophore search jobs using Univa UD
GridMP version 5.3. Schr€odinger Suite 2007 supported this
resource management system natively. As these types of com-
putations are embarrassingly parallel, this resource’s ready
availability allowed us to screen large libraries for suitable
compounds within reasonable amounts of time.
In Vitro Assays. (i)Methyltransferase Activity Assay.Unless
otherwise stated, all compounds were first tested at a single
maximum concentration of 25 or 100 μM followed by IC50
determinations with 2-fold serial dilutions starting from 25 or
100 μM following a previously described protocol.23 In brief,
inhibitors were assayed in a 96-well white opaque plates
(Corning Costar, Lowell, MA) in 50 mM Tris-HCl (pH 7.0),
10 mMKCl, 2 mMMgCl2, 2 mMMnCl2, 0.05% (v/v) CHAPS,
2 mM DTT, and 5 units of RNasin inhibitor (Promega,
Madison, WI). Typically, 25 nM DENV2 MTase enzyme
and 40 nM biotinylated RNA substrate were preincubated
with the test compounds at room temperature for 20 min,
and the reaction was initiated by addition of 0.56 μM
[methyl-3H]AdoMet (72 Ci/mmol) (Amersham Biosciences,
Piscataway, NJ). Under these conditions, the inhibitory effect
of the reaction end product is negligible, as the amount of SAH
produced during the reaction time (5-10 nM SAH produced in
20 min) is too small to have a significant impact on enzyme
activity, as shown in Figures 3 and 4 of Lim et al.23 To detect
aggregators, the assay was varied as follows. Detergent sensiti-
vity experiments were performed via addition of 0.01 or 0.1%
Triton X-100 to the reaction mix.39,40 For spin-down experi-
ments, compound solutions were centrifuged for 15 min at
14000 rpm and room temperature before addition. For IC50
shift assays, 8 or 80 nM DENV2 MTase was used to reach a
10-fold difference in enzyme concentration. All other conditions
were kept the same.
Reactions were stopped with buffer containing 100 mMTris-
HCl (pH 7), 50 mM EDTA, 300 mM NaCl, 8 mg/mL strepta-
vidin SPA beads (Amersham Biosciences), and 125 μM cold
S-adenosyl-L-methionine. Plateswere read in aTriluxmicrobeta
counter (Perkin-Elmer, Boston, MA) with a counting time of
1 min/well. All data points were measured in duplicate wells.
IC50 curves were plotted with average counts per minute against
the log of compound concentration. The standard deviationwas
calculated by the nonbiased n - 1 method, where standard
deviation={[n
P
x2 - (
P
x)2]/[n(n - 1)]}1/2. Nonlinear regres-
sion (curve fit) and the equation for the sigmoidal dose response
(variable slope) from GraphPad Prism version 3.02 (GraphPad
Prism, Inc., San Diego, CA) were used to interpolate values for
IC50. The equation is as follows:
Y ¼ bottomþðtop-bottomÞ=½1þ 10ðlog IC50 -XÞHill slope
whereX is the logarithm of concentration andY is the response.
Y starts at bottom and goes to top with a sigmoid shape. This is
identical to the “four-parameter logistic equation”.41,42
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(ii) Cell-Based Flavivirus Immunodetection (CF-I) Assays and
Cytotoxicity Assay. The ability of compounds to inhibit dengue
replication in a cell-based system (EC50) as well as the cyto-
toxicity of test compounds (CC50) was assayed as previously
described.43
Results
Structural Analysis of DENV2 Methyltransferase. Viruses
are known to benefit from short generation times and fast
evolution rates in escaping host defense reactions as well as in
developing resistance against therapeutic molecules.44,45 Inhi-
bitors must remain efficient against different serotypes and
common mutations to qualify for further development.
Figure 1A shows the conservation of individual MTase resi-
dues among peptide sequences from clinical isolates deposited
in the UniProt database,25 mapped onto the surface of
DENV2 MTase in complex with RTP and SAH. For each
residue, surface color is determined by the identity histogram
value of an alignment of 127 uniqueDENVMTase sequences,
shown in a spectrum from light gray (100% conservation)
through yellow (95% conservation) to red (33% conserva-
tion). The Y-shaped central cavity is clearly visible, with the
RNA cap located at the left-hand pocket (occupied by RTP
in the structure shown) and SAM located to the right in
place of SAH. As shown in Figure 1B, the RNA cap binding
site is rather shallow and open. The aromatic ring of Phe25
undergoes π-stacking interaction with aromatic ring systems
of the ligand. Hydrogen bonds can be formed from the ribose
moiety to backbone oxygens of Asn18 and Lys14. The
backbone oxygens of Leu20 and Leu17 likewise accept
H-bonds, stabilizing the “front end” of ribavirin or the cap
guanine. Moreover, electrostatic interactions between the
phosphate groups of RTP and Lys29, Ser150, and Ser214
further stabilize ligand binding. The binding pocket of SAM
(Figure 1C) is considerably more closed than the cap binding
site. Important interactions are hydrogen bonds at both
ends of the elongated SAM molecule, with Asp131 and
Val132 fixing the adenine moiety and Gly86, Ser56, and
Asp146 fixing the amino acid moiety at the opposite end.
The elongated binding pocket is lined with predominantly
apolar residues. Figure 1C also shows the catalytic tetrad
comprised of Lys61, Asp146, Lys181, and Glu217 essential
for RNA 20-O-methylation.17,46
Most current docking algorithms treat the protein as a
rigid structure. It is therefore of great importance to inves-
tigate and account for possible structural rearrangements
between the unliganded and liganded states. Figure 1D
shows the variations present in the availableX-ray structures
of the dengue MTase with the average per-residue root-
mean-square distance (rmsd) mapped onto the surface of
dengue MTase in complex with RTP and SAH. The varia-
bility of each residue is encodedby a color gradient from light
gray (0 A˚ rmsd) to yellow (1 A˚ rmsd) to red (g2 A˚ rmsd).
Overall, the structural variability is small andmainly located
on the outer, solvent-exposed surface of the protein. The
RNA cap binding site (Figure 1E) and the SAM binding site
(Figure 1F) show very little structural variability.
The small number of mutations observed in the MT-
ase active sites and the relative rigidity of the enzyme’s active
sites, as witnessed by structural comparisons, make the
MTase binding sites evolutionary and structurally stable
targets for rigid protein molecular docking approaches.
Validation of the Docking and Assay Pipeline. In light of
the small number of known inhibitors of the MTase, we
favored structure-based over ligand-based computational
approaches for the identification of promising inhibitory
compounds. As a first step in validating our approach, we
therefore redocked the cocrystallized ligands RTP and SAH
into their respective binding pockets. These calculations
were performed usingGlide 4.5 in XPmode. The best-scored
resulting poses were found to generally reproduce the bind-
ing mode of the crystallized ligands with heavy atom
rmsd values of 0.74 and 1.33 for RTP and SAH, respecti-
vely (Figure 2).
Despite the fact that the RNA cap site is rather shallow,
the redocked pose of RTP closely resembles that of the
crystallized compound. Notably, the terminal nitrogen of
Lys14 was designated as protonated in our protein prepara-
tion procedure, inducing a slight difference in the position of
the ribose 30-hydroxyl group with regard to the experimental
structure. As the original data contain coordinates for only
ribavirin monophosphate modeled into the Fo - Fc and
2Fo - Fc electron density maps,19 the positions of the RTP
β- and γ-phosphates were predicted, with the γ-phosphate
stabilized by hydrogen bonds to Arg57 and Lys29. Redock-
ing of SAH resulted in a pose similar to that of the SAH
modeled into the electron density maps with a few differ-
ences. As a structural water molecule is absent, the sugar
20-oxygen forms a directH-bond to the backbone nitrogen of
Glu111 rather than a water-mediated interaction as in the
Figure 2. Redocking of RTP and SAH. (A) Crystallized pose of
RTP shown with green carbons. The best redocked pose of RTP is
shown with orange carbons. Surrounding residues undergoing
important interactions are colored light blue. (B) Crystallized pose
of SAH shown with green carbons. The best redocked pose of SAH
is shownwith orange carbons.Main interacting residues are colored
light blue.
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experimental structure. This leads to a tilt in the plane of the
adenine and a loss of the hydrogen bonds to Val132 and
Asp131. Finally, the amino acidmoiety of the SAHmolecule
is well anchored toAsp146, Trp87, Gly86, and Ser56 in a less
strained conformation than that observed in the published
structure. Comparable poses were also obtained for further
known ligands of dengue MTase, GDPMP, SAM, and
sinefungin (data not shown).
Our first effort was to screen a small set of 127000
compounds from the National Cancer Institute Develop-
mental Therapeutics Program (NCI DTP).47 Separate dock-
ing calculations were set up targeting either the RNA cap or
SAM binding site. This study was conducted before the
development of the protocol described in Materials and
Methods and used a somewhat different procedure. Glide
4.5 was used in HTVS mode as a rapid first pass, mainly to
eliminate compounds unlikely to fit to the binding pockets.
Resulting poseswere ranked byGlideScore, and the top 40%
of hits against each binding site (79888 poses for the RNA
cap site and 79946 poses for the SAMsite)were extracted and
redocked using Glide in SP mode. From the SP results, 100
compounds per site were chosen, on the basis of their ranked
GlideScore and visual inspection for plausibility. Of this
compound list, 40 were randomly selected for in vitro testing
for dengue MTase inhibition. Of 36 compounds obtained
from the NCI, nine compounds (Table 1, compounds 1-9)
were found to be inhibitors of theMTase in vitro and will be
further discussed below. With the workflow from computa-
tion to inhibition data in place, we now were ready to screen
the large library of commercially available compounds
previously compiled.
High-Throughput Docking. Both binding sites were next
targeted in molecular docking campaigns using the whole
compound library described above. During the whole pro-
cedure, the two binding sites were treated separately. For
each site, compounds were docked using the funnel strategy
described inMaterials andMethods. After the first screening
step, 1.01  106 compounds for the RNA cap site and
6.72  105 compounds for the SAM site were docked using
the SP protocol; 1.09  105 compounds (RNA cap site) and
7.7 104 compounds (SAMsite) were finally subjected to the
XP procedure, and the 4000 top-ranking molecules from
each binding site were selected for further refinement.
To prevent the lowest-energy pose finally retained from
being influenced by artifacts of minimization on a 3D grid,
each hit molecule was reconstructed and minimized under
different conditions (solvent and force field). These addi-
tional input conformations were docked, and only the best-
scored pose was retained for each compound (3392 com-
pounds for the RNA cap site and 3365 compounds for the
SAM site), discarding isomers along with suboptimal poses.
Candidate Selection and Inhibition Assays.Next, we calcu-
lated additional scores for the docked compounds. First, a
correction term for ligand strain was applied to the Glide-
Score. Second, ligand binding energies were estimated using
the MM-GBSA protocol in Prime version 1.6. The three
scores were subsequently combined into a rank-based con-
sensus score. Final short lists for each binding site were as
follows: the 200 top compounds by consensus and the top
100 compounds by each of the individual scores. These
overlapping criteria resulted in approximately 350 com-
pounds per binding site, which were visually inspected and
prioritized by a jury panel drawn from our institutions,
involving four or five independent jurors. In this step,
different criteria were considered: diversity of chemical
moieties covered by selection, credibility of pose based on
experience in protein X-ray crystallography, similarity to
known inhibitor poses, and presence of one or more key and
additional intermolecular contacts with penalization of very
close distance contacts. The consensus opinion of the jurors
was used to produce a short list of 100 prioritized compounds
for each binding site.
In total, 183 compounds could be obtained from vendors
and were assayed for their ability to inhibit the transfer of a
3H-labeled methyl group from SAM to a short synthetic
GTP-capped RNA oligonucleotide using a scintillation
proximity assay.23 Initial testing for MTase inhibition was
conducted at a single concentration (25 or 100 μM), and IC50
concentrations were then determined for compounds show-
ing substantial inhibition (>40%) in these experiments. Of
the compounds tested, 23 were found to be inhibitors of
DENV2MTase with a spectrum of IC50 values ranging from
2.62 to 37.46 μM (Table 1, compounds 10-32).
Pharmacophore Screening. To retrieve further active com-
pounds from the compound database, we next built a five-
feature pharmacophore hypothesis from the predicted bind-
ing modes of compounds 10, 13, 17, 20, and 32 in the RNA
cap site, reasoning that factors important for ligand binding
may be inferred from the predicted binding poses of hit
compounds. From a 3D superposition of these five com-
pounds, a pharmacophore hypothesis was built using Phase
version 2.5, consisting of pharmacophore features common
to all compounds, resembling the protein-ligand interac-
tions as predicted by docking. The hypothesis consists of five
pharmacophoric features: two aromatic rings corresponding
to (1) the diphenylamino ring stacking with Phe25, (2) the
benzenesulfonatemoiety, aswell as hydrogen bond (3) donor
and (4) acceptor features representing the diamino/amide
moiety interacting with Ser150 and Ser214, and (5) a nega-
tively charged group on the sulfonate moiety, interacting
with Lys29 and Arg212 (Figure 3).
Searching through the compound database resulted in
4200 hits to the pharmacophore, which were subsequently
docked into theRNAcapbinding site and scored usingGlide
XP. To reduce the number of compounds but retain struc-
tural diversity, the 308 most diverse structures with the best
GlideScore were selected on the basis of structural similarity.
Resulting poses were visually evaluated by a jury as de-
scribed above. Eighteen compounds were selected and sub-
sequently tested in vitro as described above.Dose-dependent
inhibition of compounds 33-35 was found to exhibit IC50
values between 4.8 and 14.5 μM (Table 1). Additional
pharmacophore searches of the compound database were
performed using six-feature models derived from either
compound 10 only or the experimental structures of GMP
and RTP in the binding pocket, retrieving 149 and 193
compounds, respectively. Of these, five and four compounds
were selected for in vitro assays as described above, respec-
tively, but no further inhibitors of MTase were found.
Testing Hit Compounds for Unspecific Inhibition. Of the
compounds tested for inhibition, a large fraction exhibited a
Hill coefficient substantially larger than unity. A large Hill
coefficient signifies that a small increase in inhibitor con-
centration leads to an anomalously large change in inhibi-
tion, which can stem from positive ligand cooperativity,
enzymes with equivalent binding sites, but also from non-
ideal, nonspecific behavior that leads to abrupt enzyme inhi-
bition above a critical concentration. One such mechanism
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is aggregation,48 which has been recognized as a major cause
of false positives in high-throughput screening.37,39,49,50 The
addition of the nonionic surfactant Triton X-100 (0.1%) to
the assay solution is often used to prevent the formation of
compound aggregates without influencing enzymatic activ-
ity.While the addition of 0.1%TritonX-100 to our assay did
not abolish inhibition by sinefungin, it had a marked effect
on the majority of the previously chosen compounds.
Of the 35 compounds, 10 retained inhibitory activity (IC50
< 100 μM) in this assay (Table 1, compounds 2, 8-10, 14,
25, 28, 29, 31, and 35) (Figure 4), and 25 were rejected,
exhibiting essentially flat dose-response curves in the pre-
sence of surfactant. The IC50 values of four of the actives
changed e3-fold compared to measurements without sur-
factant: 14.3 μM for 2, 4.47 μM for 9, 7.14 μM for 10, and
4.91 μM for 35. Compound 8 exhibited a 6.18-fold change
with the addition of Triton X-100 but retained an IC50 value
of <10 μM. Compounds 14, 25, 28, 29, and 31 have IC50
values shifted more than 3-fold from the values obtained
without TritonX-100 and do not saturate theMTase enzyme
at the highest inhibitor concentrations (50 and 100 μM) used
in the assays (Figure 4). In Figure 5, the two-dimensional
structures and predicted binding modes are shown for hits
with IC50 values of <10 μM. As these low-micromolar
inhibitors are of particular interest, we performed two addi-
tional experiments to further rule out aggregation as the
cause of inhibition.
First, compounds were assayed after centrifugation at
14000 rpm for 15 min (spin-down assay) to deplete the
solution of any colloid particles. IC50 values obtained under
these conditions are comparable to those obtained in
previous assays with Triton X-100: 6.22 μM vs 9.46 μM
(Cpd 8), 10.52 μMvs 4.47 μM (Cpd 9), 10.68 μMvs 7.14 μM
(Cpd 10), and 4.34 μM vs 4.91 μM (Cpd 35). Second, IC50
values of the compounds were assayed in the presence of 8 or
80 nM MTase. Nonaggregating compounds should be in-
sensitive to this shift in enzyme concentration. Compounds 8
and 10 exhibit relatively small changes in IC50, whichmay be
attributed to experimental variation: 2.3-fold for Cpd 8
[from 3.16 μM (8 nM) to 7.14 μM (80 nM)] and 1.3-fold
for Cpd 10 [from 7.62 μM (8 nM) to 10.24 μM (80 nM)]. The
two remaining compounds, 9 and 35, exhibit larger shifts:
6.4-fold for Cpd 9 [from 3.27 μM (8 nM) to 20.82 μM (80
nM)] and 8.0-fold for Cpd 35 [from 1.32 μM (8 nM) to
10.6 μM (80 nM)].
All 10 active compounds were further assessed by the CF-I
assay to examine their activities against dengue virus repli-
cation. The assay is based on quantitative immunodetection of
dengue virus E protein production in target cells.43 EC50 and
CC50 values are reported in Table 1. Of the tested compounds,
only compounds 14 (EC50=12 μM), 25 (EC50=10.9 μM), and
29 (EC50=50 μM) elicited a response in the cellular assays.
Unfortunately, these compounds also exhibit cytotoxicity in
the midmicromolar range (CC50 values of 22.7, 30.7, and
75.1 μM, respectively).
Modeling of Aggregation Behavior. The unexpected elimi-
nation of many compounds that initially tested positive
due to their action as aggregators prompted us to further
investigate this nonspecific effect. Different computational
approaches that are trained on experimental data to predict
aggregation behavior of chemical compounds have been
published.35,37 For our study, we were interested in how well
similar predictors can be applied to different biological
targets and assay conditions, as training and validation sets
are usually measured under identical conditions. To assess
the transferability of the proposed methods and evaluate
them for our biological target, we have assembled three data
sets of compounds with known aggregation properties in
their respective assays: one based on the data from this work
and two based on previously published large-scale aggrega-
tor detection assays.
We adapted the decision tree proposed by Seidler et al.37 to
molecular descriptors available to us and applied this pre-
dictor to the three test sets (Table S2 of the Supporting
Information). Of the 182 compounds assayed from the large
docking study, 23 initially appeared to be active in vitro. Of
these, one compound was reliably not aggregating (IC50 <
10 μM in the presence of detergent). In this data set, our
decision tree classifier underestimated the overall aggrega-
tion tendency: 15 (65%) of these compounds were predicted
to aggregate. Furthermore, compound 10, the highest-
affinity nonaggregator, was wrongly classified. Overall, the
aggregation tendency was predicted correctly 61% of the
time. Prior to in vitro testing of the 27 compounds selec-
ted from the pharmacophoric search, we ran the same
aggregation predictor against this data set. Six (22%) of
the compounds were predicted to aggregate. Despite the
imperfections of the aggregation predictor, this value was
sufficiently low, compared to the 65% prediction for the
first-round actives, that we were confident that the second-
round compounds would exhibit a significantly weaker
aggregation tendency.
We also evaluated the use of a random forest classifier as
described by Feng et al.35 to predict aggregators in the three
test sets, on the basis of calculated physicochemical proper-
ties. Validation within test sets yielded acceptable false
positive (FP) and false negative (FN) rates (see the diagonal
elements in Table S3 of the Supporting Information), com-
parable to results reported elsewhere.35When random forest
Figure 3. Pharmacophore query. Predicted binding modes of five
compounds, obtained by docking to the RNA cap binding site and
pharmacophore hypothesis created from the predicted binding
modes. Ligands are shown as licorice sticks with colored carbons.
Compound numbers in the legend refer to Table 1. Surrounding
residues are labeled and shown with blue carbons. The pharmaco-
phore hypothesis consists of five features: two aromatic rings
(orange rings), one hydrogen bond acceptor and one donor (red
and blue spheres with arrows, respectively), and one negatively
charged group (red sphere).
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models trained on the full data set for one assay condition
were applied to data obtainedwith other biological targets or
assay conditions (Table S3 of the Supporting Information),
significantly larger false positive and false negative rates
resulted. In summary, we found both predictors to suffer
from a weak ability to discriminate nonaggregating com-
pounds (specificity), particularly when applied to conditions
other than those on which they were trained.
Figure 4. Dose-dependent inhibition of MTase activity. Recombinant NS5 MTase was preincubated with RNA cap analogue and varying
concentrations of inhibitor. After addition of radiolabeled SAM, the transfer of the labeled methyl group to the RNA substrate was quantified
using a scintillation proximity assay. Boxes and dashed lines show data for inhibitionmeasuredwithout addition of TritonX-100, and triangles
and solid lines represent measurements in the presence of 0.1%Triton X-100.Measured counts per minute were normalized by dividing by the
top curve value. (A-J) Inhibition of MTase by compounds 2, 8-10, 14, 25, 28, 29, 31, and 35 (see Table 1).
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Of the 27 compounds selected for laboratory screening
from our pharmacophoric searches, 23 came from models
that included compound 10, the best nonaggregating hit
from the large-scale docking study. It is tempting to spec-
ulate that the reason this data set exhibited the lower fraction
of aggregators among the apparent hits might be that the
nonaggregator found in the earlier search was used to derive
these models. It is not possible to draw this conclusion, given
the limited number of compounds tested. However, the
limited results we have obtained do suggest as a subject for
future investigation that similarity to nonaggregating hits
found in an early screen could be a useful criterion to
incorporate into the development of a second-generation
data set for a later screen.
Retrospective Analysis of Refinement and Rescoring Pro-
cedures. As the exact procedures for compound screening,
refining, and rescoring evolved over the course of this work,
we next performed a coherent retrospective analysis of the
total set of 263 compounds tested for MTase inhibition in
this work. In this analysis, the enrichment of compounds
active in the inhibition assay (2, 8-10, 14, 28, 29, 31, and 35)
was calculated at different steps of the procedure. All
compounds were first passed through the final screening
pipeline: (1) docking to the two binding sites using Glide XP,
(2) refinement using resampled ligand conformations, and
(3) generation of two additional scores (strain-corrected
Glide XP scores and Prime MM-GBSA binding free energy
estimates), as well as a consensus score. We next plot-
ted enrichment of actives before and after the refinement
procedure (Figure 6A). Following the procedure applied in
docking the large compound library, we next compared
enrichment of actives achieved with each of the scores
(Glide XP score of the refined pose, Glide XP score with
internal strain correction, and Prime MM-GBSA binding
free energy) and a consensus score, the rank-based average of
individual scores (Figure 6B). As the number of actives in
this data set is rather small, results from these analyses
necessarily remain indicative, rather than conclusive. Never-
theless, our data suggest that the choice of rescoring scheme
has an impact on the resulting hit list, whereas the impact of
resampling ligand conformations is at least in our system less
apparent.
Discussion
In this work, we describe the outcome of a combined
computational and experimental study searching for novel
inhibitors of dengue NS5 MTase among commercially avail-
able compounds. The viral methyltransferase possesses two
binding sites that can be targeted in principle. However, the
RNA cap site is rather shallow and solvent-exposed, so that
molecules interacting firmly with this site are challenging to
find. The second site binds the ubiquitous cofactor SAM,
which invokes problems of specificity and off-target activity.
For instance, the submicromolar inhibitor of dengue MTase
sinefungin showed promise as an antibiotic, antiviral, and
antiparasitic agent but was not further pursued because of its
severe nephrotoxicity and lack of specificity.51-53
Figure 5. Structure and binding mode of DENV2MTase inhibitors. (A) Structure of DENV2MTase inhibitors with IC50 values of<10 μM.
Compound numbers refer to Table 1, followed by the IC50 value. The predicted target site is given in parentheses (SAM, SAMsite; RNA,RNA
cap site). (B) Crystallized pose of SAH shown as green licorice sticks. Compound 8 is shown with orange carbons, and compound 9 is shown
with pink carbons. (C) Crystallized pose ofRTP shown as green licorice sticks. Compounds 10 and 35 are shownwith orange and pink carbons,
respectively.
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After an initial investigation of the target for suitability, we
launched two virtual screening campaigns. Since little infor-
mation was published about inhibitors of dengueMTase and
their binding mode at the outset of the project, we pursued a
broad-sweeping approach, using molecular docking to screen
a library of several million compounds, rather than a small
focused library. This approach was leveraged by the ready
availability of computing resources through a computing grid
that put more than 300 idle desktop PCs at our disposal.
The hits foundmust be considered starting points. The lack
of an effect in cell-based assays observed with seven of the
compounds may indicate cell permeation or stability pro-
blems, and the compounds (14 and 29) eliciting a response in
these assays show an onset of cytotoxicity close to the half-
maximal efficient dose.Nevertheless, these compounds inhibit
the enzyme in in vitro assays, represent diverse chemotypes
and predicted binding modes due to the study design, and
therefore provide a number of inroads toward more focused
approaches, which are currently under investigation.
Having at our disposal a set of 263 compounds characterized
in inhibition assays, we retrospectively investigated the effect of
decisive steps in our compound selection procedure on the
resulting hit list. Notably, this set is a mixture of actives and
very difficult decoys. All compounds initially docked well to
one of the binding sites, were scored high, and were selected by
a human panel as promising. Thus, absolute enrichment is not
as interesting as are the differences between enrichments
obtained by the various methods. In our system, increased
sampling of starting conformations had no positive effect on
the outcome, indicating that found poses and scores were not
influenced by starting conformation biases. This is a positive
finding. It indicates that the docking approach used here was
not hampered by artifacts introduced by grid-based energy
minimization. The comparison of different scoring procedures
proves to be more interesting. In this case, where we try to
discriminate between compounds scored closely together,
Prime MM-GBSA binding free energies seem to provide the
best enrichment of true actives for this target, closely followed
by the consensus score obtained by the rank average of all three
scoring methods used. Future virtual screening efforts against
dengueor closely relatedMTasesmaybenefit from this finding.
Why did our virtual screening result in the discovery of
many aggregators? Since, in a virtual screen, there is no
opportunity for multiple copies of the ligand to interact with
each other, there must be some other explanation for this
observation. Most likely, the explanation lies in the fact that
the binding sites studied here lend themselves to binding by
long, flat molecules which, due to their shape and aromatic
nature, have a strong tendency to aggregate. If this is correct,
we would expect high-ranking virtual screening candidates
obtained against binding sites more polar or more compact
than those studied here to exhibit a much weaker tendency to
aggregate. To putmatters into perspective, the overall percen-
tage of aggregators picked up in our study (25 of a total of
263 compounds tested, or 9.5%) is lower than that found in
another study, where 19% of randomly chosen druglike
compounds were acting as aggregators.35While docking does
not select against aggregators, it does not select for them,
either.
We tested two computational methods to predict com-
pound aggregation to see if nonspecific binders can be identi-
fied before the in vitro stage. When a trained classifier is
applied to a set of compounds assayed under different condi-
tions, the level of misclassification is significantly increased in
a manner independent of the training set used, making these
predictions of limited practical use. As the tested models take
compound properties but not the conditions of the assay into
account, this is not surprising. Interestingly, the decision tree
model proved to be more transferable than the random forest
models.
As described earlier, we were confident, on the basis of the
results of aggregation prediction, that the second-round
compounds would exhibit a lower fraction of aggregates than
the first-round actives. Laboratory results were in accordwith
this expectation. Of 27 compounds assayed, only two (7.4%)
turned out to be aggregators. Of the three apparent hits, one
(33%) turned out tobe a nonaggregating hit, compared toone
of 23 compounds (4.3%) from the large-scale docking screen.
Apparent hits in the phamacophoric screen were considerably
more enriched in nonaggregators than the hits from the large-
scale docking screen.
As the majority of compounds selected from the pharma-
cophoric searches came frommodels that included compound
10, the best nonaggregating hit, it is tempting to speculate that
similarity to nonaggregating hits found in an early screen
could be auseful criterion to incorporate into the development
Figure 6. Enrichment of active vs inactive inhibitors. The number of actives recovered is plotted on theY-axis against the size of the database
screened on the X-axis. (A) Enrichment obtained with standard Glide XP docking (XP, orange) and with the best-scored Glide XP pose after
increased sampling of starting conformations (XXP, black). (B) Enrichment obtained with individual scoring schemes and consensus score:
Glide XP Score (XXP, black), Glide XP Score with internal strain correction (XPþstrain, red), Prime MM-GBSA (MM-GBSA, blue), and
rank-based consensus score (Consensus, green).
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of a second-generation data set for a later screen, whichwould
be a worthwhile topic for a future study.
In summary, our results, as well as the observations of
others, do not suggest the broad use of computational meth-
ods in filtering out aggregators for two reasons. First, avail-
able methods lack accuracy and transferability between
different assay conditions. Second, a number of active ligands
andmarketed drugswere found to be bona fide aggregators in
inhibition assays37 but pharmacologically active at concen-
trations lower than that at the onset of aggregation. This
strongly suggests that the right way to control aggregation is
by preventing it from interfering with the inhibition assay
wherever possible. Aggregation prediction has a role, how-
ever, in the smart selection of limited follow-up compound
sets from primary hits.
The cost of a screening campaign is a major concern,
especially when neglected diseases are being targeted. We
explored the extent to which in vitro experiments can be
replaced by comparably inexpensive computational analysis.
Roughly 5.5million compoundswere initially considered, and
263 molecules were assayed in the laboratory. Of these, 10
were initially characterized as inhibitors. When only com-
pounds exhibiting IC50 values of <10 μM and a Hill coeffi-
cient ofe2.5 were selected, four of the 10 compounds remain
(8-10 and 35) as potentially interesting inhibitors. To further
rule out aggregation as their mode of action, we applied two
additional assays to these candidates. While the spin-down
assay validated all four compounds, only two of the com-
pounds (8 and 10) did not exhibit marked shifts in IC50 when
the enzyme concentration was changed 10-fold, strengthening
the case for these two compounds in particular.
Compounds showing inhibition in the higher micromolar
range (inparticular, compounds 2 and 28) areworth following
up, as well, but may reveal themselves to be insufficiently
specific in further tests. The future use of compounds 8-10
and 35 (Table 1 and Figure 6) should be considered in light of
their properties. The object of this investigation was to find
tool compounds and starting points for further optimization,
using a set of commercially available compounds. While the
compounds identified are not druglike in their properties and
may not readily enter cells, they can serve as tools for
cocrystallization or as starting points for scaffold hopping
and bioisostere replacements. Interestingly, compound 8 exhi-
bits a striking similarity to ATA, a low-micromolar inhibitor
of DENV2 MTase found in a docking study published while
this manuscript was being prepared.24 Compound 9 is cur-
rently under further investigation in a program directed at
identifying SAM competitive inhibitors.
In conclusion, the outcome of our study demonstrates that
iterative combination of virtual screening and validation in the
laboratory is a viable approach for the discovery of new hits
against drug targets and can serve as a model for similar
endeavors against other diseases. Computing power is becom-
ing increasingly inexpensive or even free, as volunteers openly
welcome requests for support of projects with a charitable
aspect. Indeed, a number of grid-based drug discovery efforts
have recently been launched.54-56 However, we strongly be-
lieve that the key to success is not access to virtually unlimited
computing capacity, but rather establishing a tight interaction
cycle between the computational and experimental parts of the
project even before the first calculation takes place.
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2.2. PREDICTION OF NON-SPECIFIC INHIBITORS
2.2 Prediction of Non-Specific Inhibitors
2.2.1 Introduction
High-throughput (HTS) and virtual screening (VS) are commonly used techniques to discover
novel hit compounds in the early phase of drug discovery. A major limitation of both methods
is the fact that numerous false positive hits are obtained when compounds are tested exper-
imentally. One contributing factor are nonspecific or ’promiscous’ inhibitors which affect the
assay read-out but do not specifically inhibit the target protein.68 One common mechanism
for such promiscous behaviour is the formation of colloidal aggregates of organic molecules
which non-specifically inhibit enzymes.69 Those compounds behave strangely with a weak
structure-activity relationship, steep dose-response curves, poor selectivity and non-competitive
inhibition.70 To overcome this issue, numerous experimental techniques have been developed
including high-throughput assays to detect detergent sensitivity or measure particle forma-
tion.71,72,73 In addition, different computational approaches that are trained on experimental
data to predict aggregation behavior of chemical compounds have been published.71,69 Those
methods are based on calculated physicochemical properties of the compounds and use super-
vised machine learning techniques to classify specific from non-specific inhibitors. They have
been shown to predict aggregation with good accuracy within one dataset. It was unclear,
however, how well such predictors can subsequently be transferred to different biological targets
and assay conditions.
In our study to identify novel inhibitors for the dengue virus methyltransferase,74 numerous
compounds that initially tested positive were eliminated due to their action as aggregators as
identified by an assay measuring detergent sensitivity. This prompted us to further investigate
this nonspecific effect. The overall results of this study are summarized in Section 2.1 and
detailed information about the employed method and the obtained results are given here.
For our study, we were interested in how well similar predictors can be applied to different
biological targets and assay conditions, as training and validation sets published in the literature
are usually measured under identical conditions.
2.2.2 Materials and Method
Test Sets
(A) Dengue MTase test set (DenV): The 263 compounds tested during the screening for dengue
MTase inhibitors described above were classified as 237 non-aggregators and 25 aggregators,
based on detergent sensitivity in the inhibition assay described previously. Compounds losing
their inhibitory activity in presence of 0.1% Triton-X 100 were classified as aggregators, whereas
compounds either showing no inhibition or retaining their inhibitory activity in the presence of
detergent were classified as non-aggregators.
(B) Medium-size test set (Med): Data on the aggregation behavior of 1030 molecules has
been published75,71,73 and the experimental results, based on dynamic light scattering and
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a high-throughput detergent sensitive inhibition assay against AmpC β-lactamase, have been
made available online (http://shoichetlab.ucsf.edu). From the 1030 molecules, all compounds
showing ambiguous aggregation behavior were removed, leading to a set of 653 non-aggregators
and 263 aggregators.
(C) AmpC β-lactamase test set (AmpC): Recently, a set of 70563 molecules from the
National Institutes of Health Chemical Genomics Center (NCGC) library was assayed in a high-
throughput screen for detergent-dependent inhibition of AmpC β-lactamase.73 Out of the
70563 molecules tested, 1204 were found to be unambiguously detergent-sensitive. From this
dataset, obtained from http://shoichetlab.ucsf.edu, 402 non-aggregators and 82 aggregators
were randomly picked as an additional test set.
Decision-tree based Aggregation Prediction
For a rapid attempt to predict aggregation behavior, we assembled a decision tree similar to
that which Seidler, et al. derived using recursive partitioning.69 Since we did not have access
to machinery for generating the same set of descriptors, we employed descriptors that had
similar meaning and used an iterative manual process to optimize the cut-off parameters for
our own substitute descriptors to give the best agreement against the 111-compound training
set supplied by Seidler et al. Table A.1 compares the descriptors and parameters we used with
those of Seidler et al.
Random Forest based Aggregation Prediction
Compounds were predicted as aggregators or non-aggregators, based on calculated physico-
chemical descriptors, using a Random Forest (RF) model.76 All compounds were prepared in
their neutral form using the LigPrep protocol. For each compound, all 251 physicochemical
descriptors available in MOE version 2007.09 (Chemical Computing Group, Montreal, Canada)
were calculated. For each test set described above, 70% of the compounds were randomly
selected to train a RF model, which was then tested on the remaining 30% of the data. To
determine average false positive and negative rates, 100 iterations were performed per test set,
each time producing 1000 unpruned trees from subsets of the 251 descriptors. To correct for
the imbalanced dataset, the majority class was down-sampled during training of the RF model.
For cross-validation between test sets, a RF model was trained on all compounds of a test set
and then used to predict aggregators in the other two test sets. 100 iterations were carried out
for each test set as described above. All calculations were performed using R version 2.5.16.77
2.2.3 Results and Discussion
To assess the transferability of the proposed methods and evaluate them for our biological
target, we have assembled three data sets of compounds with known aggregation properties in
their respective assays. We evaluated both a decision tree based method adapted from Seidler
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et al.69 and a Random Forest based classifier as proposed by Feng et al.71 Both are described
in Section 2.2.2.
Decision-tree based Aggregation Prediction
The decision tree proposed by Seidler et al.69 was adapted to molecular descriptors available to
us. Subsequently, this predictor was applied to the three test sets. Table 2.1 shows the results
obtained on the training set of Seidler et al. using descriptors with the parameters shown in
Section A.1 of the Appendix. With this decision tree, we achieved a prediction accuracy of
86.5%, which is not as good as the 93.4% accuracy reported by Seidler et al., but which was
useful for our purposes. 43.2% of the compounds in the training set were aggregators; we
predicted 42.3% aggregators, indicating that our false-positive and false-negative rates were
approximately equal.
Table 2.1: Results of the decision-tree based prediction of aggregation behavior for three independent test
sets.
Training Med AmpC DenV
FP 0.17 0.35 0.29 0.21
FN 0.11 0.03 0.11 0.06
Sensitivity: TP/(TP+FN) 0.88 0.95 0.87 0.93
Specificity: TN/(TN+FP) 0.84 0.74 0.75 0.82
Of the 182 compounds assayed from the large docking study, 23 initially appeared to be
active in vitro. Of these, one compound was reliably not aggregating (IC50 < 10 µM in
the presence of detergent). In this data set, our decision tree classifier underestimated the
overall aggregation tendency: 15 (65%) of these compounds were predicted to aggregate.
Furthermore, compound 10, the highestaffinity nonaggregator, was wrongly classified. Overall,
the aggregation tendency was predicted correctly 61% of the time.
Random Forest based Aggregation Prediction
We also evaluated the use of a random forest classifier as described by Feng et al.71 to predict
aggregators in the three test sets. Validation within test sets yielded acceptable false positive
(FP) and false negative (FN) rates (see diagonal elements in Table 2.2), comparable to results
reported elsewhere.71
However, when random forest models trained on the full data set for one assay condition
were applied to data obtained with other biological targets or assay conditions (see off-diagonal
elements in Table 2.2), significantly larger false positive and false negative rates resulted. In
summary, we found both predictors to suffer from a weak ability to discriminate nonaggregating
compounds (specificity), particularly when applied to conditions other than those on which they
were trained.
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Table 2.2: Results of Random Forest-based prediction of aggregation behavior for three test sets. Trans-
ferability of method is evaluated by performing all nine combinations of training and test set.
test set
Med AmpC DenV
aver stdev aver stdev aver stdev
tr
a
in
in
g
se
t
M
ed
FP 0.23 0.03 0.04 0.01 0.08 0.02
FN 0.25 0.05 0.94 0.02 0.76 0.05
Sensitivity: TP/(TP + FN) 0.76 0.50 0.55
Specificity: TN/(TN + FP ) 0.77 0.56 0.76
A
m
p
C
FP 0.88 0.01 0.42 0.05 0.95 0.01
FN 0.03 0.01 0.39 0.11 0.06 0.04
Sensitivity: TP/(TP + FN) 0.82 0.60 0.43
Specificity: TN/(TN + FP ) 0.53 0.59 0.50
D
en
V
FP 0.59 0.03 0.39 0.02 0.38 0.06
FN 0.09 0.01 0.62 0.04 0.37 0.22
Sensitivity: TP/(TP + FN) 0.82 0.50 0.63
Specificity: TN/(TN + FP ) 0.61 0.50 0.63
2.2.4 Conclusion
To summarize, our results show that the accuracy of current computational approaches to
predict compound aggregation is limited. In particular, both predictors suffer from a weak
ability to discriminate nonaggregating compounds (specificity). In addition, the transferability
of a predictor trained on one dataset to a different target set was investigated. The results
suggest that prediction of aggregation behavior is not transferable between assay conditions or
biological targets. Aggregation seems to be not only a property of the compound itself but
rather depends on numerous other factors in the assay.
Thus, our results, as well as the observations of others, do not suggest the broad use
of computational methods in filtering out aggregators but suggest to limit false-positive hits
based on aggregation by directly preventing them from interfering with the inhibition assay.
However, aggregation prediction might have a significant role in the clever selection of follow-
up compounds from primary hits for which a particular classifier could be trained.
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2.3 Experimental Characterization of Novel Inhibitors
2.3.1 Introduction
Based on a multi-stage virtual screening campaign for identifying inhibitors of the dengue
methyltransferase, ten compounds were found to specifically inhibit dengue MTase with IC50
values in the low µM range. In order to further characterize the identified inhibitors, a proce-
dure for the production of purified recombinant dengue MTase was setup in-house, additional
experimental assays were conducted and crystallization trials were performed on the five most
promising compounds.
Compounds were followed-up using two inhibition assays to determine their inhibitory effect
both on the 2’O and the N7 methylation reaction. In addition, an isothermal titration calorime-
try based assay was developed in order to determine binding of the compounds to the MTase.
Observing inhibition in two additional assays and determine compound binding could further
help to validate their specific interaction with the dengue MTase.
2.3.2 Materials and Method
Protein Expression and Purification
Methyltransferase Plasmid The gateway vector pDEST14 which encode
DENV2MTase Wild Type has been provided by Prof. Bruno Canard.1
Transformation of E. coli
For plasmid isolation After mutagenesis PCR and DpnI digestion, 5 µl were used to
transform 50 µl of competent E. coli TOP10 cells. Cells were thawed on ice, supplemented
with plasmid DNA and incubated for 20 min on ice. Subsequently, cells were heat shocked for
90 sec at 42 °C in a thermomixer and incubated on ice for another 2 min. After addition of
250 µl of LB medium, the reaction mixture was incubated for 1 h at 37 °C with shacking and
subsequently plated onto LB agar plates containing 34 µg/ml chloramphenicol and 100 µg/ml
ampicillin for selection of positive transformants. Some transformed clones were chosen for
plasmid isolation in order to sequence their insert and verify the nucleotide sequence.
LB Media: 10 g Bacto-Tryptone, 5 g Bacto-Yeast extract and 10 g NaCl in 900 ml H2O.
Adjust volume to 100 ml with H2O and sterilize by autoclaving and store at RT.
For protein expression Prior to each protein expression experiments for preparative pur-
poses, fresh transformants have been used to inoculate overnight cultures. Transformants have
been generated as previously described (see for plasmid isolation part). Instead of E. coli TOP10
cells, Rosetta BL21(DE3) pLysS cells are used in this case.
1Prof. Bruno Canard, AFMB, CNRS/University Aix-Marseille, 163 Avenue de Luminy, 13288 Marseille,
France
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Recombinant Protein Expression
Wild Type DENV2MTase Following transformation, a single colony was grown in
50 ml of LB medium at 37 °C overnight supplemented with the proper antibiotic. The culture
was diluted 1/25 in the final volume of TB medium containing 34 µg/ml chloramphenicol and
100 µg/ml ampicillin and incubated with shacking at 37 °C until an O.D. of 0.5 was reached.
After cooling down the cells to room temperature, expression was induced with 0.5 mM IPTG
and incubated overnight at 25 °C. Cells were harvested by centrifugation at 5000g for 10 minutes
at 4 °C. The bacterial pellet was resuspended in lysis buffer and stored at -20 °C.
TB Phosphate: Dissolve 2.31 g KH2PO4 (i.e. 0.17 M) and 12.54 g K2HPO4 (i.e. 0.72 M)
in 90 ml H2O. Adjust volume to 100 ml with H2O and sterilize by autoclaving and store
at RT.
TB Media: 12 g Bacto-Tryptone, 24 g Bacto-Yeast extract and 4 ml glycerol in 900 ml
H2O. Sterilize by autoclaving and cool to <60 °C. Add 100 ml of sterile 10 x TB phosphate
and store at RT.
Lysis Buffer: 50 mM TrisHCl pH 8, 0.3 M NaCl, 5% Glycerol, 0.1% Triton X-100.
SDS-PAGE Electrophoresis To estimate protein solubility and expression level, SDS-
PAGE electrophoresis have been performed. 12% acrylamide resolving gels were prepared and
protein samples were mixed with 5 x SDS + 1 x DTT loading buffer and boiled at 95 °C for
5 min before loading. Electrophoresis run was carried out at room temperature applying 40 mA
per gel. After electrophoresis, gels were stained with Coomassie solution and finally washed
in Destaining solution. The same procedure was also used to evaluate the purity of protein
fractions after purification.
Running Buffer: 25 mM TrisHCl pH 8.3, 0.2 M Glycine, 0.1% SDS
Coomassie solution: 100 ml acetic acid, 400 ml ethanol, 500 ml H2O, 2.5 g Coomassie
BB R250
Destaining solution: 50 ml acetic acid, 200 ml ethanol, 750 ml H2O
Crude Extract Preparation
Cell disruption The thawed cell suspension was placed on ice, resuspended in Lysis
Buffer with a homogenizer and complemented with a tablet of EDTA-free complete protease
inhibitor cocktail (Roche) and 10 µg/ml DNase prior to cell disruption. 2 rounds of microflu-
idizer at 12000 psi were performed to break the cells.
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Ultracentrifugation Cells debris was removed by centrifugation at 35000 rpm for 30 min
at 4 °C (Beckman, Ti70 rotor). The supernatant was sterile filtered (0.45 µm, Millipore) before
loading it on a Nickel-NTA affinity column.
Chromatographic Purification
The purification of DENV2MTase include two steps: Ni-NTA affinity and size exclusion
chromatography. All chromatographic steps were performed at 4 °C using an A¨KTA purifier
(GE Healthcare) and monitored at 280 nm.
Ni-NTA affinity chromatography The filtered crude extract was loaded on a Histrap
HP 5 ml column. The purification parameters are listed below:
Flow rate: 1 ml/min
Column Equilibration: 3 CV
Wash Out Unbound Samples: 3 CV
For WT MTase:
1st elution step: 6 CV of 15% Buffer B
2nd elution step: 15 CV of 45% Buffer B
Buffer A: 50 mM TrisHCl pH 8, 0.3 M NaCl, 20 mM imidazole
Buffer B: 50 mM TrisHCl pH 8, 0.3 M NaCl, 0.5 M imidazole
For Mutants:
1st elution step: 6 CV of 6% Buffer B supplemented with 10% glycerol
2nd gradient elution step: 21 CV of 6-60% of Buffer B supplemented with 10% glycerol
Buffer A: 50 mM TrisHCl pH 8, 0.5 M NaCl, 20 mM imidazole 10% glycerol
Buffer B: 50 mM TrisHCl pH 8, 0.5 M NaCl, 0.5 M imidazole 10% glycerol
15 ml fractions were collected and analyzed by SDS-PAGE. DENV2MTase containing frac-
tions were pooled and concentrated using Vivaspin 20, MWCO 10k centrifugal concentrator
(Sartorius) to a final volume of 15 ml for size exclusion chromatography.
Size exclusion chromatography Size exclusion chromatography was carried out with
a preparative HiLoad 26/60 Superdex 75 prep grade column (GE Healthcare). 15 ml sample
was injected to the column and eluted with 50 mM Bicine pH 7.5, 0.8 M NaCl, 10% glycerol,
1 mM DTT with a flow rate of 1 ml/min. 15 ml fractions were collected and analyzed by SDS-
PAGE. Fractions containing pure DENV2MTase were pooled and concentrated using Vivaspin
20, MWCO 10k centrifugal concentrator (Sartorius) and depending on the following steps stored
on ice, at 4 °C or at -20°C.
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Isothermal Titration Calorimetry Experiments
Sample Preparation
Protein Buffer Exchange Isothermal titration calorimetry (ITC) is very sensitive and
small buffer mismatches can generate large heats of dilution with each injection, which can
mask heat changes from ligand binding. For this reason, protein buffer exchange has to be
performed, the usual technique is dialysis. Unfortunately, this method could not be applied due
to protein stability problems. Therefore, as an alternative, analytical SEC chromatography has
been used with Superdex 75 10/300 GL column (GE Healthcare).
Due to solubility limitations of some ligands and stability problems of some mutants, different
buffers have been tested for ITC experiments.
 50 mM Bicine, 0.8 M NaCl, 10% Glycerol, 1 mM DTT, pH 7.5
 20 mM Tris, 0.2 M NaCl, pH 7.5, 5 mM TECEP
 20 mM Tris, 0.2 M NaCl, 10% Glycerol, pH 7.5, 5 mM TECEP
 20 mM Tris, 0.2 M NaCl, 10% Glycerol, pH 7.5, 5 mM TECEP 10% DMSO
Ligand Preparation Selected inhibitors for ITC experiment are listed in Table 2.3.
Ligands have been weighted and solubilized in the buffer used for protein size exclusion chro-
matography (see protein buffer exchange paragraph).
Table 2.3: Compounds selected for ITC, from the list of inhibitors identified by the screening approach
described in Section 2.1.
a IC50 values are for the 2’O reaction.74
Name ID MW IC50 a predicted soluble
(g/mol) (µM) binding pocket
NSC14778 1 288 1.51 SAM yes
ZINC02750651 8 566 2.81 RNA cap no
ZINC02911543 7 377 7.56 RNA cap yes
NSC140047 2 303 8.78 SAM yes
ZINC03369470 9 365 4.80 RNA cap no
To establish ITC experiment and to evaluate impact of mutations on the wild type
DENV2MTase a number of ligands with known inhibitory effect have been used, as summarized
in Table 2.4.
Table 2.4: Ligands used for establishing ITC assays and for evaluating effects on binding affinity of single
point mutations.
Abbrev. Name MW Spectroscopic Binding
Parameters Pocket
GTPγS Guanosine-5’-(γ-thio)-triphosphate, Lithium salt 539.24 g/mol 252 nm, 13700 cm−1 M−1 RNA cap
RTP Ribavirin-5’-triphosphate, Sodium salt 484.14 g/mol 220 nm, 7700 cm−1 M−1 RNA cap
SAH S-Adenosyl-L-homocysteine 384.40 g/mol 260 nm, 15400 cm−1 M−1 SAM
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Protein and Ligand Quantification The concentration of proteins and binding lig-
ands in solution was determined, according to the Lambert-Beer law, by measuring the ab-
sorption at the corresponding wavelength. For potential inhibitors, the molecular extinction
coefficient is unknown. Therefore, the concentration was calculated from the weighted amount
which have been weighted on a high-precision laboratory balance.
Cell Loading and Syringe Filling
The reference cell usually contains water or buffer and does not need to be changed after
every experiment.
Prior to loading the sample cell and injection syringe, the protein and ligand solution are
filtered (0.22 µm, Millipore), degassed to remove residual air bubbles and cooled down. The
cell reactant, i.e. the protein solution in our case, is added to the sample cell of the calorimeter
using a long needle glass syringe. 2 ml of protein solution is prepared to fill the cell which has
a volume of 1.3-1.5 ml. Any excess solution remaining in the reservoir is removed.
The injection syringe is filled with approximately 300 µl of ligand solution and a purge/refill
command is performed to push out potentially present air bubbles. 1 ml of solution is required
to properly fill the injection syringe and to fully remove air bubbles.
ITC Measurement
All the measurements were performed at constant temperature of 22 °C. The first injection
was set to a very small volume of 3 µL because heat disparities can appear due to a injection
volume error arising from backlash in the drive screw mechanism of the syringe. To avoid this
problem we also run a short down motion of the plunger to absorb the backlash from the up
motion of the purge/refill command.
The chosen time interval between two consecutive injections was 200 sec in order to ensure
that thermodynamic equilibrium was reached prior to the next injection.
Experimental parameters
Number of injections: 30
Run temperature: 22 °C
Reference power: 15 µcal/s
Initial delay: 200 s
Syringe solution: Ligand concentration depending on experiment
Cell solution: Protein concentration depending on experiment
Stirring speed: 300 rpm
Injection volume: 10 µL
Duration of injection: 20 s
Spacing: 200 s
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Data analysis Data analysis was performed using an ITC analysis software based on
ORIGIN 7.0. Blank experiments have been performed to validate the measured binding curves.
The heat of dilution from the “end plateau” of the sigmoidal curve was used as reference data
and the average of these values was subtracted from the entire sample data. After subtraction,
thermodynamic parameters were determined with the “One Set of Sites” curve fitting model.
Inhibition Assays
2’O MTase Inhibition Assay Inhibition of 2’O MTase activity by inhibitor candidates was
assayed in vitro based on an assay adopted from Luzhkov et al.56
Briefly, 0.5 µM of purified recombinant dengue MTase in 50 mM Tris (pH 7.5) and 5 mM
DTT was premixed with an inhibitor candidate at 20 or 100 µM final inhibitor concentration.
The reaction was started by a premix of 5 µM [3H]SAM (0.3 - 2 µCi) and 0.3 µM short capped
RNA 7MeGpppAC5 in the same buffer. The reaction was incubated at 30 °C for 3 h. To stop
the reaction, 14 µl samples were spotted into 96 wellplates containing 100 µl of 20 µM ice
cold SAH. Samples were transferred to glass-fiber filtermats and were washed twice with 0.01
M ammonium formate (pH 8.0) twice with water and once with ethanol. Scintillation fluid was
added and RNA methylation was measured using a scintillation counter.
N7 MTase Inhibition Assay Inhibition of N7 MTase activity by inhibitor candidates was
assayed in vitro based on an assay adopted from Milani et al.57
0.5 µM of purified recombinant dengue MTase in 50 mM Tris (pH 7.0), 50 mM NaCl
and 2 mM DTT was premixed with an inhibitor candidate at 16 or 80 µM final inhibitor
concentration. The reaction was started by a premix of 80 µM [3H]SAM (0.3 - 2 µCi) and
0.3 µM radiolabeled capped DENV1−351 RNA in the same buffer. The reaction was incubated
at 22 °C for 1 h. To stop the reaction, samples were heated to 70 °C for 5 min. Samples were
transferred to glass-fiber filtermats and were washed twice with 0.01M ammonium formate (pH
8.0) twice with water and once with ethanol. Scintillation fluid was added and RNA methylation
was measured using a scintillation counter.
Protein Crystallization and Soaking
Crystals of the dengue MTase were grown by vapor diffusion at room temperature. 1 µl or
0.5 µl of protein solution at 18.5 mg/ml was mixed with 0.5 µl or reservoir solution and was
allowed to equilibrate for two weeks in a hanging drop setup.
Different crystallization buffers were screened in 24 wellplates, consisting of ammonium
sulfate (1.6 to 2.1 M or 1.9 to 2.4 M) and 0.15 M sodium citrate (pH 5.3 to 5.6). Crystals
suitable for X-ray diffraction were obtained under the following conditions: 1.9 M ammonium
sulfate, 0.15 M sodium citrate at pH 5.2 and 5.3 in a mixture of 1 µl protein and 0.5 µl
crystallization buffer. Subsequently crystals were soaked for 1 h in 2.5 mM inhibitor solution
containing 5% DMSO to enhance compound solubility.
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All samples crystallized in P3121 symmetry, space group 152 with cell dimensions a=118,
b=118, c=56 and angles=90°, 90°, 120°. Structures were solved by molecular replacement
using the published structure 1R6A. Statistics are given in Table 2.5.
Table 2.5: Statistics of data collection of X-ray structures where the crystals were soaked with inhibitors.
Space group P3121
Cell parameters (A˚) a = b = 117.739, c = 56.019
Resolution range (A˚) 49.10 - 2.67
No. of total reflections 88020
No. of unique reflections 12761
2.3.3 Results and Discussion
Inhibition Assays
To further characterize the active compounds, to validate their specific interaction with the
dengue MTase and to distinguish between inhibitory activity of the two catalyzed reactions,
additional experimental assays were performed in a collaboration with Prof. Bruno Canard.
To that end, inhibition assays for both the 2’O and the N7 reactions were further refined and
selected inhibitor candidates were assayed. All results are given in Figure 2.1.
Figure 2.1: Inhibition of the dengue MTase 2’O reaction (A) and the N7 reaction (B) by selected com-
pounds.
Compound NSC14778 inhibits the 2’O reaction at low concentrations (3% activity at 100
µM, 19% at 20 µM). In addition, at 80 µM in also inhibits the N7 reaction with a reduction of
nativ methylation activity to 27%. At 16 µM concentration, no inhibition of the N7 reaction
is observed. The fact that this compound inhibits both reaction is an indication that it binds
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either to the SAM binding pocket or the RNA binding groove. This was correctly predicted by
the original docking calculations which selected this compound based on docking to the SAM
pocket.
Compound ZNC02750651 inhibits the 2’O reaction at low concentrations (2% activity at
100 µM, 5% at 20 µM). No inhibition of the N7 reaction is observed for this compound. This
suggests that this compound binds to the RNA cap pocket which should influence only the 2’O
reaction. Again, this was correctly predicted by the docking calculations which selected this
compound based on docking to the RNA cap pocket.
Sinefungine, a known inhibitor of SAM dependent methyltransferases, was used as a positive
control and shows strong inhibition at low concentrations with a reduction of native methylation
activity to 20% and 0% for the 2’O and the N7 reaction.
All other compounds, do not show inhibition of either reaction in the assays present.
Crystallization
Obtaining X-ray crystal structures of inhibitors bound to the MTase would further our under-
standing of the important interactions governing protein-inhibitor binding and could validate
predicted binding modes. This would be highly beneficial for future structure-based compound
optimizations. Therefore, in a collaboration with Prof. Bruno Canard, we started efforts to
obtain X-ray crystal structures of the inhibitors bound to the MTase.
Using the previously described purified protein of the dengue MTase domain, single crystals,
suitable for X-ray diffraction were obtained using a hanging drop setup (Figure 2.2) and were
subsequently used for soaking experiments with active compounds obtained by the previously
described inhibitor screening efforts.
Figure 2.2: Crystals of the dengue MTase suitable for X-ray diffraction.
Structures were solved of crystals soaked with compounds NSC14778, NSC14047 and
ZINC02911543 with resolutions from 2.5 to 3 A˚. Samples containing the active compounds
40
2.3. EXPERIMENTAL CHARACTERIZATION OF NOVEL INHIBITORS
aurintricarboxylic acid (ATA)57 and sinefungine were of too low quality.
The structures of NSC14778 and NSC14047 show clearly absence of inhibitor molecules. In
both structures, one molecule of SAH was observed in the SAM binding pocket. The structure
of ZINC02911543 seems more promising with observed additional electron density. However,
the actual data does not permit to say for sure that something else than SAH is bound to the
MTase.
Isothermal Titration Calorimetry
Isothermal titration calorimetry (ITC) based binding assays were performed for selected inhibitor
candidates. For assay validation three compounds with known inhibitory effect were assayed,
i.e. GTPγS and ribavarin triphosphate, binding to the RNA cap pocket, as well as SAH, binding
to the SAM pocket. For all compounds, a clear binding curve was observed.
Of the inhibitors, only three compounds (NSC14778, ZINC02911543, NSC140047) were
soluble at the concentrations necessary for ITC measurements, whereas the two compounds
ZINC02750651 and ZINC03369470 were insoluble. All ITC results are shown in Figure 2.3.
Binding of the three assayed compounds could not be confirmed. A possible reason for this is
discussed below.
Flaviviral MTases are often found to co-purify with one molecule of SAH or SAM bound
to the protein. As neither of these co-factors are added during expression, purification or
crystallization, SAH must originate from E.coli and co-purify with the methyltransferase.44,78
The fact that SAH stays bound to the protein during affinity and size exclusion chromatography
purification steps indicate that SAH either binds very tightly to the protein or has a very slow
off rate. In addition, Lim et al.58 measured the content of bound SAH to the protein under
assay conditions and found that 70% of MTase molecules were occupied by a SAH or SAM
molecule.
Therefore, the ITC assay for compounds binding to the SAM pocket might be problematic
since during a typical injection cycle (i.e. 3 min in our assay) no exchange between inhibitor
and SAH is expected to occur. This is also indicated by the low stoichiometry (i.e. N = 0.3;
expected N = 1.0) obtained for binding of SAH to wild type MTase.
Compound NSC14778 and NSC140047 are predicted to bind to the SAM pocket. In fact,
for NSC14778 it was experimentally found that it inhibits both the N7 and the 2’O reaction,
which indicates that it binds to the SAM pocket. Therefore, for those compounds, the ITC
measurement might not be reliable.
Compound ZINC02750651 on the other hand, is the only inhibitor where inhibition assays
indicated binding to the RNA cap pocket. This would be an excellent candidate for comparison,
however, this compound is insoluble in the concentrations necessary for the ITC assay.
2.3.4 Conclusion
Of the ten active compounds identified through our virtual screening approach, five promising
compounds were selected for further follow-up experimental assays. Of those, we were able to
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Figure 2.3: ITC measurements of inhibitors. (A) Three inhibitor candidates obtained from virtual screen-
ing efforts (red, blue, green) in comparison to GTPγS (black). (B) GTPγS individually to show the
approximate sigmoidal curve shape. (C) Ribavarin triphosphate (blue) in comparison to GTPγS (black) as
positive controls.
confirm the inhibitory activity of the two most active compounds from our previous assays on
the 2’O reaction. In addition, we were able to show that one of those compound inhibits also
the N7 reaction.
The selected compounds were further used in crystal soaking experiments. For three of
them, crystals suitable for X-ray diffraction were obtained. However, in two cases, the inhibitor
candidate was not present in the structure whereas in the third case, additional electron density
is observed, but the results do not permit to give a clear answer about the presence of an
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inhibitor.
In addition, an assay based on isothermal titration calorimetry was developed to determine
binding of a compound to the MTase. Of the selected compounds, three were assayed by ITC
whereas the other two were insoluble under the necessary assay conditions. However, binding
of the three assayed compounds could not be confirmed. One possible cause might be a pre-
occupied SAH binding pocket which renders ITC based measurements unfeasible for compounds
binding to the SAM pocket. To further quantify this effect, HPLC based determination of the
SAH content and the quantification of the SAH exchange rate based on a pulse-chase experiment
are necessary.
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Chapter 3
Computational Analysis of the Methyltransferase
Reaction
3.1 Introduction
Although flaviviral methyltransferases are attractive drug targets,61,79 little is known about the
mechanism underlying their function. The enzyme is known to catalyze two distinct reactions
on an RNA cap structure with a specific sequence,60,53,50 but so far the mechanism of the two
methylation reactions at an atomistic level is not known. Thus, to obtain a better understanding
of the molecular basis of this disease related enzymatic function, we aim at the elucidation of
the underlying mechanisms using computational methods.
The enzyme is known to catalyze two distinct methylation reactions on an RNA cap struc-
ture with a specific sequence, but so far neither the structure nor the mechanism of the two
methylation reactions are known at an atomistic level. Thus, we have modeled the protein
in complex with the RNA for the 2’O reaction, based on available template structures and
published mutagenesis data.
In order to characterize the underlying chemical reactions, high level ab initio electronic
structure calculations were performed on model systems approximating the biological reactions.
Reaction pathways and geometries were investigated and we found that the protein environment
substantially lowers the reaction barrier, mediated by an active site lysine residue.
Based on the modeled complex structures, we applied a computational alanine scanning
protocol employing molecular dynamics simulations and mixed QM/MM calculations in order
to identify protein hot-spots and to further characterize the effect of mutations on different
aspects of the system. We observed the influence of protein single point mutations on the
geometric arrangement between methyl donor and acceptor, on the binding affinities of the
SAM co-factor and on the reaction energetics.
Based on the results obtained by the computational alanine scanning procedure, previously
uncharacterized protein residues were selected for further characterization using both computa-
tional and experimental methods.
Furthermore, to understand the RNA sequence specificity of the enzyme, we used the
modeled structure in complex with different RNA cap structures of mutated sequences. Based
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on molecular dynamics simulations, protein residues critical for RNA sequence specificity of the
enzyme were identified and the possibility for forming an intramolecular hydrogen bond between
distinct RNA elements was observed, whose absence might be detrimental for RNA sequence
specificity.
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3.2 Modeling of the Protein-RNA Complex
Since no structure of a flaviviral methyltransferase in complex with a short capped RNA is
available, we have modeled the structure of the RNA bound DENV MTase, based on avail-
able template structures and published mutagenesis data, in order to investigate RNA binding,
protein flexibility and enzymatic reaction mechanism.
3.2.1 Method
RNA Structure Modeling
For the 2’O-methylation, the VP39 MTase structure was used as a template. The structure of
VP39 MTase (PDB code: 1av6) was superposed to the structure of DENV NS5MTase (PDB
code: 2p41). The cap-guanosine and the first phosphate was taken from 2p41 and manually
combined with the following two phosphates and the first three translated nucleotides obtained
from 1av6. In an iterative manner, the obtained structure was manually adjusted and optimized
in implicit solvent using the software MacroModel until a geometrically suitable structure was
reached. This structure showed key protein-RNA interactions, similar to the interactions in 1av6,
and no clashes between the protein and the RNA molecules were present. The nucleotides were
replaced to yield the naturally occurring RNA sequence GpppAGU. The structure was solvated
in a rectangular box of TIP3P waters. The structure was further optimized, first the solvent,
then the whole system was heated to 300K and equilibrated for 300 ps before free molecular
dynamics was performed. The structure stayed stable during 20 ns of MD simulation.
Ligand-Induced Structural Rearrangements
System Setup Structural rearrangements of the protein upon ligand binding was investi-
gated using MD simulations. Two simulation systems were setup. First, the protein without
ligands (apo simulation), second, the protein with SAM and GpppAGU RNA, modeled as de-
scribed before (holo simulation).
The systems were solvated in a rectangular box of pre-equilibrated TIP3P waters and neu-
tralized with chloride and potassium ions (0.15 M concentration). In the presence of the fixed
solutes, the solvent was first minimized for 5000 steps of steepest descent (SD) minimization
followed by an equilibration step of 300 ps at 298 K. Then the entire system was subjected
to 5000 steps of SD minimization and equilibrated for 1 ns. Free molecular dynamics was
then performed for 20 ns. All minimization and molecular dynamics runs were performed using
NAMD (version 2.7b2)80 with the CHARMM27 all-atom force field.81,82 MD simulations were
performed at constant temperature (i.e. 298 K) and pressure (i.e. 1 bar) using particle-mesh
Ewald (PME) electrostatics and a timestep of 1 fs.
For both systems, two individual free MD runs were carried out, using the same starting
conformation, but different random seeds.
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Analysis of Differences For each of the four MD runs, a frame was extracted every 100
ps, leading to 200 frames per trajectory.
When comparing two different runs, an all-against-all comparison was performed, where
each frame extracted from the first trajectory was optimally superposed against all the frames
from the second trajectory individually, leading to 40000 superpositions. For each superposition,
a per-residue root mean square distance (RMSD) was calculated and the per-residue average
over all superpositions was reported. All analysis was performed using the OpenStructure
framework.83
This comparison was performed within one set (e.g. both runs without ligands) and between
the two sets (i.e. one run without ligands, one with ligand). To obtain ligand induced differences,
the results obtained within the apo simulations was subtracted (or divided) from the results
obtained between the holo and apo simulations.
3.2.2 Validation of the Structural Model
Since no structure of a flaviviral methyltransferase in complex with a short capped RNA is
available, we have modeled the structure of the RNA bound DENV NS5MTase in order to
investigate RNA binding, protein flexibility and enzymatic reaction mechanism, as described
in section 3.2.1. The resulting conformation is shown in Figure 3.1 and structural stability is
shown in Figure 3.2.
Figure 3.1: Modeled structure of RNA bound to dengue NS5MTase: (A) overall structure, (B) binding
site. The RNA is shown in orange, SAM is shown in green.
For the N7 reaction, it has been shown that it can only take place on RNA templates
comprising at least 74 nucleotides (nt) of the viral 5’ UTR sequence.50 However, the underlying
reason is unclear. This RNA stretch is folded into a three-dimensional structure which might
significantly influence the interaction with the MTase. A size comparison between the MTase
and the first 74 nt of RNA is given in Figure 3.3. Therefore, it was not possible to obtain a
structural model of a short RNA cap showing a conformation suitable for the N7 methyltransfer
reaction.
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Figure 3.2: Stability of the modeled protein-RNA complex in MD simulations, measured by the rmsd
of the complex (top panel) and the relevant distances (bottom panel) between methyl donor and acceptor
(red) and between proton donor and acceptor (black).
Figure 3.3: Schematic representation of a model of the complex between the DENV MTase (red) and the
first 74 RNA nucleotides (blue) which are essential for the N7 reaction.
3.2.3 Ligand-Induced Structural Rearrangements
For analyzing structural rearrangements of the protein upon ligand binding, molecular dynamics
simulations have been performed on two different systems: (A) the NS5MTase without any
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ligands (apo system), (B) the NS5MTase in complex with SAM and RNA (holo system),
modeled as described in Section 3.2.2.
Structural changes have been analyzed by comparing per-residue RMSDs between two MD
simulations of the apo system with RMSDs between one MD simulation of the holo system
and one of the apo system (see Section 3.2.1 for more detail). This comparison is shown in
Figure 3.4 and the difference was mapped onto the protein structure as shown in Figure 3.5.
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Figure 3.4: (A) Ligand induced structural changes, plotted as the per-residue RMSD difference between
two sets (black: different sets (apo/holo), red: same sets (apo/apo)). (B) Subtraction (black) and division
(blue) of the two curves in (A).
Overall, structural rearrangements are small, especially within the SAM and GTP binding
pocket as well as in the active site. Most prominent, but still small structural changes are
observed in helix A3 (residues 31 to 41) and the C-terminal loop structure (residues 239 to
249). Both substructures are interacting with each other, and the former is directly involved
in binding of the 3’ end of the RNA. Upon ligand binding, a slight movement away from the
protein core is observed.
For the loop covering the SAM pocket (residues 99 to 106) it has been hypothesized that it
could form a flap, which was present in an open and a closed form.60 Although this loop shows
higher flexibility, our calculations do not support this hypothesis, since no significant difference
was observed between the apo and the holo simulations.
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Figure 3.5: Ligand induced structural changes mapped onto the protein structure. (A) Rmsd difference
(i.e. holo-apo) shown from white (difference: 0.0) to red (difference: 1.5). (B) Rmsd ratio (i.e. holo/apo)
shown from white (ratio: 1.0) to red (ratio: 2.5).
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3.3 Methylation of Guanosine N7 and Adenosine 2’O in Model
Systems
In order to characterize the chemical reactions involved in the guanosine N7 and the adenosine
2’O methyl transfer reactions, ab initio electronic structure calculations were performed on
model systems approximating the biological reactions.
Based on minimized structures of the reactants, the transition state and the products we
have explored geometric arrangements, energetics of the reaction and transfer of charges both
for the 2’O and the N7 reaction.
3.3.1 Method
Three different model systems were generated to study reaction energetics on simplified systems.
One for the N7 reaction and two for the 2’O reaction where the proton acceptor was modeled
either by a lysine like molecule or a water molecule.
Reaction energy profiles were calculated for the model system. All geometry optimizations
and energy calculations were performed in Gaussian0384 using the B3LYP85 density functional
theory method and the 6-311++G(d,p) basis set.86 Solvation effects were included both during
optimization and energy calculations based on the C-PCM implicit solvent model.87 For all
model systems, the reactant and the product complexes were fully optimized in implicit solvent
first. Then, using the obtained structures, transition state optimization with QST388 was carried
out. For all fully optimized structures, vibrational analyzes were performed on the same level of
theory in order to confirm the nature of stationary points and to compute thermal corrections
to the Gibbs free energy. From the obtained energies, a free energy profile for the reaction
was created. In addition, point charges were computed based on natural bond orbital (NBO)
analysis.89
3.3.2 Geometry
For this study, model systems were used to study the methyl transfer reaction catalyzed by
flaviviral methyltransferases using quantum chemical calculations. Two model systems were
designed, one for the 2’O reaction and one for the N7 reaction.
The model for the 2’O reaction consists of the following three groups: (1) a model of the
methyl donor SAM, which is truncated one carbon away from the reactive sulfur atom. (2) a
model of the methyl acceptor ribose moiety, which is truncated two carbon atoms away from
the reactive 2’ hydroxy group. (3) A model of the side chain of Lys181, truncated one carbon
atom away from the Nζ, which acts as a proton acceptor. The geometry optimized structures
of this model are shown in the top panel of Figure 3.6.
The model of the N7 reaction consists of two groups: (1) the same model of the methyl
donor SAM. (2) an N-Methylimidazole as a model of the methyl acceptor guanosine. For this
reaction, no proton needs to be abstracted, thus, those two groups are sufficient to describe
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Figure 3.6: Optimized structures of reactants, products and transition states obtained by ab initio calcu-
lations for the three different model systems: (top) 2’O reaction with a NH2CH3 molecule to act as proton
acceptor, (middle) 2’O reaction with a water molecule as proton acceptor, (bottom) N7 reaction
the reaction. The geometry optimized structures of this model are shown in the bottom panel
of Figure 3.6.
In addition, a third model was designed to investigate the uncatalyzed 2’O reaction. This
model consists of the same groups as the model for the catalyzed 2’O reaction, except that
the proton acceptor moiety is replaced by a water molecule that accepts the transferred proton.
To stabilize this water molecule, two additional waters were added, which are hydrogen bonded
to the active water but do not directly participate in the reaction. The geometry optimized
structures of this model are shown in the middle panel of Figure 3.6.
Figure 3.6 shows the optimized structures of all model systems for reactant state (left row),
transition state (middle row) and product state (right row). In all reactions, the methyl groups
are transferred in a SN2 type nucleophilic substitution reaction, where the lone pair of the
acceptor group attacks the positively charged methyl group. This reaction involves a inversion
of the methyl group with a planar methyl conformation in the transition state. In all reactions,
a nearly linear arrangement between the donor, the transferring methyl group and the acceptor
is observed. Geometric parameters were extracted from the optimized structures as shown in
Figure 3.7 with the values are given in Table 3.1 and Table 3.2 for the 2’O and the N7 model
systems, respectively.
The distance between the methyl donor and acceptor atoms show similar behaviors for all
reactions. Starting from the reactant complex, this distance is shortened in the transition state
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Figure 3.7: Schematic representation of the model systems for the 2’O and the N7 reaction. All reported
distances and angles are indicated in read labels. For the 2’O reaction, only the system with a NH2CH3
molecule as proton acceptor is shown since all geometric parameters are directly transferable.
Table 3.1: Geometric parameters obtained from minimized structures for model systems of the 2’O reac-
tion. Either NH3CH3, mimicking Lys181 (left columns), or a water molecule (right columns) is present in
the model system to act as a proton acceptor.
NH2CH3 proton acceptor H2O proton acceptor
reactants transition product reactants transition product
complex state complex complex state complex
d1 (A˚) 1.82 2.39 4.00 1.82 2.39 3.82
d2 (A˚) 4.78 4.36 5.43 4.82 4.36 5.25
d3 (A˚) 2.96 1.97 1.43 2.99 1.97 1.44
d4 (A˚) 0.99 1.04 1.72 0.98 1.00 1.49
d5 (A˚) 2.86 2.66 2.77 2.80 2.62 2.52
d6 (A˚) 1.87 1.63 1.05 1.83 1.63 1.03
a1 (°) 176.9 177.0 176.2 177.7 177.1 175.7
a2 (°) 174.3 175.0 174.9 173.5 171.2 174.1
Table 3.2: Geometric parameters obtained from minimized structures for model systems of the N7 reaction.
reactants transition product
complex state complex
d1 (A˚) 1.82 2.30 3.98
d2 (A˚) 4.94 4.40 5.44
d3 (A˚) 3.12 2.11 1.47
a1 (°) 177.4 180.0 176.6
by 0.54 A˚ and 0.42 A˚ for the N7 and the 2’O reaction, respectively. For the product state, a
significant increase in the afore mentioned distance is observed compared to the reactant state.
In the N7 reaction, it is increased by 0.5 A˚ and in the 2’O reaction by 0.65 A˚. Thus, a significant
compression of the structure in the transition state is observed which facilitates the reaction
process by lowering the energy barrier (as discussed below).
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For both models of the 2’O reactions, the methyl group is transferred onto a hydroxy moiety,
yielding a methoxy group as the result of the reaction. Since a protonated methoxy moiety in
instable, the proton needs to be abstracted by a proton acceptor. In the protein environment,
this is performed by the Nζ atom of Lys181 which was shown to be present in a deprotonated
state.64,65 In the uncatalyzed reaction, however, this would be performed by a water molecule.
The geometry of both model systems for the 2’O reaction are very similar for the reactant and
the transition state. For the product state, however, significant differences can be observed.
For the uncatalyzed reaction, the distance between the methyl donor and acceptor is decreased
by 0.18 A˚. In addition, the distance between the proton donor and acceptor is reduced by 0.25
A˚ which leads to a smaller distance between the proton donor and the transferred hydrogen
atom, reduced by 0.23 A˚. Thus, the transferred hydrogen atom is more strongly bound to the
methoxy group which indicates that the water molecule is a worse proton acceptor compared to
the model of the lysine. This effect is even stronger when the two additional water molecules
are removed from the model system (i.e. leaving only the reactive water molecule). In that
case, no proton transfer is observed yielding a protonated methoxy group in the product state
(data not shown).
3.3.3 Energy Profiles
Figure 3.8 shows the Gibbs free energies calculated as described in Section 3.3.1 for all geome-
tries of the optimized structures of all model systems for reactant (left), transition (middle) and
product state (right). Table 3.3 summarizes all free energies.
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Figure 3.8: Gibbs free energy profile for reactants, product and transition state, obtained from ab initio
model system calculations for the N7 (orange) and the 2’O methyltransfer reaction. For the 2’O reaction,
either NH3CH3, mimicking Lys181 (black), or a water molecule (blue) is present in the model system to act
as a proton acceptor.
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Table 3.3: Summary of the Gibbs free energies for reactants, product and transition state, obtained from
ab initio model system calculations for the N7 and the 2’O methyltransfer reaction. For the 2’O reaction,
either NH3CH3, mimicking Lys181, or a water molecule is present in the model system to act as a proton
acceptor.
2’O reaction 2’O reaction N7 reaction
(NH2CH3 proton acceptor) (H2O proton acceptor)
reactant complex 0.00 0.00 0.00
transition state 17.59 21.43 13.74
product complex -16.91 -6.34 -23.49
For both the 2’O as well as the N7 system, the calculations reveal that the reactions are
exergonic processes where the product state is energetically significantly lowered compared to
the reactant state with an energetically unfavorable transition state in between. The Gibbs free
energy difference between product and reactant is -23.5 kcal/mol for the N7 reaction and -16.9
kcal/mol for the 2’O reaction. For the transition state, an energy barrier of 13.7 kcal/mol
and 17.6 kcal/mol is observed for N7 and 2’O, respectively. From experimentally determined
kcat value,
90 the activation barrier of the 2’O reaction can be estimated using transition state
theory. This yields an estimated activation barrier of 15.2 kcal/mol for the 2’O reaction. Thus,
the calculated activation energy barriers are in a similar range indicating that the postulated
SN2 type methyl transfer reaction is energetically feasible.
Comparing the N7 to the catalyzed 2’O reaction, shows that the product state of the N7
reaction is lowered by 6.6 kcal/mol and the reaction barrier is reduced by 3.9 kcal/mol.
Comparing the catalyzed 2’O methyl transfer reaction to the uncatalyzed one, a significant
reduction of the product state free energy can be observed when going from modeling the
reaction in water to modeling the protein catalyzed reaction. The product state energy is
lowered by 10.6 kcal/mol. In addition, the reaction energy barrier is lowered by 3.8 kcal/mol.
This corresponds to a reaction rate enhancement of ∼700 times.
In summary, for the 2’O reaction, the data suggests the importance of a lysine residue,
representing Lys181 in the active site of the protein, which acts as a proton acceptor and signif-
icantly stabilizes the product state and reduces the activation barrier compared to the reaction
in aqueous solution. The N7 methyl transfer reaction on the other hand, has a significantly
lower energy barrier to overcome in aqueous solution and is thus more likely to occur without
direct protein interactions. In conclusion, the data agrees well with the mechanistic hypothesis,
where the 2’O reaction needs direct involvement of protein residues, whereas the N7 methy-
lation does not need direct contact with the protein as long as the two reactants are in close
proximity.66
3.3.4 Energy Landscapes
Figure 3.9 shows the two dimensional potential energy landscapes computed at the B3LYP/6-
311++G(d,p) level, for the model system of the N7 (left panel) and the 2’O reaction (right
panel). Enthalpies of partially optimized systems are reported. They were computed on a grid
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using two correlated reaction coordinates. First, the distance between the acceptor atom and
the transferring methyl group (x-axis; distance d3 in Figure 3.7). Second, the distance between
the acceptor and the donor atom (y-axis, distance d2 in Figure 3.7).
Figure 3.9: Two dimensional potential energy landscape for model systems of the N7 (left) and the 2’O
reaction (right). Energies are shown for two reaction coordinates: (x-axis) distance between the acceptor
atom and the transferring CH3 group; (y-axis) distance between the acceptor and the donor atoms.
Although, the absolute values do not fully correspond to the afore mentioned Gibbs free
energies obtained from fully optimized systems, they clearly indicate important features of
the potential energy landscape. For both reactions, two distinct minima are shown. One
corresponding to the reactant state with acceptor-methyl group distances above 2.5 A˚ and an
energetically more favored minimum corresponding to the product state with acceptor-methyl
group distances around 1.5 A˚. The two minima are connected by a saddle point corresponding
to the transition state. When the system is moved along its minimum energy pathway from the
reactants through the transition state to the products, the system first compresses where the
donor-acceptor distance (y-axis) reduces from ∼5 A˚ to ∼4.5 A˚ and then expands again to its
product state with a donor-acceptor distance of ∼5.5 A˚. Thus, this compression significantly
reduces the activation barrier compared to a direct movement without changing the donor-
acceptor distance. This needs to be considered when evaluating effects on the reaction energy
barrier caused by external perturbations, like single point mutations of the protein environment.
3.3.5 Point Charges
Partial charges obtained from natural population analysis89 performed on the afore mentioned
optimized model structures are shown in Figure 3.10. The charges are mapped onto the N7
and the 2’O systems using a color gradient from red (-0.8e) to green (0.8e). Partial charges
for substructures of the model systems are summarized in Table 3.4.
The computed point charges clearly indicate that the methyl group is transferred as a cation
with an overall change in the partial charges of the full SAM group of 0.98e for the N7 and
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Figure 3.10: NBO point charges from ab initio calculations mapped onto the model systems for the N7
(left) and the 2’O reaction (right). The color gradient ranges from -0.8 (red) to 0.8e (green).
0.99e for the 2’O reaction. The effect is more pronounced for the 2’O reaction, where the
charge is localized more strongly on the transferred methyl group compared to the N7 reaction,
yielding a higher charge on the methyl group both in the transition state and in the product.
In comparison, for the N7 reaction, the charge is more distributed between donor, methyl
group and acceptor, yielding a higher charge on SAM and the N-methylimidazol moiety in the
transition state.
In the product state of the N7 reaction, the charge is located predominantly on the carbon
atom at position 2 of the N-methylimidazol moiety with a point charge of 0.30e, whereas for
the 2’O reaction, the charge is located to a large extend on the proton which was transferred
to the model lysine moiety, with a charge of 0.46e.
3.3.6 Two Step Reaction
The catalytic lysine residue is envisioned to function as proton acceptor in two distinct ways:
First, a two step mechanism involving the following steps: (1) deprotonation of the 2’-hydroxy
group by the catalytic lysine residue prior to the methyl transfer reaction. This leads to the
formation of a 2’-oxyanion. (2) transfer of the methyl group onto the 2’-oxyanion.
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Table 3.4: Partial charges computed by natural bond orbital analysis for substructures of the model
systems for the 2’O and the N7 reaction. The following substructures were used: (SAM) model of SAM
without the reactive methyl group, thus consisting of CH3SCH3, (CH3) reactive methyl group, (ribose)
model of the ribose moiety without the reactive methyl group, (lysine) model of the lysine side chain for
the 2’O reaction, (guanine) model of the guanine acceptor for the N7 reaction.
2’O reaction N7 reaction
SAM CH3 ribose lysine SAM CH3 guanine
reactants 0.92 0.07 0.05 -0.05 0.90 0.08 0.01
TS 0.41 0.32 0.12 0.15 0.48 0.25 0.27
products 0.01 0.34 0.03 0.63 0.01 0.19 0.80
Second, a concerted mechanism where during the methyl transfer, the proton is transferred to
the the catalytic lysine. Thus, prior to the reaction, the proton acceptor does not deprotonate
the 2’-hydroxy group but steers its orientation. NMR experiments indicate that the latter
mechanism is used in the enzymatic reaction of vaccinia virus mRNA cap specific 2’O MTase
VP39.64
Geometry optimized model structures are in agreement with the latter mechanism, where
the proton is bound to the ribose model compound both in the reactants and the transition
state. The distance between the 2’-oxygen atom and the proton is 0.99 A˚ and 1.04 A˚ for
reactants and transition state, respectively.
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Figure 3.11: Potential energy curve for the proton transfer obtained by moving the proton from the ribose
proton donor (H-N distance: 1.9 A˚) to the lysine proton acceptor (H-N distance: 1.0 A˚). (A) the system
is in the reactant state (methyl group bound to the SAM donor). (B) the system is in the product state
(methyl group is bound to ribose acceptor).
To confirm this, a linear scan was performed by moving the proton from the 2’O hydroxy
group to the Nζ of the lysine model moiety. During the scan, the methyl group was kept in
the reactant state and thus bound to the SAM model compound. Therefore, the endpoint of
the scan yields a 2’-oxyanion. The energy profile is shown in Figure 3.11A. The calculations
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estimate the costs of the proton transfer prior to the methyl transfer to ∼10 kcal/mol. The
profile increases monotonically and no significant minimum was observed which would stabilize
the oxyanion conformation.
It should be noted that when the methyl group is moved to its product state, i.e. bound to
the ribose moiety, minimization of the structure yields a spontaneous proton transfer with no
observable barrier in between. This was confirmed by a linear scan of the proton position when
the methyl group is in its product state (Figure 3.11B). This scan estimates the energy gain for
the proton transfer in the product state to ∼20 kcal/mol.
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3.4 Impact of Single Point Mutations
Mutagenesis experiments can greatly help in understanding the mechanism of how an enzyme
catalyzes a reaction by identifying the effect of single point mutations on different aspects of
the system.
Although the effect on methylation activity of numerous single point mutations of DENV
MTase were investigated experimentally, the underlying cause of a reduced methylation activity
is still unknown since only relative methylation activity compared to wild type (WT) was mea-
sured. However, a reduced activity could have many different reasons, e.g. reduced substrate
binding affinities, incorrect arrangement of the methyl-donor/acceptor pair, increased reaction
energy barrier, misfolding of the protein.
Thus, we investigate the effect of mutations at an atomistic level using computer simula-
tions. Therefore, numerous mutagenesis experiments were performed in-silico. To validate the
simulations and to determine the contribution of each studied residue to the enzyme’s func-
tion, different observables were computed from the simulations and compared to experimental
measurements of methylation activity.
Based on a computational alanine scanning procedure, hot-spot residues were identified
which significantly influence the reaction by modulating the geometric arrangement between
methyl donor and acceptor, the methyl donor binding affinity or the reaction energy barrier.
Selected hot-spot residues were further analyzed both computationally and experimentally in
order to gain a better understanding of their role in the enzyme’s function.
3.4.1 Materials and Methods
Plasmid and Primers
Mutants of the dengue MTase were produced based on the wild type plasmid described pre-
viously. Primers were designed according to the instructions from Stratagene manual and
synthesized by Microsynth AG. The used primers are listed in Table 3.5.
Site Directed Mutagenesis
Mutants were prepared with Quick change II XL Site-Directed Mutagenesis (Stragagene), ac-
cording to manufacturer instructions. 20 ng of plasmid DNA encoding Wild Type MTase were
added to 50 µl of a mixture containing 0.2 mM of dNTPs, 6% of DMSO, 1x PfuTurbo Buffer,
0.2 µM of each primer and 2.5 U of PfuTurbo DNA polymerase. DNA was amplified with
18 cycles of PCR: denaturing at 95 °C for 50 sec, annealing at 55 °C for 50 sec, extension at
68 °C for 7 min. After mutagenesis PCR, 1 µl of DpnI restriction enzyme was added to the
amplification reaction and incubated for 1 h at 37 °C to digest non-mutated supercoiled dsDNA.
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Table 3.5: Primers used for the production of DENV2MTase mutants.
Primer Name Tm 5’ - sequence - 3’
DENV2*Glu-79 F 74.7 GAA GGG AAA GTA GTG GAG CTC GGT TGC GGC
DENV2*Glu-79 R 82.4 GCC GCA ACC GAG CTC CAC TAC TTT CCC TTC
DENV2*Asn-79 F 73.8 GAA GGG AAA GTA GTG AAC CTC GGT TGC GGC
DENV2*Asn-79 R 80.9 GCC GCA ACC GAG GTT CAC TAC TTT CCC TTC
DENV2*Ser-79 F 74.7 GAA GGG AAA GTA GTG AGC CTC GGT TGC GGC
DENV2*Ser-79 R 82.4 GCC GCA ACC GAG GCT CAC TAC TTT CCC TTC
DENV2*Thr-88 F 71.2 GGC AGA GGA GGC TGG ACC TAC TAT TGT GGG
DENV2*Thr-88 R 75.6 CCC ACA ATA GTA GGT CCA GCC TCC TCT GCC
DENV2*Asn-88 F 69.6 GGC AGA GGA GGC TGG AAC TAC TAT TGT GGG
DENV2*Asn-88 R 74.0 CCC ACA ATA GTA GTT CCA GCC TCC TCT GCC
DENV2*Asp-217 F 68.0 CGA AAC TCC ACA CAT GAT ATG TAC TGG GTA TCC
DENV2*Asp-217 R 66.6 GGA TAC CCA GTA CAT ATC ATG TGT GGA GTT TCG
DENV2*Asn-217 F 72.2 CGA AAC TCC ACA CAT AAC ATG TAC TGG GTA TCC
DENV2*Asn-217 R 63.8 GGA TAC CCA GTA CAT GTT ATG TGT GGA GTT TCG
DENV2*Gln-217 F 73.4 CGA AAC TCC ACA CAT CAG ATG TAC TGG GTA TCC
DENV2*Gln-217 R 65.6 GGA TAC CCA GTA CAT CTG ATG TGT GGA GTT TCG
DENV2*Phe-219 F 67.8 CCA CAC ATG AGA TGT TCT GGG TAT CCA ATG CC
DENV2*Phe-219 R 67.8 GGC ATT GGA TAC CCA GAA CAT CTC ATG TGT GG
DENV2*His-219 F 71.4 CCA CAC ATG AGA TGC ACT GGG TAT CCA ATG CC
DENV2*His-219 R 65.8 GGC ATT GGA TAC CCA GTG CAT CTC ATG TGT GG
Protein Expression and Purification
Small scale expression and solubility screening of DENV2MTase Mutants 50 ml
cultures of each mutant have been cultivated in the same conditions as the wild type (see above).
2 ml aliquots have been withdrawn before induction and after induction at following time points:
2 h, 4 h, 6 h and overnight. Extracted cell culture samples were centrifuged at 13000 rpm for
10 min and the supernatant was discarded. The remaining cell pellet was resuspended in 1 x
Bugbuster + 200 µg/ml lysosyme + 10 µg/ml DNase solution, and incubated 20 min at room
temperature with shaking. After centrifugation with 13000 rpm for 10 min, supernatants were
collected and treated for SDS-PAGE analysis.
Protein Purification Mutated dengue MTase was expressed and purified as described in
Section 2.3.2.
Isothermal Titration Calorimetry
Binding of S-adenosyl-L-methionine (SAH) and Guanosine-5’-(γ-thio)-triphosphate
(GTPγS) was determined using isothermal titration calorimetry as described in Section 2.3.2.
Computational Mutagenesis
Computational mutagenesis were performed using the following two distinct protocols.
Post-processing Protocol In the post-processing protocol, only simulations of the wild
type MTase are performed. From a molecular dynamics trajectory of the unmutated WT protein-
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ligand complex solvated in a cubic box of TIP3P water molecules, snapshots are extracted every
8 ps to obtain a representative ensemble of complex structures. For each snapshot the protein
residue under consideration is mutated as follows. First, all side chain atoms which are not
common in the WT and the mutated residue are removed. Second, all missing atoms of the
mutated residue are added based on standard internal coordinates as implemented in CHARMM.
Third, coordinates of the mutated residue are optimized in vacuum for 150 steps of steepest
descent minimization. The structure obtained like this is used for further analysis.
Full MD Protocol In the full MD protocol, MD simulations both of the WT and the
mutated protein-ligand complex are performed. Starting from the same initial structure as for
WT MTase, all atoms not belonging to the protein, the RNA or the SAM molecule are removed.
The protein residue under consideration is mutated using the same procedure as described in
the post-processing protocol. The structure obtained after energy minimization, is subsequently
used as the input structure for MD simulations using the same protocol as for WT MTase.
Molecular Dynamics Simulation
Molecular dynamics simulations are performed on the native complex as well as on single point
mutants thereof, containing the dengue MTase, the capped RNA fragment of the form Gpp-
pAGU and the methyl donor SAM.
For MD simulations, the initial starting conformation of the WT complex was obtained after
MD based equilibration of the modeled complex structure as described in Section 3.2.1. For
consistency, all atoms not belonging to the protein, the RNA or the SAM molecule are removed.
Using the same structure, mutations were introduced as described before.
The systems were solvated in a rectangular box of pre-equilibrated TIP3P91 waters and
neutralized with chloride and potassium ions (0.15 M concentration). In the presence of the
fixed protein-ligand complex, the solvent was first minimized for 200 steps of steepest descent
(SD) minimization. Second, the solute was minimized for 100 steps of SD minimization in the
presence of fixed solvent in order to eliminate all unfavorable steric contacts possibly introduced
by mutations. Subsequently, the solvent was further minimized for 1000 SD minimization steps
followed by 2000 steps of full system minimization. Then, the solvent was equilibrated for
1 ns at 298 K. Subsequently, the entire system was equilibrated for 3 ns. Free molecular
dynamics was then performed using two different approaches. First, a single long trajectory was
computed for 20 ns. Second, ten individual short trajectories of 2 ns length were computed
using the same input structure, but a different random number seed for the langevin thermostat.
All minimization and molecular dynamics runs were performed using NAMD (version 2.7b2)80
with the CHARMM27 all-atom force field.81,82 MD simulations were performed using periodic
boundary conditions at constant temperature (i.e. 298 K) and pressure (i.e. 1 bar) using
particle-mesh Ewald (PME) electrostatics and a timestep of 1 fs. Cutoffs for van der Waals
(vdW) interactions were set to 12 A˚ using a switching scheme.
For the RNA and SAM ligands, published CHARMM force field parameters were used.92,93,94
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Trajectory Analysis
For the analysis of MD trajectories, snapshots were extracted from MD simulations. For WT
and mutated MTase using the full MD mutation protocol, protein-ligand complex structures
were extracted every 8 ps, yielding a total of 2500 snapshots for each system, obtained either
from one long simulation or from ten individual simulations. Subsequently, all snapshots were
analyzed as described below.
Binding Affinities Free energy of binding (∆Gbind) between the SAM co-factor and the
protein were computed using the MM-GBSA32 method.
In the MM-GBSA method, ∆Gbind is calculated as the ensemble average of the free energies
of the complex system (Gcomp) and the unbound protein (Gprot) and ligand (Glig) as follows:
< ∆Gbind >=< Gcomp > −(< Gprot > + < Glig >) (3.1)
The configurational ensembles of the free protein and ligand were generated from a single
simulation of the complex by extracting the unbound protein and ligand structures.
The binding free energy is computed as the sum of the molecular mechanics gas phase
binding energy (∆EMM ), the solvation free energy (∆Gsolv) and entropic contributions (T∆S).
∆Gbind = ∆EMM +∆Gsolv − T∆S (3.2)
where ∆EMM consists of electrostatic and van der Waals interactions:
∆EMM = ∆Eele +∆EvdW (3.3)
The solvation free energy is separated into polar (∆Gpolar) and non-polar (∆Gnon−polar)
contributions, where former are approximated using the analytical generalized Born (GB) GB-
MV2 model95,96 implemented in CHARMM and latter using the solvent accessible surface area
(SASA):
∆Gsolv = ∆Gpolar +∆Gnon−polar (3.4)
∆Gsolv = ∆GGB +∆GSASA (3.5)
The entropic contributions (T∆S) consist of translational, rotational and vibrational con-
tributions:
∆S = ∆Strans +∆Srot +∆Svib (3.6)
∆Strans and ∆Srot are functions of the mass and moments of inertia, whereas ∆Svib can
be calculated from a normal mode analysis. Since calculations of ∆Svib are computationally
very expensive, entropic contributions were calculated only every 25th snapshot, using normal
64
3.4. IMPACT OF SINGLE POINT MUTATIONS
mode analysis as implemented in CHARMM on a fully minimized structure.
The relative free energy of binding between a mutant and the wild type complex (∆∆G) is
computed as follows:
∆∆G = ∆Gmutant −∆GWT (3.7)
Structural Rearrangements Structural rearrangements of mutant MTases were quan-
tified using the following three measures, based on trajectories obtained from the full MD
mutagenesis protocol.
 relative donor-acceptor arrangement, defined as follows:
r = ∥rCH3−O(WT )− rCH3−O(mutant)∥+ ∥rO−N (WT )− rO−N (mutant)∥ (3.8)
where rCH3−O is the distance between the transferring methyl group and the acceptor
2’-oxygen atom and rO−N is the distance between the acceptor 2’-oxygen atom and the
proton accepting Nζ atom of Lys181.
 relative RMSD of SAM compared to WT.
 relative RMSD of the RNA cap compared to WT. The RNA cap included the cap nu-
cleotide and the following two translated nucleotides.
Intrinsic pKa of Active Site Lysine The intrinsic pKa value of the proton acceptor
residue Lys181 was calculated for each mutant using the Poisson-Boltzmann electrostatic pro-
gram APBS (version 1.3.0).97 Every 10th snapshot extracted from multiple short simulations
generated using the full MD mutagenesis protocol was subjected to the analysis.
Reaction Energy Barriers Reaction energy barriers were computed using molecular dy-
namics based umbrella sampling in a mixed quantum mechanics/molecular mechanics
(QM/MM) system. The approximate DFT method, self-consistent charge density functional
tightbinding (SCC-DFTB98,99) was used for the QM level as implemented in CHARMM. The
CHARMM27 all-atom force field was used for the MM level.
As starting structures, four snapshots were extracted from a standard MD simulation of the
WT system. Mutations were introduced using the post-processing alanine scanning protocol
described before. The system was set up in an analogous fashion as for MD simulations.
The QM system included all atoms of SAM, the side chain of Lys181 and the first translated
RNA nucleotide. Link atoms between the QM and MM part were placed between Cα and Cβ
atoms of the Lys181 side chain and between C3′ and O3′ as well as C4′ and C5′ atoms of the
RNA.
Reaction energy profiles were computed using umbrella sampling as implemented in
CHARMM in order to sample the reaction coordinate. The following reaction coordinate was
used:
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rx =
dist(A− CH3)
dist(A−D) (3.9)
where A is the RNA 2’ oxygen methyl acceptor atom, D is the SAM sulfur donor atom and
CH3 is the transferred methyl group.
The reaction coordinate equals to 0.65 for the reactant state and to 0.30 for the product
state. 33 equidistantly spaced umbrella potentials were used, applying a force constant k of
10000 kcal/mol/A2. For each window, the system was minimized and equilibrated for 2 ps,
followed by a 10 ps production run.
The final reaction energy profiles were obtained by combining the results from the individual
simulations using the weighted histogram analysis method as implemented in the program
WHAM (version 2.0.2).100
For validation, two additional umbrella sampling runs were performed on the WT system.
First, an umbrella sampling run with longer simulation times, i.e. 10 ps equilibration and 20 ps
production run. Second, an umbrella sampling run with twice as many umbrella windows. For
both runs, the observed reaction energy profile was the same within the error margin, determined
as the standard deviation computed from individual simulations.
3.4.2 Results of Computational Alanine Scanning
To identify protein residues which significantly modulate the enzymatic reaction, and to further
investigate the underlying cause for the observed effect, computational alanine scanning was
performed. The idea behind computational alanine scanning101 originates from experimental
mutagenesis studies,102 where the influence of a protein residue is approximated by mutating it
to alanine. This relies on the assumption that alanine has a neutral influence due to its small
and non-polar side chain while being chiral and structurally rigid compared to glycine.
In the following, results of the computational alanine scanning are reported, divided into
their effects on the geometric arrangement between methyl donor and acceptor, the methyl
donor binding affinity, the reaction energy barrier and the intrinsic pKa value of the active site
proton acceptor group.
Geometric Arrangement
The geometric arrangement between the methyl donor (SAM), the methyl acceptor (RNA
2’ hydroxy group) and the proton acceptor (protein Lys181) were investigated for wild type
and single point mutations of dengue MTase using molecular dynamics simulations. The rel-
ative donor/acceptor arrangements of all alanine mutants compared to WT are plotted in
Figure 3.12 against the experimental determined methylation activity obtained from the litera-
ture.103,61,104,105,45,106,58
The figure shows the relative geometry obtained for each mutant on the x-axis and the
experimental methylation activity on the y-axis. All mutants with no experimental results
available are shown as red dots below the x-axis. The gray bar indicates uncertainties in
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Figure 3.12: (A) Relative donor/acceptor arrangements of all alanine mutants plotted against the exper-
imental determined methylation activity. Mutants with no experimental results available are shown as red
dots below the x-axis. The gray bar indicates uncertainties in computational results of WT. (B) Results
mapped onto the surface of the MTase where all mutated residues are marked in green and residues yielding
significant rearrangements are highlighted in red.
computational results of WT calculated as the standard deviation observed between 10 individual
2 ns simulations. Uncertainties observed in mutant simulations are in a comparable range as
for WT but were omitted for clarity.
In addition, the results are mapped onto the surface of the MTase where all mutated residues
are marked in green and residues yielding significant rearrangements are highlighted in red.
All results are in agreement with experimental values, since no false negatives are observed,
i.e. mutants which are experimentally active but inactive in our simulations. On the other hand,
we observe certain mutants which are inactive in experiment, but are predicted to be active from
our simulations. This is expected, since the observable investigated here, i.e. orientation of
donor/acceptor, is only one of many possible reasons to obtain a reduced methylation activity.
Thus, for those mutants, we do not observe a difference which is significant. This indicates a
different mechanism of inactivation for those mutants.
To further characterize the underlying cause of the structural rearrangement observed here,
the relative RMSD of SAM and of the RNA cap was investigated as shown in Figures 3.13 and
3.14.
The results are again in agreement with experimental methylation activity. They indicate
that the mutants S88A, D79A, D146A, K181A and E217A influence the arrangement of the
SAM methyl donor and the mutants K14A, F25A, K61A, W87A, D146A and Y219A affect the
conformation of the RNA cap structure.
Binding Affinities
Binding free energies of the methyl donor SAM to the MTase were investigated using the
MM-GBSA approach. Two distinct computational mutagenesis protocols were used where MD
simulations were performed either on the WT only (post-processing protocol) or on all mutants
individually (full MD protocol) as described before in more detail. Similar methods have been
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Figure 3.13: (A) Relative SAM RMSD of all alanine mutants plotted against the experimental determined
methylation activity. Mutants with no experimental results available are shown as red dots below the x-axis.
The gray bar indicates uncertainties in computational results of WT. (B) Results mapped onto the surface
of the MTase where all mutated residues are marked in green and residues yielding significantly increased
SAM RMSD are highlighted in red.
WT
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Figure 3.14: (A) Relative RNA cap RMSD of all alanine mutants plotted against the experimental
determined methylation activity. Mutants with no experimental results available are shown as red dots below
the x-axis. The gray bar indicates uncertainties in computational results of WT. (B) Results mapped onto
the surface of the MTase where all mutated residues are marked in green and residues yielding significantly
increased RNA cap RMSD are highlighted in red.
used for studying protein-ligand and protein-protein interactions.107,108,109 Results from the
post-processing protocol are shown in Figure 3.15.
The MM-GBSA binding free energies based on the post-processing mutagenesis protocol
are in agreement with experimental results as no false negatives were observed. In addition,
for the K14A mutant, binding of SAM to the MTase was experimentally confirmed using the
previously described ITC assay. Computationally, this was also observed in MM-GBSA binding
free energies using the post-processing mutagenesis protocol, where ∆∆G = -0.3 kcal/mol for
the K14A mutant. In contrast, when using the full MD mutagenesis protocol and MM-GBSA
energies were computed as the average of ten individual MD simulations, two false negatives
were observed. For those cases, predicted binding affinities were significantly reduced for the
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Figure 3.15: (A) Relative binding free energy of SAM to the MTase as computed by MM-GBSA. Results
for all alanine mutants plotted are against the experimental determined methylation activity. Mutants
with no experimental results available are shown as red dots below the x-axis. The gray bar indicates
uncertainties in computational results of WT. (B) Results mapped onto the surface of the MTase where
all mutated residues are marked in green and residues yielding significantly lowered binding affinities are
highlighted in red.
following two mutants which retain their methylation activity in experiments: F133A (65%
activity), E111A (57% activity). Similar findings, with more pronounced effects, were observed
when using one long (20 ns) MD simulation instead of 10 individual short (2 ns) simulations.
In addition, the experimentally examined mutant K14A, is predicted not to bind (∆∆G = 12.2
kcal/mol), which contradicts our experimental ITC binding results. Results on the geometric
arrangement of the RNA cap and inspection of the MD trajectories suggest that the mutant
K14A induces a structural rearrangement of the RNA cap and thus the protein’s active site
which in turn influences the calculated MM-GBSA binding free energies. This suggests that
MM-GBSA binding free energies are less reliable if the protein or the ligand undergoes structural
rearrangements.
To summarize, only the post-processing mutagenesis protocol yields binding affinity results
in agreement with experimental results. Similar findings have been reported for computational
alanine scanning when probing protein-protein iterfaces.107 Although this protocol is more
accurate for our study, it does not incorporate structural rearrangements taking place upon
mutation, which could lead to false positive predictions (i.e. mutants which are experimentally
inactive but do not show reduced binding affinity in the simulations).
Overall, the results predict mutants S56A, D79A, W87A, D131A and D146A to significantly
reduce the binding affinity of SAM to the MTase and thereby inhibiting the methyltransfer
reaction.
Reaction Energetics
Reaction energy barriers were computed for a selected subset of mutations using molecu-
lar dynamics based umbrella sampling in a mixed quantum mechanics/molecular mechanics
(QM/MM) system. The approximate DFT method self-consistent charge density functional
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tightbinding (SCC-DFTB98,99) was used for the QM level whereas the CHARMM27 all-atom
force field was used for the MM level. SCC-DFTB is a computationally efficient method compa-
rable to widely used semi-empirical methods such as AM1 and PM3 with reasonable accuracy.
This makes it possible to perform extensive sampling of condensed phase systems. The SCC-
DFTB method has been applied successfully to numerous biomolecular systems.110,111
Since QM/MM calculations are computationally extremely costly, only WT and the following
four protein residues were investigated as they are located closely to the reactive center: K61A,
D146A, E217A, Y219A. All of these abolish methylation activity for the 2’O reaction. For the
WT system, a energy barrier of 19.4 ± 2.0 kcal/mol was obtained. This is in a similar range as
the barrier computed from experimentally observed kcat using transition state theory (∆G
TS
exp
= 15.2 kcal/mol) and agrees well with the results obtained from QM calculations on 2’O
model systems (∆GTSmodel = 17.6 kcal/mol). Relative reaction energy barriers and fluctuations
observed between four input structures are given in Figure 3.16.
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Figure 3.16: (A) Reaction energy barriers relative to WT, computed by umbrella sampling in a QM/MM
system. Error bars were determined as the standard error obtained from four individual starting structures.
(B) Results mapped onto the surface of the MTase where all mutated residues are marked in green and
residues yielding significantly increased reaction energy barriers are highlighted in red.
The results show an increased reaction barrier for the mutants E217A and K61A. No signif-
icant increase is observed for mutant D146A and Y219A. In addition, for the mutant K181A, a
significant increase in the reaction barrier by 4.7 kcal/mol is observed. In the native protein,
Lys181 acts as the proton acceptor. Therefore, for the mutation K181A, a water molecule was
modeled in the position of Lys181 Nζ and included into the QM region. This water molecule
then acts as a proton acceptor. The increase in the reaction energy barrier for this mutant are
comparable to the results obtained from QM calculations on 2’O model systems (∆∆GTSmodel
= 3.8 kcal/mol).
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Intrinsic pKa of Active Site Lysine
During the reaction, the protein residue Lys181 acts as a proton acceptor and thus, its proto-
nation state is critical for the efficiency of the reaction, where a lowered pKa value improves
the reaction. It has been shown in VP39 methyltransferase that this residue has a significantly
lowered pKa value (pKa: 8.5) compared to an isolated lysine (pKa: 10.5).64,65
Although VP39 MTase shows significant structural differences to DENV MTase, the active
site is highly conserved both from a sequence as well as from a structural point of view.
Therefore, intrinsic pKa values of Lys181 were computed for all complex structures of all studied
single point mutants of DENV MTase based on the Poisson-Boltzmann continuum electrostatics
methods. Calculations on WT MTase show a comparable reduction for DENV MTase with a
predicted Lys181 pKa of 9.2.
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Figure 3.17: Calculated intrinsic relative pKa values of Lys181 for WT dengue MTase and all studied
single point mutations.
Predicted pKa values for all mutants are given in Figure 3.17. No significant change of
the pKa value was observed for most mutants. Only for two mutations a significant decrease
over WT was observed: E217A (pKa: 7.6, WT pKa: 9.2), D146A (pKa: 7.8) whereas for one
mutation a significant increase was observed: K61A (pKa: 10.0).
The enzyme’s active site consists of the following four residues Lys181, Asp146, Lys61 and
Glu217, where the two negatively charged residues are hold together by the two lysines. For the
reaction to occur, Lys181 must be deprotonated, and thus, the two negatively charged residues
are only hold together by one positive charge of Lys61. If this charge is removed (K61A), the
protonated and therefore positively charged form of Lys181 is favored in order to stabilize the
two negative charges. Thus, the pKa value of Lys181 is increased compared to WT. On the
opposite, if one of the negative charges is removed (e.g. D146A, E217A), the deprotonated form
of Lys181 is favored and thus, the pKa of Lys181 is reduced. However, as described previously,
mutation of D146A, E217A or K61A leads to a structural rearrangement which inhibits the
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reaction.
3.4.3 Summary of Computational Alanine Scanning
The results from all computational alanine scanning computations are summarized in Figure 3.18
and Table 3.6.
Figure 3.18: Summary of the effect of single point mutations on different aspects of the methyltransfer
reaction. The following effects are mapped onto the protein surface: structural rearrangements of the RNA
cap (red), structural rearrangements of the SAM co-factor (blue), reduced SAM binding affinity (magenta),
increased reaction barrier (cyan). Residues where mutations to alanine did not have an effect are colored
in green.
For most mutants with a significant effect on methylation activity, computations indicate
an underlying cause, except for mutants K29A, E35A, R38A and I146A where all computed
observables do not indicate any significant change. This discrepancy is caused by the fact that
the former three residues are located at the far end of the RNA binding groove and are thus
not appropriately reflected by the observables analyzed. The latter residue, on the other hand,
is located in the SAM binding pocket but the chemical change of the isoleucine to alanine
mutation is relatively small and thus, does yield a calculated binding free energy difference (2.7
kcal/mol) just below the significance threshold.
3.4.4 Experimental and Computational Analysis of Selected Mutants
Based on results from computational alanine scanning calculations, residues were selected for
further computational and experimental mutagenesis experiments.
The following mutations were characterized experimentally using ITC based binding affinity
measurements: D79E, D79N, S88T, E217D, E217Q, Y219F, Y219H. The obtained binding
curves of SAH and GTPγS are shown in Figures 3.19 and 3.20.
72
3.4. IMPACT OF SINGLE POINT MUTATIONS
Table 3.6: Summary of the effect of single point mutations on different aspects of the methyltransfer
reaction. a The — sign indicates that there is no data available in the literature.
experimental SAM SAM RNA cap protonation reaction
activity (%) a
mutant 103,61,104,105,45,106,58 binding orientation orientation state barrier
K14A 2 x
L17A 41
K22A 81
F25A 4 x
K29A 15
E35A 2
R38A 18
S56A 5 x
K61A 0 x x x
D79A — x x
W87A 4 x x
S88A — x
K105A 61
H110A 58
E111A 57
D131A 3 x
V132A —
F133A 65
D146A 0 x x x
I147A 15
S150A 55
K181A 6 x x
S211A —
T215A 104
E217A 0 x x
Y219A 8 x
As described previously, ITC based SAH binding measurements are difficult. Despite this
fact, qualitative results can still be obtained when measuring SAH binding. The results show
that SAH binds to the WT MTase (black dots) and all mutants of Tyr219 (i.e. Y219F, Y219H).
However, all studied mutants of Asp79 (i.e. D79E, D79N), Ser88 (i.e. S88T) and Glu217 (i.e.
E217D, E217Q) do not bind SAH.
Binding of the RNA was determined using GTPγS as a short cap analog. For all observed
mutants, the binding was retained. As a control experiment, binding of GTPγS to the mu-
tant K14A was measured. Lys14 is located in the RNA cap pocket and is known to abolish
methylation activity. Our ITC experiments confirm that binding of GTPγS is eliminated in this
mutant.
Mutations of Asp79
Asp79 is located in the SAM binding pocket. The side chain of Asp79 interacts with the amino
group of SAM through a water mediated interaction. Thus, mutation of Asp79 to alanine
abolishes this interaction. So far, no published methylation activities are available for mutants
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Figure 3.19: Experimentally determined ITC binding curves measured for SAH binding to WT DENV
MTase and mutants thereof.
Figure 3.20: Experimentally determined ITC binding curves measured for GTPγS binding to WT DENV
MTase and mutants thereof.
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of Asp79. Simulations however, indicate a reduced SAM binding affinity and a conformational
change of SAM, incompatible with the reaction.
Experimentally, ITC measurements of mutations to Glu and Asn were performed. The
mutation to Glu elongates the side chain by one carbon atom but retains the charge. Thus, it
probes the dependencies on size effects. On the other hand, the mutation to Asn changes the
negatively charged native residue while retaining the same size. Both mutants were shown to
abolish SAH binding in the ITC experiments.
Computational mutagenesis experiments are in good agreement with those findings. Sig-
nificantly reduced SAM binding affinities were predicted with ∆G shifts of 14.4 kcal/mol and
18.7 kcal/mol for the mutants Asp79Glu and Asp79Asn, respectively. As opposed to Asp79Ala
mutant, both mutants did not show significant structural rearrangements during MD simula-
tions with relative SAM rmsds of -0.12 A˚ and 0.25 A˚ and relative RNA rmsds of -0.16 A˚ and
-0.17 A˚.
Mutations of Ser88
Ser88 is located in the second shell of the SAM binding pocket. It is hydrogen bonded to the
previously described Asp79 and thereby it constrains the position of the latter which is involved
in SAM binding. So far, no published methylation activities are available for mutants of Ser88.
Experimentally, mutation to Thr was performed, which retains the capability of forming
hydrogen bonds while being sterically more demanding and conformationally less flexible. Due
to the close proximity to Val100 and Val124, the hydroxy group of Thr needs to adopt a different
orientation compared to the native Ser hydroxy group, where in this conformation, the hydrogen
bond to Asp79 is not retained. In the ITC experiments, the Ser88Thr mutant looses the ability
to bind SAH.
Computationally, no shift was observed in the SAM binding free energy compared to WT
(∆∆G = 0.5 kcal/mol). Since the residue Ser88 does not directly interact with SAM it likely
influences SAM binding affinity through structural rearrangements. This aspect cannot be
covered by the employed computational method since the computational mutagenesis protocol
does not adequately incorporate structural rearrangements.
Mutations of Glu217
Glu217 is located in the protein’s active site and belongs to the conserved and essential residues
of the catalytic tetrade consisting of Lys181, Asp146, Lys61 and Glu217. Glu217 interacts
directly with the proton acceptor residue Lys181. The correct positioning of Lys181 is essential
for an efficient reaction and Glu217 helps to constrain this position. Experimentally, mutant
Glu217Ala was shown to abolish methylation activity.
ITC binding affinity measurements were performed on mutants Glu217Asp and Glu217Gln.
Mutations to Asp retain the negative charge on the carboxy group but shorten the side chain by
one carbon atom. Mutations to Gln retain the side chain length but render the residue neutral
75
3.4. IMPACT OF SINGLE POINT MUTATIONS
while retaining the ability to form hydrogen bonds. Both mutants were found to eliminate SAH
binding while binding to GTPγS was retained.
Computationally, for both mutants, no significant shifts in SAM binding free energies were
observed (Glu217Asp: ∆∆G = 0.0 kcal/mol, Glu217Gln: ∆∆G = 1.4 kcal/mol). Like for the
mutants of Ser88, SAM binding is likely influenced through structural rearrangements induced
by the mutation which are not adequately covered in the computational mutagenesis protocol.
By monitoring the geometry between methyl donor, acceptor and proton acceptor in ten
individual MD trajectories for each mutant, significant conformational rearrangements were
observed in the mutants. These can be attributed to conformational rearrangements of the
proton acceptor Lys181 as indicated by a significant increased relative rmsd of the Lys181
residue compared to WT (Glu217Asp: 0.8 ± 0.14 A˚, Glu217Gln: 0.7 ± 0.09 A˚).
Mutations of Tyr219
Tyr219 is located in the protein’s active site. It is hydrogen bonded to the carboxy group of
Asp146 of the catalytic tetrade. No direct interactions with SAH or the RNA were observed.
Published activity data of mutant Tyr219Ala shows no methylation activity.
Experimentally, SAH binding affinities were measured for the mutants Tyr219Phe and
Tyr219His. In both cases, binding affinities are retained at WT levels. Calculated SAH binding
free energies are in agreement, where no significant shifts in predicted SAM binding free energies
were observed.
For the mutation Tyr219Ala, a change in the donor-acceptor geometry was observed. This
is not the case for the Tyr219Phe mutation. However, for the latter mutation, a significant
increase was observed in the relative reaction energy barrier by 2.8 ± 1.33 kcal/mol. Therefore,
computations suggest that the Tyr219Phe mutant inhibits the methylation reaction through
modulating the reaction energy barrier.
3.4.5 Conclusion
Using complementary computational methods, we have build an in-silico approach to identify
the effect of a single point mutation on different aspects governing the enzyme’s catalytic
activity.
Results of a computational alanine scanning procedure are qualitatively in good agreement
with experimentally determined methylation activity. In addition, they indicate the role of each
studied residue, thereby yielding information not easily accessible through experiments. In this
way, protein residue patches were identified which modulate the geometric arrangement between
methyl donor and acceptor, the methyl donor binding affinity or the reaction energy barrier.
Based on a computational alanine scanning procedure, previously uncharacterized hot-spot
residues were identified which were predicted to significantly influence the catalyzed reaction.
Selected hot-spot residues were further analyzed both computationally and experimentally in
order to gain a better understanding of their role in the enzyme’s function. In addition, the
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results agree well with experimental binding free energies in cases where mutations do not
induce significant structural rearrangements.
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3.5 RNA Sequence Specificity
Although flaviviral methyltransferases are attractive drug targets,61,79 little is known about
the atomistic details of the mechanism underlying their function. The enzyme is known to
catalyze two independent methyltransfer reactions onto two distinct positions of the RNA 5’-
cap structure: the guanine N7 position on the cap nucleotide and the ribose 2’O hydroxy group
on the first transcribed nucleotide.60,53,50,106 Dong et al.112 have shown that distinct RNA
elements with a specific sequence are required for the methylation of the two RNA positions,
indicating that specific RNA binding conformations and methyltransfer mechanisms are required.
So far, the underlying reason for this sequence specificity, however, has not been elucidated in
detail and the mechanism of the two methylation reactions at an atomistic level is not known.
Therefore, we are investigating effects on the methyltransfer reaction introduced by mutated
RNA sequences at an atomistic level using molecular dynamics simulations.
Since structural details about the guanine N7 reaction are largely unknown, we focus on the
ribose 2’O methyltransfer reaction. For the 2’O reaction, it has been experimentally determined
that the identity of the cap nucleotide as well as the following two transcribed nucleotides, i.e.
GpppAG-RNA, are essential for the reaction.112 Those nucleotides are conserved within all
flaviviruses. A chemical drawing of the cap structure and its interactions with the protein are
shown in Figure 3.21.
Figure 3.21: Schematic representation of wild type dengue RNA cap-1 structure located at the 5’ termini.
Specific interactions with the protein observed during molecular dynamics simulations are indicated in red.
The location of the methyl donor SAM is indicated in green letters.
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3.5.1 Method
System Setup
Wild type (WT) and nine mutated RNA sequences were modeled in the binding site of the
dengue NS5 methyltransferase. Starting from the native sequence, the structures of the nine
mutated sequences were generated by mutating the appropriate nucleotide to all other nu-
cleotides, using Maestro (Schrodinger, LLC). Each base was subjected to a full conformational
search using MacroModel (Schrodinger, LLC) with default parameters, while keeping the pro-
tein and the rest of the RNA fixed. The minimum energy structure was used as a starting point
for molecular dynamics simulations. System setup and simulation procedure was the same as
described in Section 3.2.1.
Protein-RNA Contact Distances
An RNA-protein contact map was computed as follows. First, the set of atoms in contact with
the protein was defined as all atom of protein residues where at least one atom of the residue
was closer than 8 A˚ from the RNA in the initial WT structure. Second, for each of the atoms
in this set, the closest distance to any atom of the RNA was computed. This was repeated for
every 10th frame of the MD trajectory. Mean and standard deviation were computed over the
whole trajectory. Subsequently, for each mutant those values were plotted against the same
distance in WT. All distances deviating by more than 30% were labeled by their residue number.
In addition, for a global measure of the agreement between WT and mutant, an rmsd between
the corresponding distances was computed. All analysis was done in OpenStructure (version
1.2.1).83
RNA Per-Residue RMSD
For each nucleotide, the RMSD between every 10th frame of the MD trajectory and the initial
structure was computed. Mean and standard deviation were computed over the whole trajectory.
Hydrogen Bonding Distance
The hydrogen bonding distance between the 2nd nucleotide and the γ-phosphate group of the
trisphophate linker was computed for every 10th frame of the MD trajectory and mean and
standard deviation over the whole trajectory.
Reaction Energy Barriers
Reaction energy barriers were estimated using QM/MM based umbrella sampling simulations
with the SCC-DFTB method as described in Section 3.4.1.
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3.5.2 Results and Discussion
Overall Structural Rearrangements
Since a correct alignment of the methyl donor and acceptor is essential for the reaction to occur
efficiently, structural effects of mutated RNA sequences were investigated first. Therefore,
molecular dynamics simulations were performed for MTase complexed to mutated RNA cap
structures. For each position in the RNA sequence that is essential for the 2’O reaction, all
possible RNA mutants at that position were modeled. Subsequently, those simulations were
compared to simulations performed for MTase complexed to wild type RNA cap structure.
To quantify structural rearrangements of mutant RNA sequences in comparison to WT RNA
sequence, a contact map between the RNA and the surrounding protein atoms was computed
as described in Section 3.5.1. Plots for the three RNA mutants most closely related to the
WT RNA sequence (i.e. ApppAGU, GpppGGU, GpppAAU) are shown in Figure 3.22, all plots
are given in Appendix A.1. Points on the diagonal indicate no difference between WT and
the mutant, whereas points above the diagonal indicate an elongated distance in the mutant
compared to WT. In addition, a global measure of the agreement between WT and mutant was
computed as the rmsd between the corresponding distances in mutant and WT distance maps.
The value is shown in the plot.
As shown in Figure 3.22 the most significant structural rearrangements are observer for all
mutants of the cap-nucleotide, indicated by significant distance changes and the highest overall
distance rmsd of 0.92 A˚ for the RNA sequence ApppAGU. All mutants of the 1st nucleotide
show the smallest structural rearrangements with an distance rmsd of 0.34 A˚ for the RNA
sequence GpppGGU. Mutants of the 2nd nucleotide show some structural rearrangements with
a distance rmsd of 0.51 A˚ for the RNA sequence GpppAAU.
Cap Nucleotide Mutations
In the native structure, the cap nucleotide is strongly interacting with the protein by forming
direct hydrogen bonds from the guanosine amine group to the backbone carbonyl groups of
residues Leu20 and Leu17. When mutating this position to any other nucleotide, the RNA is no
longer capable of forming this direct interaction with the protein. Thus, a less stable binding of
this residue to the GTP pocket is observed, leading to a significant structural rearrangement of
the RNA during the 20 ns of MD simulation as observed by the significantly elongated distances
between RNA and protein residues 20, 21, 22 and 24 shown in Figure 3.22. All those residues
are located in the GTP pocket, indicating the largest structural rearrangements to occur in that
subpocket.
To quantify structural rearrangements of the cap-nucleotide, Table 3.7 shows the rmsd values
of the cap nucleotide obtained during MD simulations, both for WT and all RNA mutants. It is
clear that all mutants of the cap nucleotide show a significantly increased cap nucleotide rmsd
compared to WT or all mutants of all other nucleotides.
Figure 3.23 shows a superposed snapshot obtained from the MD simulations of WT (blue)
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Figure 3.22: Differences in RNA-MTase contacts between WT and mutated RNA. Contacts are measured
by their distances observed in MT simulations of the MTase bound to SAM and WT or mutated RNA.
The three RNA mutants most closely related to the WT RNA sequence are shown: (A) cap-nucleotide
(ApppAGU), (B) 1st nucleotide (GpppGGU), (C) 2nd nucleotide (GpppAAU). Residues with significantly
modified distances are labeled by their number.
and ApppAGU mutant (green) which clearly visualizes the weaker interactions in the mutant
leading to a partial unbinding of the cap nucleotide in the GTP pocket and therefore to a
rearrangement of the overall RNA.
1st Nucleotide Mutations
Although the first transcribed nucleotide is located closely to the active side where the reaction
takes place, no significant structural rearrangement was observed when mutating this residue.
However, when investigating the interactions with the protein, it was found that the amine group
of the guanine in the mutated RNA is pointing directly towards the reactive sulfur of SAM. Thus,
the environment of the reaction is modified considerably which might have a significant effect
on the energetics of the catalyzed reaction. However, this hypothesis could not be confirmed
by reaction energy barrier calculations where no significant change was observed (∆∆GTS =
0.5 ± 1.6 kcal/mol).
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Figure 3.23: Snapshots extracted from MD simulations of MTase in complex with SAM and WT RNA
GpppAGU (blue) or cap mutant RNA ApppAGU (green). The MTase structure is represented by its
molecular surface whereas the RNA is shown in sticks. For clarity only the cap and the first two RNA
nucleotides are shown.
2nd Nucleotide Mutations
For mutants of the second transcribed nucleotide, some structural rearrangements are observed
when visual inspecting the MD trajectories. This rearrangement leads to a non-optimal geometry
between the methyl-donor and acceptor.
During the whole simulation of the native structure, the guanosine at the second transcribed
position is hydrogen bonded through the amine group at the 2 position to the side chain
carboxyl group of Glu111. This interaction might participate in constraining the position of
the bound RNA to a conformation suitable for the reaction. When this nucleotide is mutated
to an adenosine, the hydrogen bond can no longer be formed. Recently, however, data for the
WNV single point mutation of Glu111 to alanine was published which shows a reduction of the
methylation efficiency to 57% of the WT efficiency.45 This indicates, that the loss of the afore
mentioned interaction is insufficient to fully describe the almost complete loss of activity for
the RNA mutants at this position.
Inspection of the MD trajectories showed that the mutated RNA takes up a more compact
conformation compared to WT RNA. This seems to be induced by an intramolecular hydrogen
bond between the second nucleotide and the γ-phosphate group of the triphosphate linker, as
indicated in Figure 3.24 This hydrogen bond is possible in all mutants of the second nucleotide,
however not in the WT RNA. To quantify this finding, the above mentioned distance is measured
over the whole trajectory and the mean values are given in Table 3.7. The observed distance is
significantly shorter in all mutants of the second nucleotide compared to wild type RNA or all
mutants of the other RNA positions.
Although the data does not allow to draw the following conclusion significantly, due to the
large fluctuations observed in the simulations, it is interesting to note that within the mutants
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Figure 3.24: Snapshots extracted from MD simulations of MTase in complex with SAM and WT RNA
GpppAGU (blue) or 2nd-nucleotide mutant RNA GpppAAU (green/element color). The MTase structure
is represented by its molecular surface whereas the RNA is shown in sticks. The hydrogen bond between
the 2nd-nucleotide and the γ-phosphate of the triphosphate linker is indicated with a dashed yellow line.
For clarity only the cap and the first two RNA nucleotides are shown.
Table 3.7: RNA sequence specificity of dengue methyltransferase. Enzymatic activity is obtained from
the literature. Two observables obtained from molecular dynamics simulations are shown: (A) RMSD of
the cap-nucleotide from the starting geometry, (B) hydrogen bonding distance between the 2nd-nucleotide
and the γ-phosphate of the triphosphate linker.
experimental cap nucleotide h-bonding distance (A˚)
RNA sequence activity44,112 RMSD (A˚) γPO4 - 2nd-nucleotide
GpppAGU (WT) 100% 0.56 4.17
ApppAGU 0% 1.87 4.20
CpppAGU 1.51 4.02
UpppAGU 1.45 4.11
GpppGGU 0% 0.63 3.54
GpppCGU 0.63 4.28
GpppUGU 0.68 4.45
GpppAAU 33% 0.61 3.21
GpppACU 0% 0.53 2.40
GpppAUU 19% 0.65 2.89
of the second nucleotide, there is a good agreement between the observed hydrogen bonding
distance and the experimentally observed methylation activity, i.e. the distance is shorter the
lower the activity is.
3.5.3 Conclusion
Based on molecular dynamics simulations, we have investigated RNA sequence specificity and
the effects of mutated RNA cap sequences on the methyltransfer reaction.
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We have found that the guanine cap nucleotide interacts strongly with the protein’s back-
bone in the RNA cap pocket. Any mutation of this nucleotide leads to an RNA structure which
in unable to form these interactions and therefore, starts to dissociate from the protein structure
within 20 ns of molecular dynamics simulations.
In addition, simulations highlight that the identity of the 2nd translated RNA nucleotide
must be a guanine since any mutations thereof results in RNA conformations where the methyl
acceptor group is positioned in locations unsuitable for the 2’O methylation reaction. Molecular
dynamics simulations suggest that in all mutants of this nucleotide an intramolecular hydrogen
bond is formed between the 2nd nucleotide and the γ-phosphate group of the triphosphate
linker. The only nucleotide where this is not possible is guanine where no hydrogen bond donor
is located in the appropriate region. To validate this hypothesis, experimental characterization
of mutated RNA structures with non-natural nucleotides should be performed where formation
of an the afore mentioned intramolecular hydrogen bond is inhibited.
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3.6 Conclusion
Using a diverse set of computational methods, we were able to address a number of open
questions concerning the mechanism of the catalyzed methyltransfer reactions.
First, a structure of the enzyme bound to the RNA and the SAM co-factor has been mod-
eled, based on available template structures and published mutagenesis data. The model was
validated and structural rearrangements induced by binding of SAM or the RNA were assessed
by molecular dynamics simulations. The results suggest that overall, structural rearrangements
upon ligand binding are small, especially within the SAM and the RNA binding pocket as well
as in the active site. Therefore, those sites can be considered structurally stable targets for
structure-based drug discovery efforts.
Second, in order to characterize the underlying chemical reactions, ab initio electronic struc-
ture calculations were performed on model systems mimicking the biological reactions. Calcu-
lations on such model systems reveal that both the 2’O and the N7 reaction are energetically
favored processes, where the N7 reaction produces a significantly more stable product and
shows a lower activation barrier than the 2’O reaction. Comparison between the catalyzed and
uncatalyzed 2’O reaction, revealed the importance of a lysine residue which acts as a proton
acceptor and significantly stabilizes the product state and reduces the activation barrier.
Furthermore, an in-silico approach was developed to identify the effects of single point mu-
tations on different aspects of the catalyzed reaction. Using this approach in a computational
alanine scanning procedure helped to identify protein residue patches which modulate the ge-
ometric arrangement between methyl donor and acceptor, the methyl donor binding affinity
or the reaction energy barrier. In addition, previously uncharacterized hot-spot residues were
identified and analyzed further using computational and experimental methods in order to gain
a better understanding of their role in the enzyme’s function.
In addition, we have investigated RNA sequence specificity of the enzyme and effects of
mutated RNA cap sequences on the methyltransfer reaction. Based on molecular dynamics
simulations, protein residues critical for RNA sequence specificity of the enzyme were identified
and the possibility for forming an intramolecular hydrogen bond between distinct RNA elements
was observed, whose absence might be detrimental for RNA sequence specificity.
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Chapter 4
Ligand Binding Site Prediction
The reliable prediction of ligand binding sites is crucial for characterizing proteins with unknown
function. Therefore, the use of computational predictions of protein function and ligand binding
sites for proteins without experimental structures are assessed in a blind and objective way.
Limitations in the current prediction methods are analyzed and suggestions for a more reliable
evaluation are given. Following those suggestions, an extended and fully automated assessment
is implemented in the Continuous Automated Model EvaluatiOn framework.
4.1 Introduction
In the post-genomic era, the number of protein sequences with unknown structure is constantly
growing at an exponential rate. Similarly, the number of protein structures with unknown
biological function is steadily increasing. To bridge this rapidly growing gap between known
sequences and unknown function, numerous computational and experimental techniques have
been developed to help predicting the biological function.5,1, 6
Among these methods, computational approaches for identifying the precise location of
ligand binding sites and protein residues involved in ligand interaction are of high relevance
for life science research, with applications in functional characterization of novel proteins, drug
design and enzyme engineering. Various approaches for the prediction of ligand-binding sites
have been proposed, based on sequence conservation, geometric criteria of the protein surface,
or homology transfer from known structures.7
Relevant biological questions, however, can only be addressed if predictions are specific and
accurate. Therefore, evaluating the performance of prediction methods in a blind and objective
way is crucial. To achieve this goal, ligand binding site prediction methods have been assessed
since the 6th edition of the Critical Assessment of Techniques for Protein Structure Prediction
(CASP) experiment.113,114
4.1.1 Critical Assessment of Protein Structure Prediction
CASP is a community-wide experiment, with the goal to evaluate and advance the methods
for protein structure prediction. CASP is a blind experiment where the predictors receive a set
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of protein sequences for which the structure is unknown. When the experimentally determined
structures are released, predictions are evaluated by an independent assessor to identify the
current state of the art in the protein structure prediction field.
It should be noted that CASP is a double blind experiment where all predictors are given the
same question at the same time, ensuring that the same data is available to all predictors. This
is important to guarantee a fully independent, objective and comparable evaluation of current
methods. The experiment is held biannually.
The main focus of CASP lies in the evaluation of template based modeling techniques
(TBM) but it includes a number of additional categories for the evaluation of template free
modeling, model refinement, model quality prediction, disorder prediction and function pre-
diction. In the latter category, the prediction of ligand binding sites are assessed. Here, the
predictors are given a set of protein sequences with unknown structures and are asked to identify
the residues involved in ligand binding.
4.2 Assessment of Ligand Binding Site Prediction in CASP9
In the following, a published manuscript is included:
“Assessment of ligand-binding residue predictions in CASP9”
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INTRODUCTION
To perform their functions, proteins interact with a plethora of
small molecules within the cell. Most of these interactions are
unspecific and transient in nature (e.g., interactions with water and
ions), some are persistent and may play a structural or functional
role (e.g., certain metal ions), and others might be transient but
nevertheless highly specific, often resulting in essential changes of
the protein or the ligand (e.g., enzyme-substrate complexes or re-
ceptor-ligand complexes). Hence, the identification of a protein’s
functionally important residues, such as ligand-binding sites or cat-
alytic active residues, is a crucial step toward the goal of understand-
ing the protein’s molecular function and its biological role in the
cell. Although protein ligand interactions are crucial for the func-
tion of a protein, in many cases they are unknown. Although the
kind of ligands interacting with a protein is often known from bio-
chemical analyses, elucidating the structural details of these interac-
tions requires elaborate and time-consuming studies by X-ray crys-
tallography or NMR. Therefore, computational tools have been
developed aiming at predicting the precise location of binding sites,
and specifically which amino acid residues in a protein are directly
interacting with ligands. Various approaches for the prediction of
ligand-binding sites have been proposed,1 both from structure and
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ABSTRACT
Interactions between proteins and their ligands
play central roles in many physiological processes.
The structural details for most of these interactions,
however, have not yet been characterized experien-
tially. Therefore, various computational tools have
been developed to predict the location of binding
sites and the amino acid residues interacting with
ligands. In this manuscript, we assess the perform-
ance of 33 methods participating in the ligand-
binding site prediction category in CASP9. The
overall accuracy of ligand-binding site predictions
in CASP9 appears rather high (average Matthews
correlation coefficient of 0.62 for the 10 top per-
forming groups) and compared to previous experi-
ments more groups performed equally well. How-
ever, this should be seen in context of a strong bias
in the test data toward easy template-based models.
Overall, the top performing methods have con-
verged to a similar approach using ligand-binding
site inference from related homologous structures,
which limits their applicability for difficult de novo
prediction targets. Here, we present the results of
the CASP9 assessment of the ligand-binding site
category, discuss examples for successful and chal-
lenging prediction targets in CASP9, and finally
suggest changes in the format of the experiment to
overcome the current limitations of the assessment.
Proteins 2011; 79(Suppl 10):126–136.
VC 2011 Wiley-Liss, Inc.
Key words: protein function; protein structure;
evaluation; assessment; binding site; active site; co-
factor; ligand; CASP.
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from sequence, based on sequence conservation,2–7 geo-
metric criteria of the protein surface,8–12 or homology
transfer from known structures.13–17
The function prediction category (FN) was introduced
in the 6th Critical Assessment of Protein Structure Predic-
tion (CASP), where predictions for Gene Ontology molec-
ular function terms, Enzyme Commission numbers, and
ligand-binding site residues were evaluated.18,19 Because
very little new functional information becomes available
during and after the experiment, the first two categories
were difficult to assess. Therefore, since CASP8, the predic-
tion task has been to identify functionally important resi-
dues such as ligand-binding residues or catalytic resi-
dues.20 Here, we present the assessment of 33 groups par-
ticipating in the recent CASP9 experiment. In the ligand-
binding site prediction category (FN), the sequence of a
protein with unknown structure was provided to predic-
tors. The task was to predict the residues directly involved
in ligand binding in the experimental control structure.
This approach differs significantly from typical ligand-
binding studies (like docking or virtual screening), where
the chemical identity of the ligand is given, and the correct
geometric orientation of the molecule in the receptor pro-
tein is to be determined.21–25 In CASP, however, the
chemical identity of the ligand is unknown at the time of
prediction, and only the interacting residues are predicted.
In summary, all top performing groups have applied a
similar approach, using ligand information derived from
homologous structures in the PDB.26 In comparison with
CASP8,20 we could not observe a significant progress by
the top groups, but rather a larger number of groups per-
forming at the same level. We believe that this observation
is caused on one side by the bias in the data set to ‘‘easy’’
template-based predictions with only a very small number
of difficult de novo targets in recent rounds of CASP. This
gives strong advantage to methods using PDB information
directly, but discourages the development of methods
addressing the more challenging de novo cases. Another
limiting factor is the binary format of the prediction task,
which does not allow specifying probabilities for specific
residues or differentiating between types of ligands.
MATERIALS ANDMETHODS
Prediction targets
All CASP9 target structures were analyzed for nonsol-
vent, nonpeptidic ligand groups in the deposited protein
structures. Based on literature information, UniProt27
annotations, structures of closely related homologues
(Table SI, Supporting Information), and conservation of
functionally important residues, we aimed at identifying
ligands with biological/functional relevance for the spe-
cific protein. All targets, including those containing
ligands classified as ‘‘nonbiologically relevant,’’ were fur-
ther analyzed to indentify cases where a ligand clearly
mimicked the interactions of known biologically relevant
ligands for this target.
Binding site definition
For each prediction target, binding site residues were
defined as those residues in direct contact with the ligand in
the target structure, that is, all protein residues with at least
one heavy atom within a certain distance from any heavy
atom of the ligand. The distance cutoff was defined by the
CASP organizers as the sum of the van der Waals radii of the
involved atoms plus a tolerance of 0.5 A˚. In addition, differ-
ent tolerance values ranging from 0 to 2.0 A˚ were evaluated.
In cases where multiple chains with bound ligands were
present in the target structure (e.g., homo-oligomeric
assemblies), the definition of the binding site residues for
individual chains were combined into a single binding site
definition. For targets where ligands were observed to bind
in the interface between multiple chains, the oligomeric
structure as defined by the authors and PISA28 (five cases)
or only PISA (1 case) was used for the binding site defini-
tion. Analysis of structures and ligand-binding sites was
performed using OpenStructure (version 1.1).29
For targets in which only part of the relevant ligand
was present, the binding site definition was extended to
include the entire biologically relevant ligand. In these
cases, two separate evaluations of the prediction perform-
ance were conducted. First, denoted as ‘‘extended binding
site,’’ all atoms of the partial and the extended ligand
were used to define the binding site in the same way as
described earlier. Second, denoted as ‘‘partial binding
site,’’ only atoms of the partial ligand were used to define
the binding site, whereas all residues exclusively in con-
tact with the extended part of the ligand were treated as
neutral and excluded from the evaluation.
Binding site prediction evaluation
As in the previous assessment,20 binding site predic-
tion performance was measured using the Matthews cor-
relation coefficient30 (MCC), which accounts both for
over and under predictions. For each target, residue pre-
dictions were classified as true positives (TP: correctly
predicted binding site residues), true negatives (TN: cor-
rectly predicted nonbinding site residues), false negatives
(FN: incorrectly under predicted binding site residues),
and false positives (FP: incorrectly over predicted non-
binding site residues) based on the binding site definition
described before. The MCC was computed using Eq. (1):
MCC ¼ TP3TNFP3FNffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiðTPþ FPÞðTPþ FNÞðTNþ FPÞðTNþ FNÞp
MCC ranges from 11 (perfect prediction), over 0
(random prediction) to 21 (inverse prediction). Empty sub-
missions that did not include any binding site predictions
and missing predictions were assigned a MCC score of zero.
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To reduce the effects of target difficulty on the ranking,
MCC scores were standardized by computing Z scores
among all predictions P for a given target Tusing Eq. (2):
zP;T ¼ MCCP;T MCCTrT
In this equation, MCCP,T is the raw MCC score for target
T given by predictor P, MCCT is the mean MCC score for
target T, and rT is the standard deviation of MCC scores
for target T. The overall performance for each predictor
was computed as the mean of Z scores over all targets,
which was subsequently used for obtaining a final ranking.
In addition to the MCC score, we computed the recently
published binding site distance test (BDT).31 BDT takes
the actual three-dimensional locations of the predicted res-
idues into account and scores residues differently, accord-
ing to the distance between the predicted and the observed
binding site. Predictions close to the binding site score
higher than more distant predictions. The BDT score
ranges from 0, for a random prediction to 1, for a perfect
prediction.
Robustness and significance
Statistical significance of the ranking and robustness
with regard to composition of the target data set was
assessed using two different methods. First, two-tailed
Student’s paired t-tests as well as Wilcoxon signed rank
tests32 between all predictor groups were performed
based on MCC scores for each target. Both t-tests and
Wilcoxon signed rank tests were performed using R (ver-
sion 2.11.1).33 Second, bootstrapping was performed,
where scores were computed on a randomly selected sub-
set of three-fourth of all targets (i.e., 23 of 30 targets).
Seventy-five rounds of bootstrapping were executed for
different target subsets, and for each bootstrapping
experiment, mean, minimum, and maximum Z scores
per group were calculated as previously described. Addi-
tionally, the rank for each prediction group was calcu-
lated, and mean, minimum, and maximum ranks over all
bootstrapping experiments were computed.
To assess the performance of groups on different types of
ligands, we have analyzed the prediction performance sepa-
rately on targets including only metal ions (10 targets) and
on targets including only nonmetal ligands (17 targets).
Mixed targets including both metal and nonmetal ligands
(three targets) were not considered in this subanalysis.
RESULTS AND DISCUSSION
Overall performance
In the CASP9 protein-binding sites prediction category
(FN), the predictors were given a protein sequence with
unknown structure and asked to identify the residues
involved in ligand binding. According to the CASP format,
the predictions were binary, and, thus, classified each resi-
due as either binding-site or nonbinding-site residue. As
defined by the organizers, only protein-small molecule
interactions were considered in this category. The assess-
ment of this category consisted of the following three
steps: (1) identification of biologically relevant ligands in
the target structures, (2) definition of binding site resi-
dues, and (3) assessment of the prediction performance.
One dominant factor in assessing the correctness of
ligand-binding site prediction is the availability of experi-
mental data and the evaluation of the biological relevance
of the specific ligand binding. Whether a certain ligand is
observed in an experimental structure is first and foremost
determined by the specific purification procedure, by the
experimentalist’s choice of using this ligand for a co-crys-
tallization experiment, and the specific experimental con-
ditions (ligand concentration, pH and buffer conditions,
ionic strength, precipitant, etc.). If a ligand is not observed
in a specific experimental structure, it could still bind
under different conditions, that is, it cannot be considered
as a ‘‘true negative’’ data point for the assessment. On the
other hand, if a certain ligand is observed in a target struc-
ture, we can classify the residues within this structure into
‘‘binding’’ and ‘‘nonbinding’’ with regard to this specific
ligand. Note that a target protein might be able to bind
different ligands under different experimental conditions,
and only a subset of them might be present in the target
structure at hand. For example, the structure of an enzyme
might be crystallized in complex with the cofactor, but
without substrate or product molecules.
Although the identification of ligands in CASP9 was
based only on experimentally observed ligands, it was still
not straightforward to categorize their biological rele-
vance. Although in 73% of the target structures in
CASP9, various ligands were present, most of them were
not considered biologically relevant but rather as origi-
nating, for example, from solvent, crystallization precipi-
tant, or buffers. For the assessment, however, we included
only ligands that we considered to be biologically rele-
vant. The decision on biological relevance was done by
manual curation, primarily based on the type and loca-
tion of the ligand, literature information, and UniProt27
annotations. In addition, information from structurally
closely related homologues and conservation of function-
ally important residues was used to guide the selection
process. Using this approach, 16 target structures with
biologically relevant ligands were selected of the 109 tar-
gets available in CASP9 for the assessment.
In addition, we have analyzed all remaining heteroa-
tomic groups, if they occupied binding sites that mim-
icked the interactions of a known biologically relevant
ligand for this protein. In these cases, we defined an
‘‘extended binding site’’ consisting of all residues in con-
tact with the known biologically relevant ligand. We were
careful to include only targets where the assignment was
unambiguous in order to avoid the inclusion of false bind-
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ing site definitions. Using this approach, the number of
target structures in the FN category was extended by 14,
yielding a total of 30 targets in this category (Table I).
Within the selected targets, 10 were found in complex
with metal ions (Ca, Fe, Mg, Mn, Na, and Zn) and further
17 targets in complex with nonmetal ligands (Table I). The
latter included amino acids and derivatives, nucleotides,
sugars, fatty acids, and others. Additionally, in three cases,
nonmetal ligands were coordinated to metal ions (Mg, Mn,
and Zn). In most of the targets, the ligand-binding site was
located within a monomer, while, for six targets, the ligand
was bound in the interface between multiple chains:
T0515, T0547, T0591, T0636 (dimeric structures), T0629
(trimeric structure), and T0632 (tetrameric structure). The
ligands were bound between all chains of the oligomeric
structure, except for T0632 where the ligand is bound to
only three of the four chains.
Following the identification of biologically relevant
ligands, the binding site residues for those targets were
defined as those residues directly in contact with the
ligand. Atoms were considered to be in contact if they
were within a distance of the sum of their van der Waals
radii plus a tolerance distance. The list of binding site
residues used in the assessment for each target is pro-
vided in Table SI (Supporting Information). The toler-
ance distance was defined as 0.5 A˚ by the CASP organiz-
ers. We tested the influence of different values for the tol-
erance distance of the binding site definition and their
influence on the assessment of prediction performance.
No significant differences in the overall prediction per-
formances were observed for different tolerance distances
(Fig. S1, Supporting Information).
The majority of FN targets in CASP9 were classified as
template-based modeling targets (TBM), and only two tar-
gets were free modeling (FM) targets: (1) target T0629,
where the ligand binding domain had no template struc-
ture Figure 8(C), (2) target T0604, where the ligand was
bound between two domains where one was a template-
based modeling (constituting 90% of the binding site resi-
dues) and one a free modeling domain (constituting 10%
of the binding site residues). This strong bias in the data
set has direct consequences for the assessment, as it is to be
expected that template-based prediction methods will per-
form much better than de novo methods in this context.
In total, 33 groups submitted predictions in the
CASP9 FN category. A summary of the predictions is
given in Figure 1. Among the participating groups, 18
were registered as ‘‘human predictors’’ and 15 as
‘‘servers’’ (Table II). Most groups predicted at least 25 of
the assessed 30 targets, that is, 12 groups (6 humans and
6 servers) predicted between 25 and 29 of the assessed
targets and 15 groups (6 humans and 9 servers) predicted
all 30 targets; six human groups returned predictions for
only six or less targets. Binding site prediction perform-
Table I
Summary of CASP9 Targets with Bound Ligands
Target PDB Partial ligand Extended ligand Chemical class Interface CASP category
T0515 3MT1 SO4 PLP, LYS Nonmetal A–B TBM
T0516 3NO6 IMD PF1 Nonmetal TBM
T0518 3NMB NA Metal TBM
T0521 3MSE CA, CA Metal TBM
T0524 3MWX GOL GAL Nonmetal TBM
T0526 3NRE PEG GLA Nonmetal TBM
T0529 3MWT MN Metal TBM
T0539 2L0B ZN, ZN Metal TBM
T0547 3NZP PLP PLP, LYS Nonmetal A–B TBM
T0548 3NNQ ZN Metal TBM
T0565 3NPF CSA DGL, ALA Nonmetal TBM
T0570 3NO3 MG, GOL Metal, nonmetal TBM
T0582 3O14 ZN Metal TBM
T0584 3NF2 SO4 DST, IPR Nonmetal TBM
T0585 3NE8 ZN Metal TBM
T0591 3NRA LLP Nonmetal A–B TBM
T0597 3NIE ANP Nonmetal TBM
T0599 3OS6 SO4 ISC Nonmetal TBM
T0604 3NLC FAD Nonmetal TBM / FM
T0607 3PFE ZN ZN, BES Metal, nonmetal TBM
T0609 3OS7 TLA GAL Nonmetal TBM
T0613 3OBI EDO GAR, NHS Nonmetal TBM
T0615 3NQW MN, SO4 MN, GPX Metal, nonmetal TBM
T0622 3NKL SO4 NAD Nonmetal TBM
T0625 3ORU ZN Metal TBM
T0629 2XGF FE, FE, FE, FE, FE, FE, FE Metal A–B–C FM
T0632 3NWZ COA Nonmetal A–B–C TBM
T0635 3N1U CA Metal TBM
T0636 3P1T TLA HSA, PLP Nonmetal A–B TBM
T0641 3NYI STE Nonmetal TBM
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ance was measured using Z scores of Matthews correla-
tion coefficients (see Methods section).** The comparison
between all groups is shown in Figure 2, where the error
bars indicate minimum and maximum Z scores obtained
by bootstrapping on a randomly selected subset of three-
fourth of the targets. The error bars indicate a fluctua-
tion in the average Z score for each group. However, in
case of a correlated movement in the score, this would
not influence the groups ranking. Therefore, the rank for
each prediction group was computed in each bootstrap-
ping experiment and the average, minimum, and maxi-
mum rank over all bootstrapping experiments is shown
in Figure 3.
The top 12 predictors clearly distinguished themselves
from the following 21 groups and show a significantly bet-
ter performance. Two predictors from the Zhang group
(FN096, Zhang and FN339, I-TASSER_FUNCTION) show
a better performance in terms of MCC compared to the
following 10 participants, whereas the performance among
the latter group is comparable. Because many predictors
seemed to perform similarly, statistical tests were used to
assess the significance of the differences between these
groups. Paired t-tests on all targets between all pairs of
predictors were performed. The results are shown in Table
III, with cells shaded according to computed P values.
According to the t-test, the differences between the top
ranked group (FN096, Zhang) and groups FN339 (I-TAS-
SER_FUNCTION), FN242 (Seok), and FN035 (CNIO-
Firestar) are not statically significant, while the differences
between FN096 and the remaining predictors are signifi-
cant. In addition, the nonparametric Wilcoxon signed
rank test was performed, which yielded comparable results
to the t-tests (Table SII, Supporting Information).
Recently, McGuffin and coworkers published an alter-
native binding site distance test (BDT).31 Opposed to
MCC, BDT takes the actual three-dimensional positions
of the predicted residues into account and scores residues
differently, according to the distance between the pre-
dicted and the observed binding site. Hence, BDT limits
the boundary effects originating from ambiguous defini-
tion of binding sites. When applying the BDT score on
the predictions (Fig. S2, Supporting Information), for the
top ranked groups, no significant deviations to the
MCC-based prediction assessment were observed.y
As described earlier, for 14 targets, the partial binding
sites were individually extended around the observed
ligand to reflect a binding site accommodating the most
Table II
Groups Participating in the FN Category in CASP9
ID Rank Name Type Group
FN017 22 3DLIGANDSITE1 S Michael Sternberg
FN035 5 CNIO-FIRESTAR H Gonzalo Lopez
FN057 21 3DLIGANDSITE3 S Michael Sternberg
FN072 23 3DLIGANDSITE4 S Michael Sternberg
FN094 8 MCGUFFIN H Liam McGuffin
FN096 1 ZHANG H Yang Zhang
FN097 30 KOCHANCZYK H Marek Kochanczyk
FN102 15 BILAB-ENABLE S Shugo Nakamura
FN104 7 JONES-UCL H David Jones
FN110 6 STERNBERG H Michael Sternberg
FN113 9 FAMSSEC H Katsuichiro Komatsu
FN114 10 LEE H Jooyoung Lee
FN132 27 MN-FOLD S Chris Kauffman
FN147 28 GENESILICO H Janusz Bujnicki
FN154 33 JAMMING H Gabriel del Rio
FN193 24 MASON S Huzefa Rangwala
FN207 26 ATOME2_CBS S Jean-Luc Pons
FN236 12 GWS S Jooyoung Lee
FN240 32 TMD3D H Hiroshi Tanaka
FN242 4 SEOK H Chaok Seok
FN303 20 FINDSITE-DBDT S Jeffrey Skolnick
FN311 31 ALADEGAP H Kei Yura
FN315 3 FIRESTAR S Gonzalo Lopez
FN316 18 LOVELL_GROUP H Simon Lovell
FN339 2 I-TASSER_FUNCTION S Yang Zhang
FN353 17 SAMUDRALA H Ram Samudrala
FN402 13 TASSER H Jeffrey Skolnick
FN415 25 3DLIGANDSITE2 S Michael Sternberg
FN425 19 INTFOLD-FN S Liam McGuffin
FN446 16 KIHARALAB H Daisuke Kihara
FN452 11 SEOK-SERVER S Chaok Seok
FN453 14 HHPREDA S Johannes Soeding
FN458 29 BILAB-SOLO H Mizuki Morita
Figure 1
Overview of predictions per group. Predictions for targets which were
assessed in the FN category (i.e., targets with a relevant binding site) are
displayed in dark colors, additional predictions, which were not assessed
(i.e., targets without an experimentally confirmed binding site) are
displayed in light colors. Human groups are shown in purple, servers in
orange.
yThe largest change in ranking by three positions would be for group FN110.
**As described in Materials and Methods section, the authors decided that assign-
ing a MCC score of zero to empty submissions, which did not include any bind-
ing site predictions and to missing predictions would most appropriately reflect a
‘‘real life’’ prediction situation in the assessment. Please note that this policy has
consequences for the final ranking as it penalizes methods, which are not able to
make predictions for some targets, and encourages the more risky development of
novel methods as there is no implicit penalty for making predictions for challeng-
ing targets.
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probable biologically relevant ligand. To investigate the
influence of this extension, the assessment was performed
both on all residues of the extended binding site and sep-
arately on all the residues of the partial binding site while
treating the residues exclusively in the extended binding
site as ‘‘neutral’’ for the analysis. For the top-ranked
groups, no significant differences in the overall prediction
performances were observed between partial and
extended binding site definitions (Fig. S3, Supporting
Information).yy
Assessment by type of binding sites
In addition to the overall performance, subsets of the
targets were evaluated individually, according to the
ligand’s chemotype. The distinct chemical properties of
metal ions and organic ligands give raise to diverse bind-
ing sites. Thus, it could be expected that various predic-
tion methods perform differently. To address this ques-
tion, we have analyzed the prediction performance sepa-
rately on all targets including only metal ligands (10
targets) and on targets including only nonmetal ligands
(17 targets). The mean Z score per group separated into
metal and nonmetal targets are shown in Figure 4.
Within the top 10 groups, most of them show a better
performance for nonmetal targets, with the exception of
FN242 (Seok) and FN114 (Lee). Especially group FN114
shows a better performance on metal ligands, compared
to an average performance on the full set of targets.
Among the CASP9 FN targets, in six cases, the ligand
binds in the interface between multiple chains of an oli-
gomeric protein complex. Although, the number of inter-
face targets is very limited, we were interested in the
question if the prediction of ligand-binding sites of inter-
face targets is more difficult than noninterface targets.
We compared the average prediction performance, both
according to mean MCC values, as well as the number of
very good predictions (MCC > 0.85), for interface versus
noninterface targets. No significant difference was
observed; thus, on average, in those target categories, it
seems equally difficult to predict the binding site resi-
dues. However, it should be considered that four of the
six targets are ‘‘trivial’’ oligomers, where a simple blast
query returns a homologues template-ligand complex
with the correct oligomeric state.
Human versus server predictions
Looking at the top 10 groups, 8 of them were regis-
tered as ‘‘humans,’’ and only 2 as ‘‘servers.’’ Overall, there
is a striking difference between the average performance
of human groups and server groups with a mean Z score
of 0.47 and 0.15, respectively. Although predictor groups
registered as ‘‘human’’ performed considerably better
than ‘‘servers,’’ the role of human beings in the predic-
tion process was difficult to evaluate. Several aspects
seemed to contribute to this observation: human predic-
tors had access to multiple servers for structure modeling
and various server binding site predictions, while server
predictors have to rely on their own method only. While
human predictors can make use of additional annotation
from biological knowledge bases and scientific literature,
servers have to rely on structured machine-readable in-
formation. A major bottleneck in this context seems the
lack of consistent annotation of ligands found in PDB
entries with respect to their biological relevance. It
Figure 3
Mean rank based on bootstrapping experiment for the top 20 predictor
groups. Error bars show minimum and maximum rank obtained from
bootstrapping experiment. Human predictors are shown in purple,
servers in orange.
Figure 2
Mean Z scores over all targets for the top 20 predictor groups. Error
bars show minimum and maximum average Z scores obtained from
bootstrapping experiment. Human predictor groups are shown in
purple, servers in orange.
yyThe largest difference was observed for group FN113, which would change rank
by three positions.
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appears that human predictors benefit from the longer
prediction time mainly by their ability to distinguish rel-
evant from irrelevant ligand predictions.
Prediction methods have converged to a
similar approach
When comparing the methods of the top performing
groups, it seems that they have converged to similar
approaches, which are based on homology transfer from
related structures in the PDB. By identifying homologous
protein structures with bound ligands, putative binding
site residues in the target model are classified by spatial
proximity after alignment or superposition. The methods
differ in their specific implementations with regards to
the underlying structure databases (PDB vs. curated
binding site libraries), target representation (alignment to
structure vs. full atomic models), superposition to related
structures to identify putative binding sites, and the use
of residue conservation information in the prediction
process. The major drawback of these homology-based
inference methods is that they rely on the availability of
related protein structures with bound ligands and are
thus unable to make predictions for novel proteins with-
out prior ligand information.
Although many groups have used similar approaches
to make their predictions, we observed a surprising het-
erogeneity of performance within targets. As shown in
Figure 5 (and Figure S4), the 12 top performing groups
show overall a similar spectrum of results, with a few
nearly perfectly predicted targets and some poorly pre-
dicted targets. Interestingly, when analyzing the results
for individual targets, at least one good prediction was
achieved across all groups (MCC value of at least 0.56;
on average 0.84; see Fig. 6), and even predictors with a
poor overall performance, can yield the best individual
prediction for certain targets, as shown in Figure 7.
Thus, either the performance of the different methods is
highly target specific, or there is a considerable random
component in the prediction process in combination
with a strong influence by the small and biased target
data set.
Prediction examples
Obviously, target T0604 was the most difficult target
in the FN category in CASP9, with a maximum MCC
score of 0.56 for the best prediction, and an average score
of 0.29. The protein is a putative FAD-dependent oxidor-
eductase with a bound FAD molecule (PDB : 3nlc). The
protein is monomeric and forms a large binding pocket
for the ligand. The structure is shown in Figure 8(A) to-
gether with the binding site predictions of group FN035
(CNIO-FIRESTAR) as one of the best predictions for this
target. The top performing methods were able to accu-
rately predict the lower part of the binding site around
the adenine moiety, whereas all of them failed for the
upper part of the binding site around the flavin moiety.
Figure 4
Mean Z scores of the top 20 groups, separated by the ligand’s
chemotype. Metals are shown in blue, nonmetals are shown in green.
Table III
P Values Computed by Paired t-Test of All Against All Predictors
FN096 FN339 FN315 FN242 FN035 FN110 FN104 FN094 FN113 FN114 FN452 FN236
FN096 — 0.24 0.01 0.08 0.06 0.01 0.01 0.00 0.00 0.00 0.00 0.00
FN339 0.24 — 0.27 0.20 0.28 0.20 0.05 0.04 0.02 0.05 0.02 0.02
FN315 0.01 0.27 — 0.81 0.56 0.63 0.17 0.20 0.03 0.14 0.12 0.07
FN242 0.08 0.20 0.81 — 0.85 0.90 0.31 0.28 0.27 0.19 0.10 0.09
FN035 0.06 0.28 0.56 0.85 — 0.88 0.44 0.52 0.38 0.45 0.45 0.31
FN110 0.01 0.20 0.63 0.90 0.88 — 0.33 0.28 0.27 0.30 0.33 0.18
FN104 0.01 0.05 0.17 0.31 0.44 0.33 — 0.88 0.88 0.89 0.93 0.93
FN094 0.00 0.04 0.20 0.28 0.52 0.28 0.88 — 0.99 0.98 0.94 0.79
FN113 0.00 0.02 0.03 0.27 0.38 0.27 0.88 0.99 — 0.99 0.95 0.76
FN114 0.00 0.05 0.14 0.19 0.45 0.30 0.89 0.98 0.99 — 0.96 0.56
FN452 0.00 0.02 0.12 0.10 0.45 0.33 0.93 0.94 0.95 0.96 — 0.83
FN236 0.00 0.02 0.07 0.09 0.31 0.18 0.93 0.79 0.76 0.56 0.83 —
Significant differences between two groups are indicated by cells with white background. For clarity, only the 12 top performing predictors are shown, sorted by their
overall performance.
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This stems from the fact that this target structure has
only remote homologues, which differ significantly in the
flavin binding site region. This example clearly demon-
strates the limitations of prediction methods that are
based on homology transfer.
Target T0629 is the only target in the current ligand-
binding target set, which was classified as free modeling
target and thus has no template structure. The protein
(PDB: 2xgf) is the bacteriophage T4 long tail fiber recep-
tor-binding tip. It contains a long fiber like structure,
which is formed by three chains and binds seven iron
atoms. Each iron atom is complexed by six histidine resi-
dues. Each protein chain contributes two histidines to
each binding site, where the two histidines are in a His-
X-His motive, with X being either Ser, Thr, or Gly. The
target structure is shown in Figure 8(C) together with
the binding site predictions of group FN114 (Lee), the
best predictor for this target among the top 10. Common
to all predictions for this target is that they correctly pre-
dicted a subset of the seven binding sites—most likely
due to local similarity to another metal binding protein
Figure 6
Overall target difficulty. MCC value of the best overall prediction for
each target.
Figure 7
Number of targets where a particular group returned the best
prediction. Groups are sorted by their overall performance. For one
target, multiple groups can perform equally.
Figure 5
MCC scores for the 12 top performing groups for all targets. Targets were sorted by their respective MCC score, individually for each group.
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with a His-X-His motif - but no predictor identified all
sites correctly.
The structure of target T0632 (PDB : 3nwz) is a
homo-tetramer, which binds coenzyme-A. This ligand is
interacting with three of the four chains of the protein,
which seems to present a challenge for binding site resi-
due prediction observed by a low average MCC of 0.22.
An excellent prediction was obtained by group FN096
(Zhang) with an MCC of 0.72, which is depicted in Fig-
ure 8(B) along with the target structure. Many residues
were well predicted despite originating from different
chains. In this prediction, the largest errors originate
from missing some binding site residues due to an elon-
gated terminus compared to structurally closely related
templates.
CONCLUSION
The task of predicting binding sites from a protein’s
sequence is of high relevance for life science research,
ranging from functional characterization of novel pro-
teins to applications in drug design, and consequently
the ligand-binding site prediction category in CASP has
received increasing attention over the past years. In
CASP9, it attracted a total of 33 predictors—10 more
groups than in CASP8. In contrast to the previous
CASPs, where only three predictors yielded reliable pre-
dictions,20 in this assessment, nearly half of the predic-
tion groups yielded reliable predictions for the majority
of targets. Two groups (FN096, Zhang; FN339, I-TAS-
SER_FUNCTION) performed better than the rest (when
accounting for missing target predictions in the assess-
ment), while the following ten prediction groups per-
formed comparably well. This is not very surprising with
respect to the observation that in this round all top per-
forming groups based their methods on approaches,
which are similar to the best performing strategy in pre-
vious CASP experiments (i.e., Sternberg34 and Lee15).
Limitations of the current format and
recommendations for future experiments
The very low number of target structures with relevant
ligands is a major limitation to the assessment as it does
not allow to draw significant conclusions on the specific
strengths and weakness of different prediction methods,
for example, with regard to target difficulty or type of
the ligands. Only 30 of the total 109 CASP9 targets
(28%) were considered to have a biologically relevant
ligand bound in the target structures and were thus
assessed in the FN category. It is likely that some of the
Figure 8
Examples of binding site predictions. All ligands are shown in spheres render mode. The protein backbone is shown in cartoon mode with each
chain colored separately. All side chains of observed and predicted binding site residues are shown in licorice sticks. Correctly predicted residues
(true positives) are colored in green, incorrectly under predicted binding site residues (false negatives) in yellow and incorrectly over predicted
nonbinding site residues (false positives) in red. A: Target T0604 with predictions of group FN035. B: Predictions of group FN096 for target T0632.
C: Group FN114’s predictions for target T0629.
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remaining target proteins would bind interesting ligands
under different experimental conditions, but such con-
clusions can not be made with the available data. In the
previous CASP8 experiment, the total number of targets
in this category was 27, illustrating that this is a recur-
ring problem—and not specific to this round of CASP.
Another rather drastic limitation of the FN category is
the binary prediction format that classifies residues as ei-
ther ligand binding/nonbinding based on a hard distance
cutoff. Consequently, all ligands are currently treated uni-
formly, independent of their chemical type, and all
potential binding sites are treated uniformly, independent
of their affinity (or binding probability) for different
ligands. Moreover, most targets in the FN category were
straightforward TBM targets with numerous, closely
related template structures, and only one of the 30 tar-
gets was categorized as free modeling (FM). However,
exactly this class of target structures is of highest interest
for computational ligand-binding site prediction, where
no obvious information about the location of their bind-
ing sites is available. We suggest the following modifica-
tions to the assessment of ligand-binding site predictions
to enable the community to benefit even further from
future rounds of this experiment:
 In order to accumulate a sufficiently large number
of prediction targets, the assessment of this category
should be done continuously based on a weekly
PDB prerelease. This would allow assessing the per-
formance in different ranges of target difficulty, sim-
ilar to other CASP categories and faciliate analyzing
the strengths and weakness of different approaches.
During the CASP meeting in Asilomar, we have sug-
gested that the CAMEO project (Continuous Auto-
mated Model EvaluatiOn) of the Protein Model Por-
tal35 could contribute to this effort.
 Binding sites differ chemically and structurally from
each other, for example, a metal ion binding site has
different characteristics compared to, for example, a
sugar-binding site. We therefore suggest that the
assessment of binding site residue predictions should
be made according to chemotype categories of the
ligand expected to be bound. We propose the follow-
ing categories: ‘‘metal ions’’ (e.g., Na, Ca, Zn, Fe,
Mn, and Mg), ‘‘inorganic anions’’ (e.g., SO4 and
PO4), ‘‘DNA/RNA’’ for poly-ribonucleic acid binding
sites, and ‘‘organic ligands’’ for cofactors, substrates,
and receptor agonists/antagonists (e.g., NAD, FAD,
ATP, SAM, CoA, and PLP). More fine-grained
assessment categories might be necessary if more
specific prediction methods emerge in the future.
 The binary prediction of binding site residues should
be replaced by a continuous probability measure,
thus reflecting the likelihood for a residue to be
involved in binding a ligand of a certain type. For
example, a certain residue might be predicted as
having a high probability to bind a metal ion, but a
low probability to bind an organic ligand. The
assessment of continuous prediction variable (e.g.,
using ROC type analysis) would better reflect the
spectrum of ‘‘high affinity’’ and ‘‘low affinity’’ sites
of different types.
 The experimentalist solving a protein structure typi-
cally will have more insights and experimental evi-
dence for the biological role and relevance of ligands
observed in a protein structure than the informa-
tion, which is publicly available to assessors during
the CASP experiment. It would therefore be benefi-
cial to capture the information about the biological
role of ‘‘HETATM’’ records during PDB deposition.
Predicting binding sites from a protein’s sequence has
the potential for yielding high impact on life science
research—if the predictions are specific and accurate
enough to help addressing relevant biological questions.
We hope that with the suggested modifications, the
assessment of ligand-binding site predictions will be
more suited to evaluate the current state of the art of
prediction methods, identify possible bottlenecks, and
further stimulate the development of new methods.
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4.3 CAMEO Ligand Binding
4.3.1 Introduction
In the post-genomic era, the number of protein structures with unknown biological func-
tion is steadily growing. To bridge this rapidly growing gap between known sequences and
unknown function, numerous computational and experimental techniques have been devel-
oped.5,1, 6 Among these methods, structural comparison of the three dimensional shape to
homologous proteins with known function can often help to assign the function of unknown
proteins.19 However, the accuracy of such an approach is often insufficient since proteins with
the same global fold can have different biological functions. In addition, for many applications
knowing the global function of a protein is insufficient and it is critical to elucidate the structural
details of how the protein interacts with its ligands.115 Hence, the identification of a protein’s
functionally important residues, such as ligand-binding sites or catalytic active residues, is a
crucial step toward the goal of understanding the protein’s molecular function and its biological
role in the cell. Although those interactions are crucial for the function of a protein, they are
often unknown and require elaborate and time-consuming studies by X-ray crystallography or
NMR. To facilitate this process, numerous computational methods have been developed with
the goal of identifying the precise location of ligand binding sites and the protein residues directly
involved in interacting with the ligand.7
Predicting binding sites from a protein’s sequence is of high relevance for life science re-
search, ranging from functional characterization of novel proteins to applications in drug design
and enzyme engineering. Consequently, the development of automated methods for predicting
ligand-binding sites has received increasing attention over the past years.
However, relevant biological questions can only be addressed if predictions are specific
and accurate. Therefore, evaluating the performance of prediction methods in a blind and
objective way is crucial. To achieve this goal, ligand binding site prediction methods have been
assessed since the 6th edition of the Critical Assessment of Techniques for Protein Structure
Prediction (CASP) experiment.113,114 This process has been extended and fully automated in
the Continuous Automated Model EvaluatiOn (CAMEO) framework as a new category.
In CAMEO Ligand Binding we continuously evaluate the accuracy and reliability of ligand
binding site prediction services in a blind and fully automated manner to assess the current
state of the art of prediction methods, identify possible bottlenecks, and further stimulate the
development of new methods.
As mentioned before, ligand binding site (LB) predictions have been assessed in recent
CASP experiments.25,24,23,113 However, the setup in CASP has shown some major limitations
which prevented to draw significant conclusions:
 A very low number of challenging target structures with relevant ligands.
 A limited prediction format which treats all ligands uniformly, independent of their chem-
ical type and treats all potential binding sites uniformly, independent of their affinity for
different ligands.
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Hence, in CAMEO a number of changes were made to alleviate the shortcomings of previous
CASP LB experiments:
 First, in CAMEO participating servers are evaluated continuously, every week, based on
all newly released PDB structures in order to accumulate a sufficiently large number of
prediction targets.
 Second, in CAMEO we have modified the ligand binding site prediction format to allow
a more fine-grained prediction and a more detailed assessment.
 Third, binding sites differ chemically and structurally from each other e.g. a metal ion
binding site has different characteristics compared to a sugar binding site. We therefore
assess ligand binding site predictions according to chemotype categories of the ligand
expected to be bound.
 Fourth, the prediction of binding site residues employs continuous probability measures
as opposed to the binary prediction format used in CASP, thus reflecting the likelihood
for a residue to be involved in binding a ligand of a certain type.
4.3.2 CAMEO Workflow
Figure 4.1: Schematic overview of the general CAMEO workflow. Every Friday afternoon, CAMEO sends
the sequences of the weekly PDB prerelease to all registered servers. Each Wednesday, upon release of the
structures, CAMEO Ligand Binding evaluates all predictions received prior to that date.
The workflow used in CAMEO is schematically depicted in Figure 4.1. It consists of three
independent steps.
Collecting all PDB prerelease sequences (i.e. sequences ready to be released within the
next release cycle), filtering them to remove duplicates and subsequently submitting them
to all participating servers.
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Collecting the responses from the participating servers and checking for format errors.
Evaluating automatically all predictions received prior to the new PDB release and pre-
senting the results on the CAMEO web pages.
It should be noted that CAMEO functions in a blind and fully automated fashion. This
is important to guarantee a fully independent, objective and comparable evaluation of current
methods.
For CAMEO Ligand Binding, the biological role of ligands can be annotated by the users
through a web-based, consensus wisdom of the crowd approach available as the CAMEO
Structure Annotation System.
4.3.3 Prediction Targets
All protein sequences from the weekly PDB prerelease with a minimum length of 30 amino
acids are submitted to the participating ligand binding site prediction servers five days before
the structures are published. Predictions are only accepted if deposited before the new PDB
release. Upon release of the target structures, all protein structures containing biologically
relevant ligands are used for further evaluation of the accuracy of the prediction servers.
4.3.4 Ligand Annotation
All ligands present in the newly released PDB structures are classified based on their biological
relevancy (i.e. ’biological relevant’ or ’biological irrelevant’). Classification is based on manual
inspection of all newly released protein structures. The user is assisted by an automatic ligand
classification algorithm which suggests the biological relevancy for each ligand in a protein
structure, based on the following criteria:
distance between protein and ligand atoms must be within a certain cutoff distance
commonly observed irrelevant ligands (e.g. common buffers, crystallization molecules)
are excluded
covalently bound post-translational modifications are removed
All automatic assignments can be overwritten by the user through a publicly available, web-
based structure annotation platform, which we have developed for straightforward inspection of
protein-ligand complex structures.116 This allows the user to easily navigate through all ligands
of a structure using 3D visualization. Additional structural information is displayed and a direct
access to the corresponding publication is given in order to facilitate the user’s decisions. All
ligands can be annotated according to the ligand classification scheme (see Section 4.3.5) and
all annotations are stored in a database for further access. In addition, literature references can
be added and discussions among users is possible within the annotation system.
Assignment of the biological role of a ligand in a structure has been one of the major
limiting factors in the field of binding site and function prediction but is not limited to this
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field. Thus, building a publicly available resource of manually curated ligand annotations has
a great potential for improving current methods for protein structure and function prediction.
Annotating ligands in CAMEO is a community effort. Thus, all people in the research community
are invited to annotate their favorite structures. By using such a wisdom of the crowd
approach a consensus answer can be obtained directly and controversial cases can be identified.
4.3.5 Ligand Classification Scheme
For the functional annotation of ligands present in CAMEO target structures, a new ligand
classification scheme has been developed as shown in Figure 4.2. This classification scheme is
based on a ligand-centric functional annotation approach as opposed to a binding-site-centric
approach. For each ligand class a corresponding ligand classification number (LC number) was
assigned consisting of a number for each depth level of the tree, separated by dots in order to
easily determine the super class for a given LC number and to facilitate possible extensions of
the current ontology.
post-translational
modification
[1.2.1]
chemical
modification
[1.2.2]
ligands
[1]
structural ligand
[1.3.1.5]
signaling ligand
[1.3.1.4]
product
[1.3.1.2]
substrate
[1.3.1.1]
cofactor
[1.3.1.3]
natural
[1.3.1]
synthetic
[1.3.2]
non-covalently
bound
[1.3]
impurities
[1.1.3]
solvent
[1.1.2]
buffer
[1.1.1]
irrelevant
[1.1]
covalently bound
[1.2]
Figure 4.2: Current ligand classification ontology used in the CAMEO Structure Annotation System. For
each ligand class its classification number is shown in square brackets.
Currently, the ontology consists of three super classes: irrelevant ligands [1.1], covalently
bound ligands [1.2] and non-covalently bound ligands [1.3]. The first super class includes buffers
[1.1.1], solvents [1.1.2] and other impurities [1.1.3]. The second super class includes natural
post-translational modifications [1.2.1] like glycosylations or phosphorylation and chemical mod-
ifications [1.2.2] like addition of MTSL spinlabels. The third super class includes natural [1.3.1]
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and synthetic [1.3.2] non-covalently bound ligands where the former is further divided into sub-
strates [1.3.1.1] and products [1.3.1.2] of enzymatic reactions, functional cofactors [1.3.1.3] like
ATP or SAM, signaling ligands [1.3.1.4] like steroid hormones and structural ligands [1.3.1.5]
like structurally important metals ions. For CAMEO ligand binding, the evaluation is currently
limited to the last super class.
4.3.6 Ligand Categorization
All ligands are categorized into four predefined categories and predictions are assessed individ-
ually for each category where at least one ligand was observed in the target structure. Ligand
categorization is based on the preliminary ligand classification (chemtype) of the PDB, as de-
fined in the chemical component dictionary117 under the item ’ chem comp.pdbx type’.
Table 4.1: Definition of ligand categories in CAMEO LB and rules that are applied to categorized ligands
according to the ligand classification (chemtype) of the PDB.
aAll chemtypes of the organic category are included if covalently linked to ligands in the respective category.
Category Description Enclosed PDB Chemtype Examples
I ions HETAI, HETIC ZN, SO4, ACT, NH4, IOD
(non polymeric)
O organics HETAIN, ATOMS, ATOMN, ATP, FAD, SAM, GLA, F3S
ATOMP, HETAC, HETAD
(non-polymeric: resnum ≤ 2)
N poly-nucleotides ATOMN + organicsa A, DA, G, U, T
(polymeric: resnum > 2)
P poly-peptides ATOMP + organicsa ALA, KCX, LLP, PTR
(polymeric: 2 < resnum ≤ 10)
The following four CAMEO ligand categories are currently evaluated: ions (I ), organics (O),
poly-nucleotides (N) and peptides (P). Each category is defined as a subset of the available
PDB chemtypes, as summarized in Table 4.1. All ions must be monomeric and thus, consist of
a single residue. Organics can be monomeric or dimeric. Peptides and poly-nucleotides must
consist of at least three residues and at maximum of 10 and 200 residues, respectively. In order
to include capped peptides and poly-nucleotides, residues of the organic type are allowed in the
latter two categories given that they are covalently linked to the peptide or nucleotide.
4.3.7 Assessment
Preparation of Target Structures
Upon release, all target structures are obtained from the PDB118 in the mmCIF file format, are
filtered and prepared for further use through the following steps.
All structures which fail to align to the sequence which was sent to the predictors (i.e.
SEQRES sequence) are discarded.
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All non-standard amino acids are converted to their respective standard amino acid to
match the exact sequence that was sent to the predictors.
All biological assemblies defined by the PDB are considered.
Covalently linked residues are grouped together into ligand entries.
Each ligand entry is uniquely categorized into one ligand class.
Calculation of the Reference
Based on the prepared target structure, a reference binding site prediction is calculated for
each biological assembly of each protein-ligand complex. The reference contains a binding site
probability value for each heavy atom of the protein which is observed in the released structure.
This value is computed based on the protein-ligand distance (r) using a sigmoidal curve of the
following form:
pref =
1
1 + exp(1.5 ∗ r − 7.5)
Thus, a distance of 5 A˚ yields a binding site probability value (pref ) of 0.5 whereas a
distance of 3 A˚ and 7 A˚ leads to a probability close to 1.0 or 0.0, respectively.
pref values are computed for each ligand category individually by considering only the subset
of ligands corresponding to that category. In addition, for ligands belonging to the categories I
and O, pref values are computed individually for each specific ligand found in the structure.
In case multiple protein chains are present in the biological unit, the reference is computed
for each protein chain individually. In this step, all ligands of a particular category are included,
not just the ones contained in the current chain. This allows to compute probabilities for ligands
bound in the interface between multiple chains.
In case multiple biological assemblies are defined, an individual reference is generated for
each biounit as previously described.
Compare Prediction with Reference
Each prediction is evaluated by comparing it to the reference as described in Section 4.3.8. A
number of considerations apply for numerous special cases.
Multiple chains If the prediction contains multiple chains with matching sequences, each
chain is scored against the reference and the mean score of all chains is reported.
If the reference contains multiple chains with the same SEQRES sequence, the prediction
is evaluated against each chain of the reference and the highest score is reported.
In case that both the reference and the prediction contain multiple matching chains, each
prediction chain is evaluated against each reference chain. To obtain the overall score, the best
score for each chain in the prediction is averaged over all available prediction chains.
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Multiple biological assemblies In case where multiple biological assemblies are defined
in the mmCIF file, a reference is generated for each biounit. Since none of these assemblies is
a priori more correct then the others, the prediction is assessed against each of those references
and the value for the biounit with the best score is reported.
Level of Prediction When comparing a prediction against a reference, the reference always
contains p-values for each atom present in the structure. The prediction however, can contain
p-values for all atoms or for all residues or mixed for some atoms and some residues. Therefore,
for the comparison, prediction values at the atom level are used if available. Otherwise, for
each atom present in the reference, the p-values of the corresponding residue are used. If no
p-values are given both for the atom as well as the corresponding residue, all p-values are set
to 0.0.
Specific Compound Predictions When predictions are given for specific compounds in
addition to the ligand categories, the reported score is exclusively computed based on the
compound predictions, if the following condition applies: For each ligand category individually,
all compounds observed in the target structure must be present in the prediction. Predictions
for additional compounds which are not present in the structure are neglected. If the condition
is not fulfilled, the reported value is based solely on the category prediction values.
4.3.8 Scoring
Predictions are currently scored based on four different methods. Receiver operating char-
acteristics (ROC) area under the curve,119 Pearson’s correlation coefficient, Spearman’s rank
correlation coefficient120 and Matthew’s correlations coefficient.121
ROC area under curve is a measure for the ability of a classifier to produce relative scores,
i.e. predicting higher values for residues in the binding site compared to those not in the binding
site. For ROC curves, a cutoff p-value must be defined on the reference. For CAMEO this
cut-off is set to a p-value of 0.5 corresponding to a distance of 5 A˚.
Pearson’s correlation coefficient is a measure of the linear dependence between the
prediction and the reference and does not need any cutoff. However, it has two drawbacks: (1)
it is highly dependent on the mathematical function used to generate the reference, (2) it is
heavily influenced by p-values for residues that are far away from the binding site, where the
correct ordering, from a biological point of view, is of limited importance.
Spearman’s rank correlation coefficient quantifies the non-parametric statistical de-
pendency between the prediction and the reference. Opposed to Pearson’s correlation coeffi-
cient, it is independent of the mathematical function used to generate the reference, however,
it is still heavily influenced by p-values for residues that are far away from the binding site.
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Matthew’s correlation coefficient is implemented for comparison with the results of
previous CASP experiments24,25 where it was used as a measure to evaluate the ligand binding
site prediction category. It is a measure that accounts both for over and under-prediction.
However, it needs both a cutoff value for the reference as well as one for the prediction to classify
all p-values into positives and negatives. Thus, the advantage gained by introducing continuous
probability prediction values is lost. As with ROC, the cutoff p-value for the prediction and the
reference was chosen as 0.5 corresponding to a distance of 5 A˚ in the target structure.
4.3.9 Baseline Servers
For comparison of server performances, three na¨ıve servers were added to establish a baseline
for what a straightforward method would predict. Each of these servers focuses on a specific
approach: (1) sequence conservation, (2) homology transfer and (3) geometric binding pocket
identification.
Na¨ıve Conservation
A server that computes the conservation of each residue in a query sequence using sequence con-
servation information only. This server focuses on the most difficult case where no homologue
structure of the query protein is detectable.
Given a query sequence, the server performs the following three operations: (1) sequence
search in a protein database: a blast122 search is performed on the NR-90 database. All HSPs
with an E-value of less than 0.1 are accepted. (2) multiple sequence alignment: using the list of
HSPs obtained from blast, a multiple sequence alignment is built using ClustalW.123 (3) com-
putation of conservation values: conservation scores for each amino acid in the query sequence
are computed from the multiple sequence alignment according to the ConSurf method.124 The
raw conservation scores are used to assign ligand binding site probabilities with equal values for
all four ligand categories.
Na¨ıve Homology
A server that computes ligand binding sites by homology transfer based on ligands found in
homologous structures in the PDB. This server focuses on the most straightforward case where
there is at least one homologue structure which contains biological relevant ligands.
The ligand binding predictions are created from models generated by SWISS-MODEL.125,126
Ligands present in the template structure are inserted into the protein model if certain criteria
are met:
If a compound is included in a list of selected biologically important compounds1, its binding
site, defined as all residues within 3 A˚ of the ligand, is superposed onto the model and all ligand
1currently the following small molecules are taken into account in the SWISS-MODEL pipeline:
cations: CA, CO, CU, CU2, FE, FE2, MG, MN, MO, NA, NI, ZN
cofactors: ADP, AMP, ATP, BTN, COA, BGC, GLC, GDP, GMP, GTP, GSH, FAD, FMN, HEM, HEA,
HEB, NAD, NAP, NDP, NAI, PLP, SAM, THG, TPP, UDP, CDP, SF4, FES
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heavy atoms are copied into the model. If the ligand clashes with the model, i.e. any protein-
ligand distance is less than 1.5 A˚, or the RSMD of the binding site residues is larger than 2 A˚,
the ligand is rejected.
For each atom in the protein the distance between its position and the position of all the
ligand atoms is computed and used to calculate the prediction score. If multiple ligands of
the same category are present, the maximum of the computed score for this category or that
specific compound is reported.
The score is calculated with a capped linear function bounded between zero and one using
the following formula:
score(d) =

1 if d < 3
2− (13 ∗ d) if 3 ≤ d ≤ 6
0 if d > 6
where d corresponds to the distance between the protein and ligand atom.
Na¨ıve Pocket
This baseline server predicts ligand binding sites according to an analysis of the shape of the
protein structure as computed based on a homology model of the input sequence. This server
focuses on an intermediate case where there is at least one homologue structure which however,
does not contain any biological relevant ligands.
First, a comparative model is built using SWISS-MODEL.125,126 Second, all ligands in the
modeled structure are discarded and the molecular surface of the protein is computed using
MSMS.127 A three dimensional grid spanning the whole protein is generated. On every point
of that grid, the number of surface points within a distance of 10 A˚ is counted and stored as a
value on that grid point. The computed grid is then smoothed using a Gaussian filter with a
smoothing radius of 4 A˚. Subsequently, for each atom of the protein structure, the probability
of being a ligand binding site is computed from a trilinear interpolation of the values of the 8
closest grid points. The values are then scaled to match the range of 0.0 to 1.0. The method
is described in detail in Section 4.4.
4.3.10 Prediction Format
Although, predictions in the format used by the predictioncenter128 during previous CASP
experiments25,24,23 are accepted, a new format which follows the suggestions from the last
assessment for the ligand binding category during CASP925 is implemented, allowing much
more detailed predictions.
This new format consists of three sections separated by the "|" symbol:
The first section is a unique identifier for a residue or atom. It has two mandatory fields,
the residue name (”r”) and the residue number (”n”). In addition, two optional fields
can be specified, the chain name (”c”) and/or the atom name (”a”).
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The second section contains predicted p-values for four ligand categories: ions (”I”),
organics (”O”), poly-nucleotides (”N”) and peptides (”P”). Predictions for all four cat-
egories are mandatory. The values are probabilities resembling the likelihood of binding
a ligand belonging to a specific category.
The last section is optional and allows the assignment of p-values for specific ligands
denoted by their three letter PDB code.
The following additional details about the new prediction format should be noted:
 All values must be specified as a key-value pair, where the value is separated from the
key by a ”=” sign. All key-value pairs must be terminated by a ”;” sign.
 The order of the key-value pairs within one of the three sections is irrelevant, whereas
the order of the three sections is fixed.
 All predicted values must be in a range from 0.0 to 1.0.
 To simplify the prediction format, lines can be omitted if they contain only zero values
for the predictions, both in the categories and the compounds section.
 Predictions can be made at the residue and/or atom level. In the case of the latter, the
atom name must be specified in the unique identifier section (key: ”a”).
 Predictions are mandatory for all four ligand categories, whereas for specific compounds
they are optional.
A general format description is given here:
r=<resname>; n=<resnum>; [c=<chainname>;] [a=<atomname>;] | ←↪
I=<ion prob>; O=<org prob>; N=<nucl prob>; P=<pep prob>; | ←↪
[<compound ID1>=<compound prob>;] [<compound ID2>=<compound prob>;] ...
where text in between < > brackets are placeholders for actual values and all key-value pairs
in between [ ] brackets are optional. The ←↪ sign indicates that this represents one line in a
file.
Two examples of the new prediction format are given in Appendix A.2.1.
Conversion from CASP format Predictions using the binary CASP format are accepted
and internally converted to the new prediction format. Since the latter is much more detailed,
numerous limitations apply when converting.
Predictions are converted into p-values of 0.0 (non-binding site) and 1.0 (binding site),
with no values in between.
Predictions for all four categories are set to the same value.
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Predictions for specific compounds are not assigned.
Predictions are assigned on the residue level only and no specific predictions at the atom
level are done.
Predictions containing residue numbers outside of the sequence range are discarded, ex-
cept for residue number 0, indicating that no binding site was predicted.
4.3.11 Results and Discussion
Number of Relevant Targets
A major limitation of previous CASP LB experiments was the limited number of target structures
that could be evaluated for the ligand binding site category. Although, the number of target
structures in recent CASPs was around 120, only about one fourth of those (i.e. around 30
structures) had biologically relevant ligands bound, and only very few of them were hard cases
where either no structure or no ligand information was present in the PDB. To alleviate this
shortage of ligand binding sites, CAMEO evaluates all servers weekly based on all newly released
PDB structures to obtain a large number of target structures.
Figure 4.3: Number of targets per week evaluated by CAMEO Ligand Binding.
We have analyzed the number of CAMEO LB targets with biologically relevant ligands over
a period of 35 weeks. The results are summarized in Figure 4.3 where the number of targets
for each category is shown over time. Overall, 1647 structures were evaluated. On average 47
structures were assessed every week, with a minimum of 1 and a maximum of 114. Of those,
48.1% contained ions, 72.8% organic ligands, 6.8% poly-nucleotides and 5.1% poly-peptides.
It should be noted that using CAMEO LB, the number of targets available in a single week
is larger than the number of targets present in a full round of CASP.
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Category Predictions
Figure 4.4 shows the CAMEO LB target 4EQP 1 (CAMEO date: 2012.04.27). The structure is
a Staphylococcal nuclease which is bound to a calcium ion and the organic inhibitor thymidine-
3’,5’-diphosphate (THP). The target contains two binding sites. The first contains the calcium
ion which is bound through the side chains of Asp21, Asp40 and Glu43 and the backbone car-
bonyl of Thr41. The second binds the organic ligand THP which is in direct contact with Arg35,
Lys84, Tyr85, Arg87, Leu89, Tyr113, Tyr115. The prediction from the homology based baseline
server is mapped onto the structure. Binding site residues are shown in sticks representation
and are colored according to the predicted p-values using a gradient from red (non-binding site)
to green (binding site).
Figure 4.4: Structure of a Staphylococcal nuclease (4EQP) bound to a calcium ion and the organic inhibitor
thymidine-3’,5’-diphosphate (THP). The ligands are shown in sphere representation, with the calcium ion
colored in cyan, and THP in element coloring. Predictions from homology based baseline server (na¨ıve
homology) are mapped onto the structure using a gradient from red (non-binding site) to green (binding
site). The ROC score of both ligand categories is reported at the lower right hand side.
This target is an excellent example of the strength of using the new prediction format
allowing to give different predictions for different ligand categories. The na¨ıve homology server
predicted only the binding site of the calcium ion but not of the organic ligand THP, since the
latter is not in the list of commonly observed, relevant organic ligands used by this server for
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prediction. From Figure 4.4 it is obvious that the binding site of the ion is perfectly predicted
with an ROC auc of 1.0. However, since no prediction for the organic category was given, the
performance is assigned a score of a random prediction (ROC auc of 0.5). If this target was
predicted and assessed as a whole, as was done in recent rounds of CASP, a ROC auc score of
0.69 would be obtained. This example clearly shows the strength of predicting and assessing
multiple ligand categories individually. The overall score would indicate a rather weak prediction
performance (ROC auc of 0.69) which clearly does not appropriately reflect the real prediction
performance, which in this example is excellent for the ion binding site but poor for the organic
ligand binding site.
Specific Compound Predictions
If specific compound predictions are given for all ligands present in the target structure, the
prediction performance will be assessed on these specific predictions instead of the corresponding
category. This has the advantage in the case where, for example a protein has two binding sites
for two distinct metal ions but in the target structure only one of the two is occupied.
To demonstrate the effect, we have generated an example based on the CAMEO ligand
binding target 3RVH 1 (CAMEO date: 2012.05.04). The structure is a lysine-specific histone
demethylase JMJD2A. The structure contains two metal ions: a structurally important zinc ion
and a nickel ion substituting for the catalytically relevant iron ion. In addition, the protein is
bound to an organic small-molecule inhibitor (HQ2) which is in direct contact with the catalytic
metal ion. The two metal ions bind to two distinct binding sites located 15 A˚ apart. The na¨ıve
homology prediction server gives predictions at the specific compound level and predicts both
metal ion binding sites correctly. To investigate the difference in the prediction performance
between specific compound predictions and category predictions, the structural zinc ion in the
target structure was removed prior to the assessment, yielding a target structure where only
one metal ion binding site was present. Subsequently, the prediction was evaluated using both
the category or the compound predictions exclusively.
Table 4.2: Comparison between the evaluated prediction performance when assessed either based on
categories or based on specific compounds exclusively. All scores are computed for the ion category.
assessed on
categories compounds
ROC auc 0.994 0.997
Spearman’s correlation coefficient 0.395 0.538
Pearson’s correlation coefficient 0.474 0.651
From Table 4.2 a significant increase can be observed for Spearman’s and Pearson’s corre-
lation coefficient when specific compounds are predicted. A much smaller increase is observed
for ROC auc, since ROC only accounts for relative scores and in both cases, all high probability
binding site residues are well scored.
112
4.3. CAMEO LIGAND BINDING
Oligomeric State
Figure 4.5 shows the CAMEO LB target 4G8S 1 (CAMEO date: 2012.08.03). The structure is
a nitroreductase from Geobacter sulfurreducens PCA which forms a homodimer. It binds the
organic cofactor riboflavin-5’-phosphate (FMN) which is located in the interface between the
two protein chains and is in contact with 13 residues of chain A and 9 of chain B. The target is
a relatively easy case, where the close homologue 4DN2 (sequence identity: 76%, superposition
rmsd: 1.0 A˚), also a homodimer, binds the same ligand in the same location. The prediction
from the INTFOLD-FN server is mapped onto the structure. Binding site residues are shown
in sticks representation colored according to the predicted p-values using a gradient from red
(non-binding site) to green (binding site).
Figure 4.5: Homodimeric structure of a nitroreductase from Geobacter sulfurreducens PCA (4G8S) bound
to the organic cofactor riboflavin-5’-phosphate (FMN). Predictions from the server INTFOLD-FN are
mapped onto the structure using a gradient from red (non-binding site) to green (binding site). The
ROC score of both ligand categories is reported at the lower right hand side.
From Figure 4.5 it is obvious that INTFOLD-FN only predicts binding site residues from
one single chain and thus does not consider the correct oligomeric state. This is also true for all
other registered non-na¨ıve servers. The performances are generally good as shown in Table 4.3.
It is obvious that the performance could be further improved by considering the oligomeric state
of the target structure for the prediction as clearly demonstrated by the na¨ıve homology server,
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Table 4.3: Comparison of the prediction performance for CAMEO ligand binding target 4G8S 1.
INTFOLD-FN HHfunc server5 na¨ıve homology
ROC auc 0.83 0.71 0.83 0.98
Spearman’s correlation coefficient 0.55 0.42 0.55 0.77
Pearson’s correlation coefficient 0.70 0.54 0.70 0.81
Matthew’s correlation coefficient 0.78 0.59 0.77 1.00
which is the only server that currently takes the correct oligomeric state into account.
Web-based Representation of the Results
All servers are evaluated based on a number of different scores and all raw numbers are reported
on the CAMEO Ligand Binding web site. To facilitate the interpretation of these numbers,
CAMEO Ligand Binding presents them in more user friendly graphical representation as the
averaged performance (according to ROC auc) of each server against the number of targets
that were predicted by the server. Thus, a server on the upper left hand corner performs very
well on a small number of selected targets but does not give predictions for all the other targets.
On the other hand, a server on the right hand side, might on average perform less good than
the previously described server, but gives predictions for nearly all targets. Depending on the
users application, both approaches might be valid and thus the user can select what is needed
or combine predictions from multiple servers in order to obtain the best suited predictions. In
addition, to observe the development of a server, plots of its performance over time are given
on the CAMEO Ligand Binding web site.
4.3.12 Conclusion
CAMEO Ligand Binding has been publicly released recently.129 Despite the short period since
the announcement, it is already used by the ligand binding site prediction community. In this
short time, three external servers, coming from the McGuffin and the So¨ding groups, have
joined.
CAMEO Ligand Binding has already shown significant improvements over recent CASP lig-
and binding site prediction experiments by evaluating a significantly increased number of targets
and by allowing to predict binding sites in a more fine grained manner through categorization
and continuous prediction values.
CAMEO Ligand Binding has already proven to be useful by identifying possible bottlenecks
in current prediction methods like for example the incorrect use of the oligomeric state of target
and template structures. CAMEO LB also helps the server administrators by testing the server
on a weekly basis, by notifying them in case where no predictions are received and by reporting
server response times to obtain a measure for the technical performance.
CAMEO Ligand Binding helps the users of ligand binding site prediction methods by identi-
fying which methods are best suited for a particular use-case. This is achieved by assessing the
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prediction performance on individual ligand categories and by identifying strength and weak-
nesses of each server, like the difference between highly accurate servers which predict only
few targets and less accurate servers which predict nearly all targets. The information obtained
through CAMEO could further help the user to combine multiple server predictions in order to
obtain the best predictions for a particular purpose.
CAMEO Ligand Binding is continuously extended and improved in order to challenge all
participating servers and to provide the most useful information to the community. Ultimately,
CAMEO should be able to determine which methods should be chosen in order to yield the best
predictions for a particular target sequence.
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4.4 Geometry Based Ligand Binding Site Prediction
4.4.1 Introduction
A quantitative comparison of the performance of ligand binding site prediction methods is not
always straightforward. In particular, different methods perform differently based on the data
available for a particular prediction case. For example, a method that depends on homology
transfer from related structures might not perform well in the case where either no homologue
structure is available or where no ligands are bound in the homologue structures. Whereas, in
such a case, a method depending only on sequence conservation might yield a good perfor-
mance. However, comparing methods with each other that use completely different underlying
methodologies might be problematic.
To alleviate this problem, methods might be compared to a na¨ıve baseline method which uses
the same methodology in a conservative manner, without incorporating the latest developments
in the field. Thus, for CAMEO Ligand Binding, we have developed three baseline servers, each
focusing on a individual approach as described in Section 4.3.9: (1) sequence conservation, (2)
homology transfer and (3) geometric binding pocket identification. Here, we describe the latter,
na¨ıve geometric binding pocket identification server, named na¨ıve pocket. This server focuses
on an intermediate case where homologue structures are present, but they do not contain any
ligand information.
4.4.2 Method
The geometric prediction server is based on BScore (see 5). Briefly, BScore uses the molecular
surface to define the protein shape and analyzes the distribution of surface vertices to identify
binding pockets. The following steps are performed:
The solvent excluded surface of a protein structure is computed by MSMS (version
2.6.1)127 using a probe radius of 1.4 A˚ and a sampling density of 6.
A 3-dimensional orthogonal grid is produced with a grid spacing of 1 A˚ and the dimension
of the protein lengths plus a margin of 3 A˚ on each side. For each point on this grid, the
number of surface points that are within a certain cutoff distance rmax is computed. In
addition, surface points can be excluded based on the direction of the surface normal n⃗j
and a cutoff angle γmax.
The computed grid is smoothed using a Gaussian filter with a smoothing radius σ.
The score b(r⃗i) on grid point i at position r⃗i is computed as
b(r⃗i) =

j
δj(P⃗j , r⃗i) (4.1)
where
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δj(P⃗j , r⃗i) =
1 if ∥P⃗j , r⃗i∥ ≤ rmax and γ ≤ γmax0 if ∥P⃗j , r⃗i∥ > rmax or γ > γmax (4.2)
where P⃗j is the position of surface vertex j and γ is the angle between the vector from the grid
point r⃗i to the surface vertex P⃗j and the surface normal n⃗j computed as
γ = arccos

(r⃗i − P⃗j) · n⃗j
∥r⃗i − P⃗j∥ · ∥n⃗j∥

(4.3)
4.4.3 Results and Discussion
Set of Protein-Ligand Complexes
All crystal structures used in CAMEO Ligand Binding from December 2011 to January 2012
containing ligands in the organic category were used as a training set. The crystal structures
were obtained from the PDB,130,118 all ligands were removed and predictions were performed
on these structures. Reference prediction entities were generated for all biologically relevant
ligands (according to the CAMEO LB classification) and the predictions were assessed using
the CAMEO LB pipeline.
Parameter Optimization
As shown in Section 4.4.2 the method depends on the parameters rmax, γmax and σ). To
optimize the method to obtain the best performance, those parameters were systematically
varied as follows:
rmax: 2 to 10 in steps of 2
γmax: 20,45,90,135,180°
σ: 0 to 20 in steps of 2
The performance of the method was evaluated for each parameter combination by computing
the area under the curve (AUC) of the receiver operating characteristics (ROC), Spearman’s
rank correlation coefficient (rank) and Pearson’s correlation coefficient (correl) for each structure
of the set of protein-ligand complexes described previously. For each of the three scores, the
overall performance was computed by averaging the score over all structures in the test set.
Prediction Performance on Crystal Structures
The performance of the na¨ıve pocket server, as evaluated on the previously described set of
crystal structures, is shown in Figure 4.6. Independent of the metric used for evaluating the
preformance (i.e. ROC auc, rank, correl), similar behavior is obtained. Overall, the performance
dependents highly on all three parameters as follows:
Cutoff Distance (rmax) Generally, good performance is obtained for a broad range of cutoff
distances from 5 to 10 A˚. Independent of the other parameters, an increase of the cutoff distance
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Figure 4.6: Performance of the na¨ıve pocket server evaluated on X-Ray structures using three different
scores: ROC area under curve (top panel), Spearman’s rank correlation coefficient (middle panel), Pear-
son’s correlation coefficient (bottom panel). The scores are shown using a color gradient from blue (lower
performance) to red (better performance) and are plotted against the three parameters of the scoring func-
tion: cutoff angle γmax (individual plots from left to right), cutoff distance rmax (x-axis within one plot),
smoothing factor σ (y-axis within one plot).
yields an increase in performance, with a maximum at 10 A˚.
Cutoff Angle (γmax) When discarding surface points where their surface normal vector
points away from the grid point, i.e. decreasing the curoff angle, the performance of the
method is improved. The optimal performance is obtained using a cutoff angle between 20 and
45°.
Smoothing Factor (σ) Using a Gaussian function to smooth the scores of the grid has a
significant impact on the binding site prediction performance, where both no smoothing (i.e.
σ = 0) or extensive smoothing (e.g. σ > 10) yields poor performance but intermediate smooth-
ing shows a significant improvement with a maximum performance at 4.0.
Overall, prediction performances are encouraging where optimal parameters yield a good
ROC auc of 0.855. For the na¨ıve pocket server included in CAMEO Ligand Binding, the
following parameters were chosen which give rise to the optimal performance without severely
limiting the number of included surface vertex points: γ = 45°, rmax = 10 A˚, σ = 4.0.
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Figure 4.7: Performance of the na¨ıve pocket server in the organic ligand binding site category of CAMEO
LB. (A) The ROC AUC averaged over all CAMEO LB targets of the last seven month is plotted against
the number of modeled targets for all participating servers. (B-D) Comparison of weekly scores between all
participating servers: (B) ROC AUC, (C) Spearman’s rank correlation coefficient, (D) Pearson’s correlation
coefficient.
Prediction Performance on Models
In addition to crystal structures, the na¨ıve pocket server is applicable to homology models and
was evaluated on comparative protein structure models produced by SWISS-MODEL.125,126
The server was added to CAMEO Ligand Binding in January 2012, and its performance over
the first seven month is shown in Figure 4.7 (server name: na¨ıve pocket). Since the server only
predicts binding sites for organic ligands, only this category is evaluated.
The accuracy according to ROC auc is comparable to non-na¨ıve servers. However,
na¨ıve pocket is one of the few servers which predicts nearly all targets (97%), significantly
more than all non-na¨ıve servers currently included in CAMEO Ligand Binding (Figure 4.7 A,B).
The performance according to Spearman’s rank correlation and Pearson’s correlation coefficient
is relatively low with a correlation coefficient of 0.32 and 0.31, respectively (Figure 4.7 C,D).
The high ROC score but the low correlation scores highlight, that na¨ıve pocket is able to cor-
rectly classify residues into binding site and non-binding site residues, but has limited ability to
correctly rank the residues within the two classes.
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4.4.4 Conclusion
The na¨ıve geometric prediction server depends on a reliable protein structure to determine
binding pockets and is both applicable to experimentally determined protein structures as well
as protein structure models originating from comparative modeling.
Although, the methodology used by the na¨ıve pocket predictor for identifying ligand binding
sites is straightforward, its capability to predict binding sites for organic ligands is promisingly
high and outperforms most other servers. This clearly illustrates that current binding site
prediction methods have to advance further in order to predict binding sites accurately and
reliably.
In addition, by combining such a straightforward prediction server with other methodologies
like homology transfer, further improvements of the prediction performance could be easily
achieved which might lead to one of the top performing methods in the field.
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Chapter 5
BEscore: a Novel Method for Rapid Scoring of
Protein-Ligand Complexes
5.1 Introduction
Computational methods have a significant impact on the drug discovery process for example by
greatly accelerating the identification of early hit compounds.28,131 In cases where 3-dimensional
structural information is present, or where accurate models can be built, virtual screening using
molecular docking is often the method of choice, due to its good compromise between accuracy
and computational efficiency.
In spite of major progress in recent years docking is often still hampered by the generation
of a large number of false positive hits. Amongst other shortcomings, one underlying reason
for false positive predictions is the generation of many incorrect, but highly scored, ligand con-
formations. This problem becomes particularly important when applying post-filtering methods
such as protein-ligand interaction footprint filtering132 or re-scoring based on free energy meth-
ods133,134 which rely on finding the best poses, i.e. those which are close to the experimentally
observed placement of the ligand. Despite those limitations of scoring functions, an expert’s
eye, however, can often distinguish the best poses from decoys by visual inspection.135 For
example, a set of docking results usually offers a number of poses with different yet plausible
hydrogen bonding patterns. With visual inspection most of the unreliable poses can be filtered
out. In our experience these are often the less buried ones,74 and in most cases an expert
would prefer placements with an intimate binding of the ligand in sub-pockets, even at the
expense of fewer polar interactions. This is in agreement with the notion that, generally, steric
complementarity plays a larger role in molecular recognition than polar and electrostatic inter-
actions.136 Such a visual inspection approach has been commonly applied in successful docking
studies137,138,139 where manual inspection of selected ligand poses was performed as a manual
post-filtering step. Although it is a promising approach, it clearly cannot be performed in a
high-throughput docking experiment due to its high time demand and its subjectivity.
The inability of scoring functions to always detect the best poses is just one part of the scor-
ing function problem. This problem has been extensively discussed and reviewed.136,140,141,142,143,144
A number of validation studies on scoring functions and docking have also been published,136,144,145,146,147,148,149,150,151
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complemented by articles on the intrinsic difficulties and flaws associated with such stud-
ies.152,153
As a consequence we have developed a scoring function that aims to identify the best poses
by quantifying the degree of burial and the electrostatic interactions of the ligand poses in a
binding site. Here, we present the initial results of these investigations.
5.2 Method
5.2.1 Shape Term (Degree of Burial)
In the approach pursued here the ligand binding cavity is converted into a representation that
reflects just the shape of the protein surface. The method relies only on a 3-dimensional protein
structure, obtained from experiment or through comparative modeling. It does not require
affinity data, atom typing or elaborate deduction of potentials. The shape term in the new
scoring function aims to assess docking poses based on their degree of burial in a ligand binding
pocket. Such measures have so far been used for detecting cavities on a protein surface,15,154
which implies that the degree of burial can be useful for identifying protein surface depressions
and quantitatively describing their geometric characteristics. Here, the degree of burial is used
for re-scoring the poses of docking calculations.
The starting point for deriving the local degree of burial b(r⃗i) for a given protein at a given
position r⃗i is the shape of its ligand binding site, which is represented by the points of the
solvent excluded surface calculated by MSMS (version 2.6.1).127 A schematic representation
is shown in Figure 5.1. From the surface points the b(r⃗i) values are calculated over the r⃗i
coordinates of an orthogonal three-dimensional grid. For each position r⃗i on this grid, the local
degree of burial b(r⃗i) in the binding site is estimated by counting the surface points P⃗j , within
a given distance rmax from the orthogonal grid point r⃗i:
b(r⃗i) =

j
δj(P⃗j , r⃗i) (5.1)
where
δj(P⃗j , r⃗i) =
1 if ∥P⃗j , r⃗i∥ ≤ rmax0 if ∥P⃗j , r⃗i∥ > rmax (5.2)
Gaussian Weighting
As an alternative to applying a simple distance cutoff, Gaussian functions can also be used for
calculating the local degree of burial. The Gaussian weighted version of this score is designated
bg(r⃗i):
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Figure 5.1: Schematic representation of the BScore and BScoreg method. (A) The protein is represented
in light gray with its surface (black line) as defined by surface vertices (black dots) and their normal vectors
(black arrows). The score is computed on each grid point (colored dots) where the value is shown in a color
gradient from yellow (low score) to red (high score). (B) Cut-out of plot (A) representing the different terms
used in Equation 5.1- 5.10
bg(r⃗i) =

j
C · e−α(∥P⃗j−r⃗i∥−rmax)2 (5.3)
where C is a normalization factor to make bg(r⃗i) independent of α
C =
1
√
2π

1
2α
(5.4)
Gaussians allow the surface to be scanned within a given distance range. In this way
a distance-weighted measure for the protein-ligand contact area is calculated, which is more
related to the vdW interaction energy than the simple distance cutoff functional form.
Surface Directionality
To introduce surface directionality, surface points are excluded based on the direction of the
surface normal n⃗j relative to the current grid point r⃗i. This applies to both versions of the
score:
bdir(r⃗i) = δdir(γ) · b(r⃗i) (5.5)
bg,dir(r⃗i) = δdir(γ) · bg(r⃗i) (5.6)
where
123
5.2. METHOD
δdir(γ) =
1 if γ ≤ γmax0 if γ > γmax (5.7)
where γmax is an adjustable cutoff angle and γ is the angle between r⃗i − P⃗j and the surface
normal n⃗j computed as
γ = arccos

(r⃗i − P⃗j) · n⃗j
∥r⃗i − P⃗j∥∥n⃗j∥

(5.8)
Atomic and Total Score
The atomic score b(x⃗k) for an atom k at position x⃗k in a ligand pose is calculated as its local
degree of burial, as given in the scoring grid. bdir(x⃗k) is calculated using a trilinear interpolation
of the eight orthogonal grid points closest to the atom. The total shape score Bscore for a
particular ligand pose is then the sum of the atomic contributions b(x⃗k) at each atom position
x⃗k (see equation 5.9). The same applies to bg,dir(x⃗k) leading to the total shape score Bscoreg
of equation 5.10.
Bscore =
atoms
k
bdir(x⃗k) (5.9)
Bscoreg =
atoms
k
bg,dir(x⃗k) (5.10)
Direct Scoring
The orthogonal scoring grid is used in order to reduce computational costs when scoring many
ligand poses. The scores bdir or bg,dir need to be evaluated only on each grid point and the
atomic scores can be computed extremely fast by trilinear interpolation. However, interpolation
introduces an error which is dependent on the grid spacing and, in case of bg, on the width
of the Gaussian weighting function (α). Therefore, the scores can also be computed directly
on the atom positions which avoids this error. However, in this case, the scores must be
evaluated for each atom of each ligand pose separately which can lead to a significant increase
in computational costs.
5.2.2 Electrostatic Term
Since Bscore and Bscoreg can be seen as approximations of the intermolecular van der Waals
(vdW) energy between the ligand and the receptor, the introduction of an additional electro-
static correction term seems to be reasonable. For this purpose, the molecular electrostatic
potential ϕ(r⃗i) generated by the protein is calculated and stored over the r⃗i coordinates of an
orthogonal three-dimensional grid using the Poisson-Boltzmann methods implemented in APBS
124
5.3. SETS OF RECEPTOR-LIGAND COMPLEXES
(version 1.3).97 The MMFF94 force field,155,156,157,158,159 as implemented in OpenBabel (ver-
sion 2.3.1),160 is used for calculating partial charges qk for all ligand and protein atoms. The
electrostatic interaction energy between the receptor and a ligand atom k at position x⃗k with
a partial charge qk is approximated as the product of the partial charge qk and the value of ϕ
at position x⃗k. In this case the same interpolation procedure is used as for the estimation of
b(x⃗k) and bg(x⃗k). This leads to the following form for Escore, the electrostatic part of our
scoring function:
Escore =
atoms
k
qk · ϕ(x⃗k) (5.11)
5.2.3 BEscore
By linearly combining the shape and the electrostatic terms described above, we introduce the
new scoring functions BEscore and BEscoreg:
BEscore = Bscore− ω · Escore (5.12)
BEscoreg = Bscoreg − ωg · Escore (5.13)
where ω and ωg are linear weighting factors balancing the relative contributions of the two
terms.
The new scoring functions are implemented using OpenStructure (version 1.2.2).83
5.3 Sets of Receptor-Ligand Complexes
We applied our new scoring function to three different sets of receptor-ligand complexes. One
set consists of the same receptor bound to different ligands (i.e. cross-docking), while the other
two sets includes different receptors, each binding a different ligand (i.e. re-docking).
5.3.1 Thrombin Set
Thrombin inhibitor complex structures with a resolution of less than 2.0 A˚ were selected from
the PDB.130,118,161 Structures with covalently bound ligands and peptides were ignored. All
structures were aligned by superimposing the protein structures on the PDB structure 1etr162 us-
ing the binding site superposition algorithm implemented in Maestro (version 9.3, Schrodinger,
LLC, New York, NY, 2012). The target structure 1etr was prepared by the Protein Preparation
Wizard in Maestro (Suite 2011, Schrodinger, LLC). Hydrogen atoms were added to all ligands
and the most stable protonation states and tautomers at pH 7.0 was generated using Epik (ver-
sion 2.2, Schrdinger, LLC).163 Standard precision (SP) Glide (version 5.7, Schrdinger, LLC)67
was employed as the docking tool using default parameters. As in previous work of Graves et
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al164 the scoring function is supposed to discriminate ligand poses which are far away from the
X-ray ligand structure (decoys) from the best poses.
Therefore, we generated a large set of differently placed protein-ligand complex confor-
mations. For this purpose the experimentally observed ligand structure was used as starting
geometry in the subsequent docking calculations. All poses were generated in various docking
runs with 1etr as receptor. All ligands were excluded for which no acceptable conformation was
found by the Glide docking run (i.e. symmetry corrected rmsd ≤ 2.0A˚). This yielded a set of
66 thrombin inhibitor structures. On average 164 complex structures were generated with a
minimum of 56 and a maximum of 276. Of those, on average, 17 are considered correct with
an rmsd ≤ 2.0A˚, with a minimum of 2 and a maximum of 90. Thus, this dataset gave rise
to a retieval rate of 10.2% when selecting ligand poses randomly. For re-scoring purposes, the
functions b(r⃗i), bg(r⃗i) and ϕ(r⃗i) (see equations 5.1,5.3 and 5.11) were evaluated on the points
of a three-dimensional orthogonal grid for the PDB structure 1etr, and were then applied to all
66 thrombin structures.
5.3.2 Astex Diverse Set
This set is a high-quality test set designed for the validation of protein-ligand docking perfor-
mance.165 It contains the structures of 85 diverse protein-ligand complexes retrieved from the
PDB. These complexes share the following main characteristics: the ligands are drug-like; no
particular target is represented more than once; the proteins are all drug discovery or agrochem-
ical targets; only high quality structures are included. Major protein families are represented
in the set, with 11 kinases, 9 nuclear receptors, 5 serine proteases and 3 members of the
phosphodiesterase family.
Although the Astex diverse set is a high quality test set, a number of significant problems
were observed, mainly due to wrongly parametrized co-factors observed in the structure. Thus,
all complexes were visually inspected and manually cleaned prior to the docking. Subsequently,
for each protein-ligand complex we applied the same preparation, docking and re-scoring pro-
cedure as for the thrombin test set using Glide SP. On average 141 poses were generated with
a minimum of 22 and a maximum of 447 of which, on average, 36 were correctly placed, with
a minimum of 3 and a maximum of 152. This yields a random retrieval rate of 28.8%. No
alignment had to be performed and the functions b(r⃗i), bg(r⃗i) and ϕ(r⃗i) (see equations 5.1,5.3
and 5.11) were individually calculated on the points of three-dimensional orthogonal grids for
each receptor.
5.3.3 S3DB
S3DB166 is a database of manually curated protein-ligand complex structures, based on the
ligand-protein database167 which contains a diverse set of protein families and ligand chemo-
types.
Similar to the Astex diverse set, all complex structures in S3DB were prepared for docking
by the Protein Preparation Wizard in Maestro (Suite 2011, Schrodinger, LLC). Structures
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generating errors in Maestro were excluded from further analysis. For each complex structure
the corresponding ligand was docked using standard precision Glide. Structures where no correct
pose (i.e. rmsd ≤ 2.0A˚) was generated were discarded. This lead to a set of 145 protein-ligand
complex structures. On average, 127 poses were generated (minimum: 20, maximum: 311)
of which, on average, 29 are correctly places (minimum: 1, maximum: 150). This yields a
random retrieval rate of 24.7%. No alignment had to be performed and the functions b(r⃗i),
bg(r⃗i) and ϕ(r⃗i) (see equations 5.1,5.3 and 5.11) were individually calculated on the points of
three-dimensional orthogonal grids for each receptor.
5.4 Validation
In order to assess the prediction performance we computed four commonly used measures:
retrieval rate,164 enrichment area under curve (AUC), ∆RMSD and Pearson’s correlation coef-
ficient.
Retrieval Rate
Given a set of receptor-ligand complexes such as the thrombin or the Astex diverse sets described
in the previous section, the retrieval rate is the percentage of complexes where the ligand pose
ranked best by the scoring function is within 2.0 A˚ symmetry corrected root mean square
deviation (rmsd) of the X-ray structure.
Enrichment AUC
Enrichment area under the curve is a measure for the ability of a scoring function to rank
correct poses higher than incorrect ones, where correct poses are defined as conformations with
an symmetry corrected rmsd ≤ 2.0A˚.
∆RMSD
For a set of docking poses for a particular ligand, ∆RMSD is the difference in symmetry
corrected rmsd between the best scored pose and the crystal structure.
In the following paragraphs all four scores resulting from Bscore, Bscoreg, Escore,
BEscore and BEscoreg have been calculated for the thrombin, the S3DB and the Astex
diverse set.
5.4.1 Shape Term
According to our model the shape term of the scoring function can have two functional forms:
Bscore (equation 5.9) and Bscoreg (equation 5.10) both of which depend on different param-
eters (equations 5.2 and 5.3).
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Figure 5.2: Evaluation of the performance of Bscore based on the Astex diverse set using (A) retrieval rate,
(B) enrichment AUC, (C) ∆RMSD and (D) Pearson’s correlation coefficient averaged over all complexes in
the test set.
Bscore
Equation 5.2 depends only on the parameter rmax, whereas when including surface directionality
(Equation 5.5), the parameter γmax is added. Figure 5.2 and 5.3 show the performance for the
Astex diverse set and the thrombin set (see Appendix A.3 Figure A.3 for the S3DB test set)
for different γmax values. For the Astex diverse set and the S3DB set the highest performance
values were obtained for an rmax value between 3.2 and 3.4 A˚ and γmax between 15 and 30°,
with retrieval rates of 56.5% and 52.4% and enrichments of 68.9% and 65.3%, respectively. For
the thrombin set, a broader maximum is observed with the same optimal γmax value (30°) but
slightly larger optimal rmax values (in the range of 4.0 to 4.5 A˚) were observed, with retrieval
rates of 52.5% and enrichments of 86.4%.
Since the Astex diverse set and the S3DB set represent a broader spectrum of binding site
properties and ligand chemotypes and the optimal values obtained for those two sets are in
good agreement, the optimal values for Bscore parameters were chosen as follows:
rmax = 3.4 A˚ and γmax = 30°
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Figure 5.3: Evaluation of the performance of Bscore based on the thrombin set using (A) retrieval rate,
(B) enrichment AUC, (C) ∆RMSD and (D) Pearson’s correlation coefficient averaged over all complexes in
the test set.
Bscoreg
Equation 5.3 depends on two parameters, rmax and α, and when including surface directionality
(Equation 5.6), the parameter γmax is added. Figures 5.4 and 5.5 show the retrieval rates as
a function of rmax and α for different γmax values for the Astex diverse set and the thrombin
set, respectively (see Appendix A.3 Figure A.4 for the S3DB test set). For the thrombin set the
highest retrieval rates (56.1%) and enrichments (75.2%) are achieved for rmax values around
3.0 A˚, ln(α) values between 0 and 3 and γmax value 45°. In the case of the Astex diverse set
the highest retrieval rates (up to 65.9%) and enrichments (69.6%) are observed for rmax values
between 2.3 and 2.4 A˚, ln(α) values between 2 and 4 and a γmax value 45°. For the S3DB set
similar optimal parameters were obtained as for the Astex diverse set (rmax between 2.3 and
2.4 A˚, ln(α) between 0 and 4, γmax 45°) with highest retrieval rates (60.0%) and enrichments
(65.9%).
The distribution of the retrieval rates for the sets depicted in Figures 5.4, 5.5 and Figures A.4
and the fact that the Astex diverse set and the S3DB set represent a broader spectrum of binding
site properties and ligand chemotypes, led us to choose optimal values for Bscoreg parameters
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Figure 5.4: Evaluation of the performance of Bscoreg based on the Astex diverse set using (A) retrieval
rate, (B) enrichment AUC, (C)∆RMSD and (D) Pearson’s correlation coefficient averaged over all complexes
in the test set.
with the following values:
rmax = 2.4 A˚, ln(α) = 4.0 and γmax = 45°
The optimal rmax values for Bscore and for Bscoreg (rmax = 3.4 A˚ and rmax = 2.4 A˚,
respectively) are not far from typical vdW contact distances. This suggests that the Bscore
and Bscoreg values approximate the vdW energy, which correlates with the size of the contact
surface area.
Directionality
When adding the directionality term γmax to Bscore or Bscoreg, a significant improvement in
the performance scores can be observed compared to when using no directionality restrictions
(i.e. γmax = 180°).
For Bscore the retrieval rate increases from 38% to 56.5% (Astex diverse set, Figure 5.2),
from 34% to 52.4% (S3DB set, Figure A.3) and from 28% to 52.5% (thrombin set, Figure 5.3).
The enrichments increase from 62% to 68.9% (Astex diverse set), from 62% to 65.3% (S3DB
set) and from 84% to 86.4% (thrombin set).
For Bscoreg the retrieval rate increases from 55% to 65.9% (Astex diverse set, Figure 5.4),
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Figure 5.5: Evaluation of the performance of Bscoreg based on the thrombin set using (A) retrieval rate,
(B) enrichment AUC, (C) ∆RMSD and (D) Pearson’s correlation coefficient averaged over all complexes in
the test set.
from 46% to 60.0% (S3DB set, Figure A.4) and from 44% to 56.1% (thrombin set, Figure 5.5
). The enrichments increase from 65% to 69.6% (Astex diverse set), from 63% to 65.9% (S3DB
set) and from 73% to 75.2% (thrombin set).
5.4.2 Electrostatic Term
The electrostatic potential ϕ(r⃗i) in equation 5.11 (and consequently Escore) depends, among
other parameters, on the value of the dielectric constant ε which is assigned to the interior of
the protein, and on the type and concentration of mobile ions. We tested the effect of these
two parameters on the scoring performance of the electrostatic term alone. For ε we tried
different values ranging from 1 to 80. For the mobile ion charge density we tested the following
three configurations: the absence of mobile ions (in this case the Poisson-Boltzmann equation
becomes a Poisson equation) and the presence of 0.15 mol/L or 0.30 mol/L of sodium chloride
(NaCl).
The performance of Escore is shown in Figure 5.6 for the Astex diverse set and Figure 5.7
for the thrombin set (see Appendix A.3 Figure A.5 for S3DB). The highest retrieval rates
and enrichments for the Astex diverse set (60.0% and 63.8%, respectively) and the S3DB set
(49.1% and 66.9%, respectively) are obtained for a dielectric constant between ε between 20
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Figure 5.6: Evaluation of the performance of Escore based on the Astex diverse set using (A) retrieval rate,
(B) enrichment AUC, (C) ∆RMSD and (D) Pearson’s correlation coefficient averaged over all complexes in
the test set.
and 30 and in the presence of 0.15 to 0.30 mol/L NaCl. For the thrombin set, Escore based
retrieval rates are low (21.2%) whereas enrichments are in a similar range as for the other sets.
Optimal retrieval rates are obtained for ε values around 6.0 and in the presence of 0.15 to 0.30
mol/L NaCl. Those parameters yield also optimal enrichments (63.5%) when not considering
enrichments at a mobile ion concentration of 0.00 mol/L, in which case the average is dominated
by a small number of outliers.
Since the Astex diverse set and the S3DB set represent a broader spectrum of binding site
properties and ligand chemotypes, the optimal values for Escore parameters were chosen as
follows:
ε = 25, mobile ion concentration = 0.15mol/L
5.4.3 Summary of Individual Terms
The optimized retrieval rates and enrichment values are summarized in Table 5.1. We emphasise
the fact that the retrieval rates obtained using the local degree of burial alone (65.9% for the
132
5.4. VALIDATION
Figure 5.7: Evaluation of the performance of Escore based on the thrombin set using (A) retrieval rate,
(B) enrichment AUC, (C) ∆RMSD and (D) Pearson’s correlation coefficient averaged over all complexes in
the test set.
Astex diverse set and 56.1% for the thrombin set, using the Gaussian functional form) are
higher than the retrieval rates obtained using the electrostatic term alone (60.0% for the Astex
diverse set and 21.2% for the thrombin set). The same holds true for enrichment values.
This confirms the notion that, generally, steric complementarity plays a larger role in molecular
recognition than polar and electrostatic interactions.136 It should be mentioned that reasonable
polar interactions were already generated by the docking program prior to these re-scoring
calculations.
5.4.4 Comparison to Van der Waals Interaction Energies
Since the shape terms are related to standard van der Waals (vdW) interactions and might
simply approximate the latter, we compare the results obtained with Bscore or Bscoreg for
the Astex diverse set with vdW interaction energies as computed by Glide SP. Correlations
are computed for all poses of each target of the Astex diverse set and a histogram of the
correlation coefficients is shown in Figure 5.8. On average, a correlation coefficient of -0.51 and
-0.48 is obtained for Bscore and Bscoreg, respectively. This intermediate average correlation
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Figure 5.8: Histogram of the correlation between the shape terms (A: Bscore, B: Bscoreg) and standard
van der Waals interactions as computed by Glide SP. Correlations are computed for all poses of each target
of the Astex diverse set.
coefficient indicates a certain degree of similarity between the two methods but clearly shows
that there are significant differences between the two.
5.4.5 BEscore
As defined in equations 5.12 and 5.13, BEscore or BEscoreg linearly combines Bscore or
Bscoreg with Escore via the ω or ωg parameter. In order to determine the optimal value of ω
and ωg for both equations, we used the optimised parameters for Bscore, Bscoreg and Escore
as described in the previous paragraphs:
Bscore: rmax = 3.4 A˚, γmax = 30°
Bscoreg: rmax = 2.4 A˚, ln(α) = 4.0, γmax = 45°
Escore: ε = 25, mobile ion concentration = 0.15mol/L
Figure 5.9 shows the retrieval rate of BEscore as a function of ω for the Astex diverse
sets, the thrombin set and the S3DB set. The highest retrieval rates and enrichments for the
Astex diverse set (65.9% and 73.3%, respectively) are obtained for ω = 360, for the thrombin
set (53.0% and 86.3%, respectively) for ω = 180, while for the S3DB set (67.2% and 72.1%,
respectively) for ω = 160. Figure 5.10 shows the retrieval rate of BEscoreg as a function of
ωg for both sets. For the Astex diverse set the highest retrieval rates and enrichments (71.8%
and 73.5%, respectively) are observed at ωg = 330, for the thrombin set (45.5% and 84.3%,
respectively) for ωg = 230 and for the S3DB set (69.3% and 72.7%, respectively) for ωg = 230.
The optimized retrieval rates and enrichment values are summarized in Table 5.1.
On averageBEscoreg exhibits higher retrieval rates and enrichments compared toBEscore.
From the distributions in Figures 5.9 and 5.10 we chose as optimal value for ω = 180 and
ωg = 240.
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Figure 5.9: Evaluation of the performance of BEscore based on the Astex diverse set, the S3DB set and
the thrombin set using (A) retrieval rate, (B) enrichment AUC, (C) ∆RMSD and (D) Pearson’s correlation
coefficient averaged over all complexes in the test set.
Table 5.1: Summary of the results obtained from optimizing the parameters of Bscore, Bscoreg, Escore,
BEscore and BEscoreg. The retrieval rates and enrichments obtained with the optimal parameters are
shown for the three test sets. a Best parameters were optimized for each set individually. b Selected
parameters were selected to perform well on all sets.
best parametersa selected parametersb
Astex S3DB Thrombin Astex S3DB Thrombin
Bscore retrieval 56.5% 52.4% 52.5% 57.6% 52.4% 45.5%
enrichment 68.9% 65.3% 86.4% 68.5% 65.3% 84.9%
Bscoreg retrieval 65.9% 60.0% 56.1% 62.4% 57.2% 43.9%
enrichment 69.6% 65.9% 75.2% 68.9% 64.9% 71.9%
Escore retrieval 60.0% 49.1% 21.2% 57.6% 49.1% 18.2%
enrichment 63.8% 66.9% 63.5% 63.7% 66.8% 62.9%
BEscore retrieval 65.9% 67.2% 53.0% 62.4% 65.5% 53.0%
enrichment 73.3% 72.1% 86.3% 73.7% 72.1% 86.3%
BEscoreg retrieval 71.8% 69.3% 45.5% 69.4% 69.3% 45.5%
enrichment 73.5% 72.7% 84.3% 73.7% 72.7% 84.2%
5.5 Analysis of Surface Point Distribution
The distribution of surface points around ligand atoms was analyzed for the 85 protein-ligand
complexes of the Astex diverse set.
For each complex, all ligand poses were divided into correct and incorrect poses according to
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Figure 5.10: Evaluation of the performance of BEscoreg based on the Astex diverse set, the S3DB set and
the thrombin set using (A) retrieval rate, (B) enrichment AUC, (C) ∆RMSD and (D) Pearson’s correlation
coefficient averaged over all complexes in the test set.
their all-atom RMSD values of ≤ 2.0 A˚ (correct) and > 4.0A˚ (incorrect). For each atom of each
ligand pose, a histogram of the distribution of surface points versus the distance from the atom
is computed. For each ligand pose the per-atom distributions are summed and a normalized
histogram is computed. For both, the correct and the incorrect poses, the distributions from all
contributing ligand poses are averaged and scaled to the range from 0.0 to 1.0. The difference
between the distribution of correct and incorrect poses is plotted in Figure 5.11. The actual
distributions are shown in Figure A.2 in Appendix A.3. The procedure was repeated with
different cutoff values for angle between the vector from the atom to the surface vertex and
the normal vector of the surface vertex (γmax).
For all different γmax values, a maximum in the distribution difference is observed at r =
2.3A˚. This corresponding to a distance range where the correct poses show an increased surface
point density compared to the incorrect poses. Thus, exclusively selecting distances in a range
around 2.3 A˚ should yield the highest separation between correct and incorrect poses and thus
the best scoring performance.
Figure 5.12 shows an enlarged part of the surface point distribution difference for γmax =
180° as a representative example. The maximum of the difference between the distributions
(black line) can be fitted well by a Gaussian curve (red line) with a peak (rmax) at 2.3 A˚ and
a width (ln(α)) of 2.1. This indicates that selecting a Gaussian shaped function to weight the
individual contribution of surface points to the per-atom BScoreg seems reasonable.
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Figure 5.11: Difference between the distributions of surface vertex points around the ligands of the Astex
diverse set. Ligands are categorized into correct (rmsd ≤ 2.0 A˚) and incorrect poses (rmsd > 4.0A˚) based on
their rmsd to the crystal structure. The difference between the scaled distributions of correct and incorrect
poses is plotted for different γmax angles: (A) 15°, (B) 30°, (C) 45°, (D) 90°, (E) 135°, (F) 180°.
When comparing the distributions for different γmax values, a more pronounced difference
is observed for small γmax values up to γmax = 45°. This indicates that small γmax values
should better discriminate correct from incorrect ligand poses. Since the number of included
surface points decreases with smaller γmax, the noise in the distributions increases. Thus, an
optimal γmax is in the range of 30 - 45°.
It is worth noting that the values for rmax and α obtained through the surface point
distribution are in excellent agreement with the values obtained from parameter optimization
of Bscoreg (rmax = 2.4A˚, ln(α) = 4.0).
5.6 Results
5.6.1 Astex Diverse Set
Figure A.6 (Appendix A.3) shows BEscoreg as a function of the rmsd for each docked pose
from the relative X-ray ligand position for the 85 complexes in the Astex diverse set. The
following combination of parameters was used: rmax = 2.4 A˚, ln(α) = 4.0, γmax = 45° and
ωg = 240. For those parameters the retrieval rate is 69.4%, the enrichment is 73.7%, ∆RMSD
is 1.95 A˚ and the correlation coefficient is -0.52.
Figure 5.13 shows an example for the target structure 2bm2 of the Astex diverse set with
atomic Bscoreg values mapped onto the ligand structures using a gradient from blue (low
score) to red (high score). The ligand pose (A) resembles closely the X-ray ligand conformation
(rmsd = 0.2 A˚) and has a high score (Bscoreg = 2160) whereas pose (B) is incorrectly placed
with an rmsd of 3.0 A˚ and has a lower score (Bscoreg = 1499). The coloring represents well,
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Figure 5.12: Fit of a Gaussian curve (red line) to the difference between the distributions of surface vertex
points around the ligands of the Astex diverse set (black line) for γmax = 180°.
which parts of the ligand are incorrectly placed and not in intimate contact with the protein
surface.
In 59 cases the top ranked structure was within 2.0 A˚ rmsd. In three additional cases the
best ranked structure was between 2.0 and 2.5 A˚ rmsd and in three more cases between 2.5
and 3.0 A˚ rmsd, while in the remaining 20 cases the top ranked structure deviated more than
3.0 A˚ rmsd from the X-ray structure.
If not only the best ranked pose, but the two, five or ten best ranked poses are considered,
the retrieval rate increases significantly from 69.4% to 76.5%, 87.1% and 94.1%, respectively.
This illustrates that in most cases accurate poses are found within the first few top ranked
conformations. In fact, only five complex structures did not yield a correctly placed ligand pose
within the ten best ranked structures.
5.6.2 Thrombin Set
Figure A.8 (Appendix A.3) shows BEscoreg as a function of the rmsd for each docked pose
from the relative X-ray ligand position for the 66 thrombin inhibitor complex structures. The
same combination of parameters as in the paragraph above was used. The retrieval rate is
45.5%, the enrichment is 84.2%, ∆RMSD is 3.24A˚ and the correlation coefficient is -0.57.
In 30 cases the top ranked structure was within 2.0 A˚ rmsd of the X-ray ligand crystal
structure. For additional six cases the deviation was found to be between 2.0 and 2.5 A˚ rmsd
and in four more cases between 2.5 and 3.0 A˚. The remaining 26 cases the top ranked structure
deviated more than 3.0 A˚ rmsd from the X-ray structure.
The thrombin set shows a relatively low retrieval rate but a high enrichment, which suggests
that when including not only the best ranked pose in the calculation, the retrieval rates should
increase significantly. Retrieval rates increase from 45.5% to 50.0%, 74.2% and 87.9% for
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Figure 5.13: Two arbitrarily chosen poses for target 2bm2 of the Astex diverse set with atomic Bscoreg
values mapped onto the ligand structures using a gradient from blue (low score) to red (high score). The
protein is represented as a molecular surface, whereas the ligand is shown in stick representation. The ligand
pose (A) resembles closely the X-ray ligand conformation (rmsd = 0.2 A˚) whereas pose (B) is incorrectly
placed with an rmsd of 3.0 A˚. The overall score is computed as the sum of atomic Bscoreg contributions.
including the two, five and ten best ranked poses, respectively. Thus, when including the ten
best ranked poses, only eight out of the 66 thrombin structures did not yield a correctly placed
ligand pose.
5.6.3 S3DB
Figure A.7 (Appendix A.3) shows BEscoreg as a function of the rmsd for each docked pose
from the relative X-ray ligand position for the 66 thrombin inhibitor complex structures. The
same combination of parameters as in the paragraph above was used. The retrieval rate is
69.3%, the enrichment is 72.7%, ∆RMSD is 2.05A˚ and a correlation coefficient of -0.46 was
found.
In 100 cases the top ranked structure was within 2.0 A˚ rmsd of the X-ray ligand structure.
In ten additional cases the rmsd of the top ranked pose is between 2.0 and 2.5 A˚ and in twelve
cases between 2.5 and 3.0 A˚. The remaining 23 structures exhibit an rmsd greater than 3.0 A˚.
As with both the Astex diverse set as well as the thrombin set, the retrieval rates increase
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significantly when not only the top ranked pose is considered. Retrieval rates increase from
69.3% to 77.2%, 90.4% and 95.6% when including the two, five and ten best scored poses,
respectively.
5.7 Comparison to X-Score and Glide SP
For a direct comparison, we compared our results to the Glide SP67 results and additionally
applied the X-Score scoring function168 to the Astex diverse sets.
For X-Score, retrieval rates of 68.2% and enrichments of 73.5% were obtained. Those
values are very similar to what we obtained with BEscoreg (retrieval rate: 69.4%, enrichment:
73.7%). Thus, BEscoreg seems to be able to compete well with X-Score and thus other
comparable scoring functions.
For Glide standard precision, retrieval rates of 83.5% and enrichments of 77.2% were ob-
tained. Although the performance values obtained using BEscoreg (retrieval rate: 69.4%,
enrichment: 73.7%) are slightly lower than what was obtained using Glide SP, the performance
of BEscoreg is still very promising, especially when considering it’s simplicity compared to a
full blown scoring function as Glide SP.
5.8 Combining with X-Score and Glide SP
Our new scoring function BEscoreg is intended for re-scoring of docking poses and thus as
a post docking filtering step. As such, ligand poses generated by a docking/scoring method
would then be filtered based on BEscoreg with the aim of reducing false positive placements.
To validate such a strategy, BEscoreg has been combined with the two scoring functions
X-Score and Glide SP on the Astex diverse set. All ligand poses, generated as described
above, where first scored using X-Score or Glide SP score and were subsequently re-scored
using BEscoreg. Only the ten poses ranked best according to BEscoreg where retained and
retrieval rates according to X-Score or Glide SP score were computed. Using this strategy,
retrieval rates could be significantly improved for X-Score from 68.2% to 76.5% and slightly for
Glide SP from 83.5% to 84.7%.
5.9 Discussion
The retrieval rates obtained for the Astex diverse set (69.4%) and for the S3DB set (69.3%)
using BEscoreg are very promising and they outperform a number of commonly used scoring
functions. Retrieval rates between 70 and 80% for identifying the best docking poses from a
number of poses can be reached with a number of scoring functions, including CHARMM,169
DOCK,170 DOCK6,171 ChemScore,172 DrugScorePDB,173 AutoDock,174 EADock175 and Lead
Finder176 while the PMF function177 achieved about 60%. A study by Velec et al. presented
DrugScoreCSD, a knowledge-based scoring function with a retrieval rate of 87% for 100 protein-
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ligand complexes,178 and even higher retrieval rates of 91% have been claimed for ICM.146,179
These are, to the best of our knowledge, the highest figures reported to date. The study
by Velec also reported retrieval rates for a number of scoring functions, including, for exam-
ple, Cerius2/PLP (76%), DrugScorePDB (72%), AutoDock (62%), Cerius2/PMF (42%), and
SYBYL/Chemscore (35%). These few examples highlight the difficulties of comparing pose re-
trieval rates, which can differ significantly depending on the targets, the number of decoys, and
the way in which the pool of decoy poses are generated. In our study, we used up to 447 poses
generated by Glide SP, in contrast to up to 100 decoys used in Velecs work, and an unknown
number in the ICM study. This underlines the influence of the pose/decoy generation method,
and the need for a publicly available and commonly agreed standardised test set that comprises
a well defined set of decoys for different protein-ligand complex structures which adequately
cover the space of potential poses, and allow for more objective benchmarking procedures.
Since comparing different methods on different sets of protein-ligand complex structures or
different numbers of correct and decoy poses is difficult,152 we compare our results directly with
other commonly used scoring functions. We compared our results to the Glide SP67 results
and additionally applied the X-Score scoring function168 to the Astex diverse sets. X-Score
gave comparable results whereas Glide SP slightly outperformed BEscoreg. The performance
of BEscoreg is thus very promising, especially when considering it’s simplicity compared to a
full blown scoring function as Glide SP. In addition, two points should be considered. First,
the Astex diverse set is a very commonly used test set to evaluate and train scoring functions.
Since this set was released previous to the current version of Glide SP, it is likely that the Glide
SP scoring function has been trained in order to obtain good results on this test set. Second,
Glide SP might have an advantage since it was used in order to generate the ligand poses and
thus, Glide SP scores were optimized in contrast to BEscoreg values which were only used for
re-scoring.
Since BEscoreg is intended for re-scoring of docking poses and thus as a post docking
filtering step, we evaluated the performance of BEscoreg when used to filter docking poses
scored with the scoring functions X-Score and Glide SP. Using this strategy, retrieval rates were
significantly improved for X-Score and slightly for Glide SP. This first proof of concept shows
that such a strategy has high potential and that BEscoreg could significantly improve the
current methodologies by reducing the problem of a large number of false placements.
Another important aspect is the general applicability of the scoring function parameters
which could in principle be adjusted for a particular protein family or for a particular class
of ligands. An ideal scoring function should of course be invariant of target, cavity and ligand
characteristics. To better reach this goal we have chosen to work with the three different sets of
protein-ligand complexes presented in section 5.3. In section 5.4 we have pursued an extensive
analysis and validation of all the scoring function parameters: rmax, α, γmax, ω, ωg, ε and the
ion salts concentration. This has shown that in the case of BEscoreg the optimal values for
α, γmax, the ion salts concentration and ω are very similar for the three sets of protein ligand
complexes. The optimal values of rmax, α and ε are nearly identical for the Astex diverse
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set and the S3DB set but show some small differences for the thrombin set. However, using
an intermediate value for all parameters the retrieval rate for both sets drops only about 2.5%
whereas the enrichments stays constant. This proves that our scoring function is robust towards
its parameters.
The method opens up a number of new options for structure-based drug design. For
example, re-scoring could be done on selected portions of the cavity, in order to find fragments
that can bind to particular sub-pockets of a binding site. A ligand efficiency measure180,181 for
the degree of burial for ligands could be introduced. Re-scoring grids derived from a series of
superimposed structures could be easily derived. These would, for example, allow representation
of the highest possible degree of burial in a binding site exhibiting flexibility, and could help to
account for small induced fit effects. In addition, multiple scoring grids could be easily derived
for protein structures including different solvent molecules. Thus, the effect of displaceable
water molecules could be accounted for. Obviously, another option is to complement the array
of existing scoring functions for use with consensus scoring approaches.182,183,184,185
These prospects, the simplicity of the method and the promising results proves that our
scoring function is a potentially powerful tool for structure-based drug design that could com-
plement the array of computational methods, and provide an alternative way of looking at
protein-ligand shape complementarity in virtual screening.
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Chapter 6
Design and Evaluation of a Novel, Intuitive
Human-Computer Interface Device
6.1 Introduction
Structural biology is a branch of biology interested in understanding the three dimensional
structure of biological macromolecules. Characterizing macromolecular structures is one of the
key approaches for obtaining a detailed understanding of their biological function, how they
are regulated, how they interact with other molecular systems and how modifications of their
structure affect their function. Since biological macromolecules, like proteins and nucleic acids,
are detrimental to most processes in living cells, a detailed understanding of their structure and
function leads to a broad range of applications in life-science research, ranging from functional
characterization of novel proteins to applications in drug design and protein engineering.
Since structural biology provides vast amount of data, it is often challenging to access
and interpret this data without being overwhelmed.186 Most often, structural information is
accessed through means of molecular visualization, which is used not only by structural experts
but has become widely accepted in the biological research community.187 In order to efficiently
access structural information, sophisticated visualization techniques based on computer graphics
and intuitive means to interact with the molecular representation are required. Although,
visualization tools have significantly improved over the last decades, both in their rendering
quality as well as their user-friendliness,188 however, systems to interact with those tools in an
intuitive and natural way are largely missing.
Picking up small objects, moving them around and reorienting them is clearly a straight-
forward task in the real world that can be done within seconds. However, performing similar
movements in a virtual world is often much more challenging, since current human-computer
interface devices do not reflect those natural movements.
Traditionally, interaction with a virtual three-dimensional environment is performed using
standard computer peripherals like keyboard and mouse. Those input devices are inexpensive
and commonly available, but have been designed to perform two-dimensional movements. The
virtual scene, however, requires movements along six degrees of freedom. Therefore, using
standard equipment to interact with a three-dimensional scene, is often unintuitive and imposes
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a substantial hurdle to non-expert users. Over the years, numerous dedicated input devices, de-
signed for movements in a three-dimensional environments, have been developed,189,190,191,192
of which currently, to our knowledge, only the SpaceMouse is commercially available.193
In a recent attempt to introduce fundamental principles of structural biology to a non-expert
audience, we have experimented with both a user interface based on a SpaceMouse as well as
a standard computer mouse/keyboard combination. Using a stereographic display, a simplified
three-dimensional representation of a protein structure, i.e. its molecular surface, was shown
to the user. In addition, a known small molecular inhibitor of that protein was displayed. The
user could manipulate the position and orientation of the inhibitor by applying translation and
rotation movements. A snapshot of the system is shown in Figure 6.1
Figure 6.1: Visualization of the protein ligand system used during the demonstration of the basics of
structure based drug discovery. The molecular surface of the protein is shown in gray, the small molecular
inhibitor is shown in a sphere representation, where each sphere indicates an atom and the colors indicate
different elements.
For most users, independent of their age and computer experience, a substantial hurdle was
introduced by either of the afore mentioned user interface devices. In fact, this barrier was so
high that most users could only focus on how to interact with the virtual environment while
being completely distracted from the scientific content that was displayed.
This experiment clearly indicates that there is a need for a natural and intuitive user interface
device designed specifically for tasks common to the field of structural biology and related
areas. A transparent human-computer interface could substantially facilitate the interaction
and improve the user experience. This would attract a broader community of life scientists and
therefore could lead to a better use of the available data produced by structural biology studies.
Therefore, we have designed and evaluated a new user interface device which allows to use
natural movements to interact intuitively with the afore mentioned virtual biological system.
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6.2 Interface Device Design
The new user interface device uses a combination of an inertial measurement system (IMU) to
follow the rotation of the user’s hand and an optical motion sensing system, i.e. a Microsoft
Kinect sensor to track the hand’s position. The device represents an isotonic sensor, measuring
its travel and applies direct position control with a linear relationship between the sensor and
the virtual object movement. It is designed with large screen environments in mind and is based
on inexpensive consumer grade equipment.
It has been shown that a number of design decisions are crucial for designing an intuitive
user interface device:
Movement Separation Positioning of an object in a three-dimensional environment re-
quires at least six degrees of freedom (DOF), three for object translation and three for rotation.
A strict separation between the three translational and the three rotational DOFs was shown
to be an integral part of a user-friendly device.194 This point has only been poorly incorporated
in the SpaceMouse, where translation often triggers a slight rotation and vice versa.
Movements of real objects are clearly separated into a rotational and a translational compo-
nent performed by individual body parts. Translations, are mainly performed by movements of
the elbow and shoulder. Rotations however, are often executed by the finger tips and the wrist
– for example when rolling an object between the fingers. The latter movements have been
shown to yield precise rotational input.195 Therefore, the new device was designed to mimic
the same movements as used for real object manipulation.
Shape Mismatch Generally, the device held in the users hand is nothing like the object
manipulated in the virtual environment. Although numerous attempts were taken to match
the shape of the input device to the virtual object,196,197 we decided to use a spherical device
for three reasons: First, a spherical input device behaves isotropically and thus can easily be
rotated and does not interfere with the user. Second, an input device in the shape of the virtual
object requires auto-fabrication of a new device for each represented system.198,199 Although,
nowadays this is feasible, it significantly limits the interchangeability of the device. Third, such
a device would need accurate alignment of the absolute orientation between the real and the
virtual object in order to produce a realistic impression on the user.
Device Location It has been shown that the location of the input device can have an
effect on its usability.200,201 Usually, the input device is held to the side of the computer
and therefore movements do not correspond directly to the natural movements involved for
manipulating real objects. However, having an input device where the movements correspond
to natural movements requires lifting of the device off the ground. Although this might be
fatiguing, in our experience, it significantly improves the design.
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6.2.1 Hardware Architecture
The hardware used in our new input device is separated into two devices. Translation detection
is based on an off-the-shelf Microsoft Kinect sensor. Rotation detection however, is based on
a custom made hardware as described in more detail below.
Rotation Input Device
The core of the system is based on an 8-bit microcontroller (Atmel ATmega324-PA) which is
interfaced to different hardware modules. The block diagram of the hardware design is shown
in Figure 6.2 and the board layout in Figure 6.3. The direction of the communication process
is indicated by arrows between the components labeled with the respective interface bus. The
core microcontroller has three main tasks: communication with the inertial measurement unit
(IMU), communication with the host computer and processing/filtering of the IMU data stream.
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Figure 6.2: Schematic representation of the hardware architecture of the rotation input device. The core
of the system is based on a microcontroller which interfaces different hardware modules. The direction
of the communication process is indicated by arrows between the components labeled with the respective
interface bus.
The inertial measurement unit (Sparkfun Razor 9DOF SEN-10736) senses both linear and
angular acceleration as well as the absolute magnetic field in three axis each. It uses low-cost
consumer-grade MEMS based sensor components, i.e. an Analog Devices ADXL345 triple-axis
accelerometer, an InvenSense ITG-3200 triple-axis gyroscope and a Honeywell HMC5883L triple-
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Figure 6.3: Front (A) and back (B) copper layer and silkscreen showing the layout of the custom made
printed circuit board of the rotation input device.
axis magnetometer. The sensor values are processed by an on-board ATmega328 microcontroller
which uses the firmware by Bartz et al.202 (version 1.4.0) to compute heading, attitude and yaw
information from the raw sensor values. The results are transmitted to the core microcontroller’s
UART1 port using the RS-232 protocol.
The core microcontroller communicates with the host computer through two distinct inter-
faces. First, a cable-based USB interface and second, a wireless class 1 Bluetooth interface
with a range of up to 100m. Both interfaces are bidirectional. The incoming signals from
the PC are translated to the RS-232 protocol using either an FT232RL USB-UART converter
chip or an RN41 Bluetooth-UART converter module, for USB and Bluetooth communication
protocols, respectively. Since the ATmega324-PA has two separate UART ports, but one is
occupied by the IMU, the communication with both converter chips share the UART0 port.
Since RS-232 is a point-to-point interface, sharing of a port between multiple devices is not
natively supported and would even lead to the destruction of the interface chips if both devices
communicate at the same time. Thus, we implemented a simple solution, using two Schottky
diodes and a 100kΩ pull-up resistor to emulate open collector output ports on the two interface
chips. Schematics of the electronic circuit are shown in Appendix A.4. This solution allows the
core microcontroller to send data through both interfaces in parallel and to receive data from
both interfaces in a sequential manner.
The microcontroller interfaces with an array of push buttons to sense a compression of the
input device casing. This allows for an easy, omnidirectional input signal which can be operated
independent of the orientation of the device. The output signal caused by a compression event
is arbitrarily configurable and can be used for example to activate/deactivate the input device.
In addition, the system has an expansion connector which allows to connect up to eight analog
or digital sensors, like flex or force sensors or additional push buttons. Additionally, both the
I2C as well as the SPI bus are connected to an output header in order to add any input or
output modules based on those protocols.
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The device is able to produce optic, acoustic and haptic feedback. To accomplish this, three
output modules are interfaced to the microcontroller. First, a full-color light emitting diode
(ASMT-YTB2-0BB02) connected through a parallel interface. This allows to produce any
color combination to communicate status information and for general visual feedback. Second,
a piezoelectric buzzer, interfaced through a general purpose input-output (GPIO) pin where the
frequency is controlled by a hardware pulse-width modulated (PWM) signal to emit a variable
pitch acoustic signal. Third, a vibration motor connected to an appropriate motor controller
(DRV8830) which is interfaced to the microcontroller through the I2C bus. This allows to
produce haptic feedback through vibration of the input device. All output modules can be
steered by signals from the input modules, events on the IMU data stream or commands from
the host computer which are all interpreted by the core microcontroller.
The system also incorporates a 1000 mAh lithium polymer battery and the corresponding
battery management unit (MCP73831T). Thus, charging of the battery is simply performed
by connecting the device through the USB interface. The battery voltage of 3.7 V is then
regulated to the appropriate 3.3 V used by all components by a low dropout linear voltage
regulator (MC33375ST). Thus, the device incorporates all modules for power management and
can be charged without removing the battery. The lifetime of the battery is in the range of
days.
6.2.2 Software Architecture
The software used in our new device interfaces with the two hardware devices. A schematic
overview of the software architecture is given in Figure 6.4.
processing and
comunication unit
inertial
measurement unit
Microsoft Kinect
USB host controllervirtual serial port
OpenNI / NITEQT serial portlibrary
OpenStructure device driver interface
OpenStructure scene
QT signals
Figure 6.4: Schematic representation of the software architecture.
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As described above, the inertial measurement unit, used for rotation input, is connected
to a microcontroller platform responsible for signal processing and communication with the
host computer through a wireless Bluetooth communication link. On the host computer, the
Bluetooth kernel module emulates a serial port. Based on the QT serial port library QExtSe-
rialPort203 a general device driver interface was implemented in OpenStructure,83 allowing to
connect to any device using the RS-232 serial port communication protocol.
The Microsoft Kinect sensor, used for translation input, is connected to the host computer
through the USB interface. Based on the OpenNI framework204 and the NITE middleware205
skeleton tracking is performed. In OpenStructure a driver was implemented that interfaces with
the NITE skeleton tracking and extracts the three-dimensional coordinates of the user’s joints.
The driver interface now allows to attach either any graphical object or the camera itself
to any hardware controller. This in turn allows the object’s position and orientation to be
controlled by the input devices. The flexibility of this interface has the advantage, that multiple
input devices can be combined or different graphical objects, e.g. protein and ligand, can be
controlled by different input devices.
6.3 User Experience
In order to illustrate computational approaches in structural biology and their application in
modern life science to the general public, we have developed Drug The Bug – a 3D projection
display installation with intuitive, interactive structure manipulation capabilities based on the
newly developed user interface. This system demonstrates the basic ideas of structure based
drug design approaches.
The software is written in Python and is based on OpenStructure,83 an open-source, modu-
lar, flexible, molecular modeling and visualization environment. Within the application, different
molecular systems can be chosen, each consisting of a known protein-ligand complex structure
obtained from the PDB.118 The user can interactively manipulate the position and orientation
of the ligand with the aim of finding the orientation which fits best into the binding pocket of
the corresponding target protein. For simplicity, the position of the protein atoms as well as the
internal degrees of freedom of the ligand are fixed. This is thus, a simplified version of what
molecular docking programs like Autodock,174 Glide67 or Dock170,171 do, which are commonly
used in structure based drug discovery.
The biological system is visualized as two individual objects. First, the protein structure is
represented by its molecular surface computed by MSMS.127 This is a reduced representation
of the actual structure which allows for easier identification of surface exposed binding pockets.
Second, the ligand is represented in sphere mode where each atom is drawn as a sphere with
its radius set to the standard van der Waals radius of the corresponding element.
Molecular recognition between a protein and its ligand is manifold. To estimate bind-
ing affinities computationally, current methods employ numerous approximations.29 Binding
affinities are often estimated based on a combination of scores accounting for geometric fit,
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electrostatic complementarity or van der Waals interaction energy. To illustrate these concepts,
Drug The Bug displays different scores to the user. First, steric clashes between the ligand
and the protein are displayed by coloring the protein surface. A color gradient is used to indi-
cate the severeness, where white corresponds to no clash and red to a severe clash. Second,
geometric complementarity and electrostatic interactions between the ligand and the protein
are computed using BEscore (see Section 5) and the ligand atoms are colored accordingly using
a gradient from blue (no interaction) to green (good interaction). All scores are continuously
updated to give an immediate feedback to the user. To allow this rapid score update, BEscore
is precomputed on all points of a three dimensional grid encompassing the whole protein. The
score for each atom of a given ligand orientation can then be computed extremely fast through
trilinear interpolation of the values at the eight closest grid points.
Figure 6.5: (A) A participant of the recent demonstration holding a prototype of the new input device in
her right hand. (B) Photo of the current prototype.
The installation has been displayed on several occasions to the general public and was used
for teaching of undergraduate students. A snapshot of a participant using a prototype of the
input device is shown in Figure 6.5. The project was very well received by a highly diverse range
of people with different age, computer experience and scientific or technical education. The
barrier that was observed in previous experiments, where commercially available input devices
like a standard computer mouse or the dedicated SpaceMouse was used, were significantly
reduced. This was clearly indicated by the fact that most users did neither need a thorough
explanation of how the interface worked nor did they need any training. It was commonly
observed that the user forgot about the device and was fully immersed into the virtual world.
6.4 Conclusion
We have described here a new user interface device for three-dimensional virtual environments
which fully relies on natural movements that the user knows from everyday motions. The new
user interface device uses a combination of an inertial measurement system and an optical
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motion sensing system. The system is an isotonic sensor which directly translates real space
movements into the same movements in the virtual world. This renders it highly intuitive and
is a step forward to a fully transparent user interface which does not distract the attention of
the user from what is on the screen but allows him to fully dive into the virtual world.
The device has been intensively used in our newly developed interactive 3D projection
display installation – Drug The Bug – which illustrates computational approaches in structural
biology and their applications in modern life science to the general public. Due to the use of
this device, the barrier between the user and the virtual environment was substantially reduced
compared to earlier events where other input methods were used. This allowed the users to
focus entirely on the scientific content of the demonstration. Drug The Bug is an excellent
basis for further developments of interactive structure visualization and manipulation techniques
including approaches like continuous energy minimization206 or interactive molecular dynamics
simulations.207
The device opens up a number of new options for the intuitive interaction with three-
dimensional biological structures. It is able to produce optic, acoustic and haptic feedback
through the incorporation of a full-color light-emitting diode, a piezoelectric speaker and a
vibration motor. Thus, a bidirectional communication between the user and the software appli-
cation is possible where different feedback channels can be activated depending on the event.
For example, when the device is used for docking of a ligand, unfavorable steric clashes between
the ligand and the protein could be reported to the user by vibrating the input device, with the
strength of the vibration depending on the magnitude of the clash. Future developments could
incorporate additional communication channels, like olfactory or temperature output, to exploit
the full spectrum of human sensory channels.
151

Chapter 7
Summary and Outlook
In this study we have successfully employed a combination of structure-based virtual screening
methods and enzymatic inhibition assays in order to discover inhibitors of the dengue virus
methyltransferase. Ten hit compounds were initially identified and the inhibitory activity of the
two most active compounds was confirmed in additional inhibition assays. Due to solubility
issues only a subset of three compounds was assayed in a subsequent ITC experiment, however,
their binding to the dengue MTase could not be confirmed. One underlying reason for this might
be a pre-occupied SAM binding pocket which renders ITC based measurements unfeasible for
compounds binding to the SAM pocket. This effect should to be further quantified, for example
by determination of the co-purified SAH content and by quantification of the SAH exchange
rate.
The investigation of the catalytic mechanism of the dengue MTase addressed a number of
open questions concerning the mechanism of the methyltransfer reactions.
By characterizing the underlying chemical reactions based on ab initio electronic structure
calculations applied to model systems approximating the biological reactions, it was found that
the 2’O and the N7 reactions are energetically favored processes, where the N7 reaction produces
a significantly more stable product and shows a lower activation barrier than the 2’O reaction.
Comparison between the catalyzed and uncatalyzed 2’O reaction, revealed the importance of a
lysine residue which acts as a proton acceptor and significantly stabilizes the product state and
reduces the activation barrier.
Furthermore, an in-silico approach was developed to identify the effects of single point mu-
tations on different aspects of the catalyzed 2’O reaction. In a computational alanine scanning
procedure protein residue patches were identified which modulate either the geometric arrange-
ment between methyl donor and acceptor, the methyl donor binding affinity or the reaction
energy barrier. In addition, previously uncharacterized hot-spot residues were identified and
analyzed further using computational and experimental mutagenesis in order to gain a better
understanding of their role in the enzyme’s function. The analysis indicate that those mutations
either modulate SAM binding or increase the reaction energy barrier. With the knowledge ob-
tained in this study, we hope to facilitate the rational development of inhibitors against dengue
fever and related diseases caused by flavivirus.
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The evaluation of methods for predicting ligand binding sites for proteins with unknown
structure during the CASP9 experiment highlighted the state of the art of current prediction
methods. The results demonstrate that all top performing methods are based on homology
transfer from known structures. However, such methods are limited to cases where a closely
related protein structure with bound ligand is available which is not commonly the case. Thus,
there is a clear need for the development of new methods allowing de-novo predictions of ligand
binding sites. The setup of the ligand binding site prediction category in CASP has shown some
major limitations primarily caused by a very low number of challenging target structures with
relevant ligands and a restricted prediction format which treats all ligands uniformly, independent
of their chemical type. To overcome those limitations, an extended assessment of ligand binding
site predictions was implemented into the CAMEO framework introducing a format more suitad
for high accuracy predictions. This allows now to continuously evaluate the accuracy and
reliability of ligand binding site prediction services in a blind and fully automated manner to
assess the current state of the art of prediction methods, identify possible bottlenecks, and
further stimulate the development of new methods.
We have successfully developed a rapid scoring function to identify the best ligand poses out
of an ensemble of pre-docked poses. By quantifying the degree of burial and the electrostatic
interactions of the ligand in a binding site promisingly high retrieval rates were achieved for
selecting the best poses from a pool of decoy poses. Inspection of the scoring functions results
indicates some limitations of the current method and suggests possible improvements to be
addressed by further development. The main issue being an appropriate inclusion of water
mediated interactions to further improve the scoring function’s performance on protein-ligand
complexes where molecular recognition is governed by water mediated interactions.
154
Acknowledgments
I would like to thank my two supervisors, Prof. Torsten Schwede and Prof. Markus Meuwly for
giving me the opportunity to perform my PhD studies in their groups and for their continuous
support and fruitful discussions.
I would also like to say thanks to all my colleagues from both groups for the pleasant and
fruitful working environment. In particular, I thank Dr. Juergen Haas for numerous stimulating
discussions, guidance and encouragement during all phases of this work and for critically reading
my thesis and providing constructive feedback. Special thanks goes to Mohamed-Ali Mahi for
his competent work in the wet-lab, conducting all experimental measurements. Furthermore, I
would like to thank Marco Biasini for many (scientific) discussions and for his continuous efforts
in developing OpenStructure, without this much of the work would have been impossible.
Additionally, I am grateful to all collaboration partners from Schrodinger, the NITD and the
group of Prof. Bruno Canard.
Last but foremost, I would like to express my thanks to my wife Nicole, my daughter Anina
and my family for their endless support and love without whom this work would not have been
possible.
155

Bibliography
[1] Jones, S. and Thornton, J. M. Searching for functional sites in protein structures. Current
Opinion in Chemical Biology 8(1), 3–7 (2004).
[2] Kalyaanamoorthy, S. and Chen, Y. P. P. Structure-based drug design to augment hit
discovery. Drug Discovery Today 16(17-18), 831–839 (2011).
[3] Mulholland, A. J. Modelling enzyme reaction mechanisms, specificity and catalysis. Drug
Discovery Today 10(20), 1393–1402 (2005).
[4] Chothia, C. and Lesk, A. M. The relation between the divergence of sequence and structure
in proteins. Embo Journal 5(4), 823–826 (1986).
[5] Gabaldon, T. and Huynen, M. A. Prediction of protein function and pathways in the genome
era. Cellular and Molecular Life Sciences 61(7-8), 930–944 (2004).
[6] Wolfson, H. J., Shatsky, M., Schneidman-Duhovny, D., et al. From structure to function:
Methods and applications. Current Protein and Peptide Science 6(2), 171–183 (2005).
[7] Gherardini, P. F. and Helmer-Citterich, M. Structure-based function prediction: approaches
and applications. Brief Funct Genomic Proteomic 7(4), 291–302 (2008).
[8] Berezin, C., Glaser, F., Rosenberg, J., et al. ConSeq: the identification of functionally and
structurally important residues in protein sequences. Bioinformatics 20(8), 1322–4 (2004).
[9] Casari, G., Sander, C., and Valencia, A. A method to predict functional residues in proteins.
Nat Struct Biol 2(2), 171–8 (1995).
[10] del Sol, A., Pazos, F., and Valencia, A. Automatic methods for predicting functionally
important residues. J Mol Biol 326(4), 1289–302 (2003).
[11] Fischer, J. D., Mayer, C. E., and Soding, J. Prediction of protein functional residues from
sequence by probability density estimation. Bioinformatics 24(5), 613–20 (2008).
[12] Innis, C. A. siteFiNDER—3D: a web-based tool for predicting the location of functional
sites in proteins. Nucleic Acids Res 35(Web Server issue), W489–94 (2007).
[13] Pazos, F., Rausell, A., and Valencia, A. Phylogeny-independent detection of functional
residues. Bioinformatics 22(12), 1440–8 (2006).
157
BIBLIOGRAPHY
[14] Glaser, F., Morris, R. J., Najmanovich, R. J., et al. A method for localizing ligand binding
pockets in protein structures. Proteins 62(2), 479–88 (2006).
[15] Hendlich, M., Rippmann, F., and Barnickel, G. Ligsite: Automatic and efficient detection
of potential small molecule-binding sites in proteins. Journal of Molecular Graphics and
Modelling 15(6) (1997).
[16] Hernandez, M., Ghersi, D., and Sanchez, R. SITEHOUND-web: a server for ligand binding
site identification in protein structures. Nucleic Acids Res 37(Web Server issue), W413–6
(2009).
[17] Huang, B. and Schroeder, M. LIGSITEcsc: predicting ligand binding sites using the
Connolly surface and degree of conservation. BMC Struct Biol 6, 19 (2006).
[18] Laskowski, R. A. SURFNET: a program for visualizing molecular surfaces, cavities, and
intermolecular interactions. J Mol Graph 13(5), 323–30, 307–8 (1995).
[19] Brylinski, M. and Skolnick, J. A threading-based method (FINDSITE) for ligand-binding
site prediction and functional annotation. Proc Natl Acad Sci U S A 105(1), 129–34 (2008).
[20] Oh, M., Joo, K., and Lee, J. Protein-binding site prediction based on three-dimensional
protein modeling. Proteins-Structure Function and Bioinformatics 77, 152–156 (2009).
[21] Pandit, S. B., Brylinski, M., Zhou, H., et al. PSiFR: an integrated resource for prediction
of protein structure and function. Bioinformatics 26(5), 687–8 (2010).
[22] Wass, M. N., Kelley, L. A., and Sternberg, M. J. E. 3DLigandSite: predicting ligand-
binding sites using similar structures. Nucleic Acids Research 38, W469–W473 (2010).
[23] Lopez, G., Rojas, A., Tress, M., et al. Assessment of predictions submitted for the CASP7
function prediction category. Proteins-Structure Function and Bioinformatics 69, 165–174
(2007).
[24] Lopez, G., Ezkurdia, I., and Tress, M. L. Assessment of ligand binding residue predictions
in CASP8. Proteins-Structure Function and Bioinformatics 77, 138–146 (2009).
[25] Schmidt, T., Haas, J., Cassarino, T. G., et al. Assessment of ligand-binding residue
predictions in CASP9. Proteins-Structure Function and Bioinformatics 79 (2011).
[26] Ko, J., Park, H., Heo, L., et al. Galaxyweb server for protein structure prediction and
refinement. Nucleic Acids Research 40(W1), W294–W297 (2012).
[27] Roy, A., Yang, J. Y., and Zhang, Y. COFACTOR: an accurate comparative algorithm for
structure-based protein function annotation. Nucleic Acids Research 40(W1), W471–W477
(2012).
[28] Kitchen, D. B., Decornez, H., Furr, J. R., et al. Docking and scoring in virtual screening for
drug discovery: Methods and applications. Nature Reviews Drug Discovery 3(11) (2004).
158
BIBLIOGRAPHY
[29] Gilson, M. K. and Zhou, H. X. Calculation of protein-ligand binding affinities. Annual
Review of Biophysics and Biomolecular Structure 36, 21–42 (2007).
[30] Leach, A. R., Shoichet, B. K., and Peishoff, C. E. Prediction of protein-ligand interactions.
Docking and scoring: successes and gaps. J Med Chem 49(20), 5851–5 (2006).
[31] Brooijmans, N. and Kuntz, I. D. Molecular recognition and docking algorithms. Annual
Review of Biophysics and Biomolecular Structure 32, 335–373 (2003).
[32] Kollman, P. A., Massova, I., Reyes, C., et al. Calculating structures and free energies of
complex molecules: Combining molecular mechanics and continuum models. Accounts of
Chemical Research 33(12), 889–897 (2000).
[33] Aqvist, J., Medina, C., and Samuelsson, J. E. New method for predicting binding-affinity
in computer-aided drug design. Protein Engineering 7(3), 385–391 (1994).
[34] Senn, H. M. and Thiel, W. Qm/mm methods for biomolecular systems. Angewandte
Chemie-International Edition 48(7), 1198–1229 (2009).
[35] Kastner, J. Umbrella sampling. Wiley Interdisciplinary Reviews-Computational Molecular
Science 1(6), 932–942 (2011).
[36] The Togaviruses: Biology, Structure, Replication, chapter Togavirus morphology and mor-
phogenesis, 241–316. Schlesinger R.W. (1980).
[37] Grubler, D. Dengue/dengue haemorrhagic fever: history and current status. In New
Treatment Strategies For Dengue And Other Flaviviral Diseases, volume 277 of Novartis
Foundation Symposium, 3–16. John Wiley and Sons, Ltd, (2006).
[38] Mackenzie, J. S., Gubler, D. J., and Petersen, L. R. Emerging flaviviruses: the spread and
resurgence of japanese encephalitis, west nile and dengue viruses. Nature Medicine 10(12),
S98–S109 (2004).
[39] Halstead, S. B. Dengue. Lancet 370(9599), 1644–1652 (2007).
[40] Whitehead, S. S., Blaney, J. E., Durbin, A. P., et al. Prospects for a dengue virus vaccine.
Nature Reviews Microbiology 5(7), 518–528 (2007).
[41] Mukhopadhyay, S., Kuhn, R. J., and Rossmann, M. G. A structural perspective of the
flavivirus life cycle. Nature Reviews Microbiology 3(1), 13–22 (2005).
[42] Harris, E., Holden, K., Edgil, D., et al. Molecular biology of flaviviruses. In New Treatment
Strategies For Dengue And Other Flaviviral Diseases, volume 277 of Novartis Foundation
Symposium, 3–16. John Wiley and Sons, Ltd, (2006).
[43] Perera, R. and Kuhn, R. J. Structural proteomics of dengue virus. Current Opinion in
Microbiology 11(4), 369–377 (2008).
159
BIBLIOGRAPHY
[44] Egloff, M. P., Benarroch, D., Selisko, B., et al. An rna cap (nucleoside-2 ’-o-)-
methyltransferase in the flavivirus rna polymerase ns5: crystal structure and functional
characterization. Embo Journal 21(11), 2757–2768 (2002).
[45] Dong, H. P., Ren, S. P., Zhang, B., et al. West nile virus methyltransferase catalyzes
two methylations of the viral rna cap through a substrate-repositioning mechanism. Journal
of Virology 82(9), 4295–4307 (2008). Dong, Hongping Ren, Suping Zhang, Bo Zhou,
Yangsheng Puig-Basagoiti, Francesc Li, Hongmin Shi, Pei-Yong.
[46] Issur, M., Geiss, B. J., Bougie, I., et al. The flavivirus ns5 protein is a true rna guany-
lyltransferase that catalyzes a two-step reaction to form the rna cap structure. Rna-a
Publication of the Rna Society 15(12), 2340–2350 (2009).
[47] Sampath, A. and Padmanabhan, R. Molecular targets for flavivirus drug discovery. Antiviral
Research 81(1), 6–15 (2009).
[48] Cleaves, G. and Dubin, D. Methylation stratus of intracellular dengue type 2 40 S RNA.
Virology 96, 159–165 (1979).
[49] Furuichi, Y. and Shatkin, A. J. Viral and cellular mrna capping: Past and prospects.
Advances in Virus Research, Vol 55 55, 135–184 (2000).
[50] Ray, D., Shah, A., Tilgner, M., et al. West nile virus 5 ’-cap structure is formed by
sequential guanine n-7 and ribose 2 ’-o methylations by nonstructural protein 5. Journal of
Virology 80(17), 8362–8370 (2006).
[51] Martin, J. L. and McMillan, F. M. Sam (dependent) i am: the s-adenosylmethionine-
dependent methyltransferase fold. Current Opinion in Structural Biology 12(6), 783–793
(2002).
[52] Benarroch, D., Egloff, M. P., Mulard, L., et al. A structural basis for the inhibition of the
ns5 dengue virus mrna 2 ’-o-methyltransferase domain by ribavirin 5 ’-triphosphate. Journal
of Biological Chemistry 279(34), 35638–35643 (2004).
[53] Egloff, M. P., Decroly, E., Malet, H., et al. Structural and functional analysis of methylation
and 5’-RNA sequence requirements of short capped RNAs by the methyltransferase domain
of dengue virus NS5. Journal of Molecular Biology 372(3), 723–736 (2007).
[54] Stevens, A. J., Gahan, M. E., Mahalingam, S., et al. The medicinal chemistry of dengue
fever. Journal of Medicinal Chemistry 52(24), 7911–7926 (2009).
[55] Lim, S. P., Wen, D. Y., Yap, T. L., et al. A scintillation proximity assay for dengue
virus ns5 2 ’-o-methyltransferase-kinetic and inhibition analyses. Antiviral Research 80(3),
360–369 (2008).
160
BIBLIOGRAPHY
[56] Luzhkov, V. B., Selisko, B., Nordqvist, A., et al. Virtual screening and bioassay study of
novel inhibitors for dengue virus mrna cap (nucleoside-2’o)-methyltransferase. Bioorganic
and Medicinal Chemistry 15(24), 7795–7802 (2007).
[57] Milani, M., Mastrangelo, E., Bollati, M., et al. Flaviviral methyltransferase/rna interac-
tion: Structural basis for enzyme inhibition. Antiviral Research 83(1), 28–34 (2009). Mi-
lani, Mario Mastrangelo, Eloise Bollati, Michela Selisko, Barbara Decroly, Etienne Bouvet,
Mickael Canard, Bruno Bolognesi, Martino EU IP Project Vizier [Cr 2004-511960]; Italian
Ministry for University and Scientific Research FIRB Project 30 ELSEVIER SCIENCE BV
464BP.
[58] Lim, S. P., Sonntag, L. S., Noble, C., et al. Small molecule inhibitors that selectively
block dengue virus methyltransferase. Journal of Biological Chemistry 286(8), 6233–6240
(2011).
[59] Stahla-Beek, H. J., April, D. G., Saeedi, B. J., et al. Identification of a novel antiviral
inhibitor of the flavivirus guanylyltransferase enzyme. Journal of Virology 86(16), 8730–
8739 (2012).
[60] Zhou, Y. S., Ray, D., Zhao, Y. W., et al. Structure and function of flavivirus ns5 methyl-
transferase. Journal of Virology 81(8), 3891–3903 (2007).
[61] Dong, H. P., Zhang, B., and Shi, P. Y. Flavivirus methyltransferase: A novel antiviral
target. Antiviral Research 80(1), 1–10 (2008). Times Cited: 11.
[62] Hodel, A. E., Gershon, P. D., and Quiocho, F. A. Structural basis for sequence-nonspecific
recognition of 5 ’-capped mrna by a cap-modifying enzyme. Molecular Cell 1(3), 443–447
(1998).
[63] Hager, J., Staker, B. L., Bugl, H., et al. Active site in rrmj, a heat shock-induced methyl-
transferase. Journal of Biological Chemistry 277(44), 41978–41986 (2002).
[64] Li, C., Xia, Y., Gao, X., et al. Mechanism of rna 2 ’-o-methylation: Evidence that the
catalytic lysine acts to steer rather than deprotonate the target nucleophile. Biochemistry
43(19), 5680–5687 (2004).
[65] Li, C. and Gershon, P. D. pk(a) of the mrna cap-specific 2 ’-o-methyltransferase catalytic
lysine by hsqc nmr detection of a two-carbon probe. Biochemistry 45(3), 907–917 (2006).
[66] Fabrega, C., Hausmann, S., Shen, V., et al. Structure and mechanism of mrna cap
(guanine-n7) methyltransferase. Molecular Cell 13(1), 77–89 (2004).
[67] Friesner, R. A., Banks, J. L., Murphy, R. B., et al. Glide: A new approach for rapid,
accurate docking and scoring. 1. method and assessment of docking accuracy. Journal of
Medicinal Chemistry 47(7) (2004).
161
BIBLIOGRAPHY
[68] McGovern, S. L., Caselli, E., Grigorieff, N., et al. A common mechanism underlying
promiscuous inhibitors from virtual and high-throughput screening. Journal of Medicinal
Chemistry 45(8), 1712–1722 (2002).
[69] Seidler, J., McGovern, S. L., Doman, T. N., et al. Identification and prediction of promis-
cuous aggregating inhibitors among known drugs. Journal of Medicinal Chemistry 46(21),
4477–4486 (2003).
[70] Shoichet, B. K. Screening in a spirit haunted world. Drug Discovery Today 11(13-14),
607–615 (2006).
[71] Feng, B. Y., Shelat, A., Doman, T. N., et al. High-throughput assays for promiscuous
inhibitors. Nature Chemical Biology 1(3), 146–148 (2005).
[72] Feng, B. Y. and Shoichet, B. K. A detergent-based assay for the detection of promiscuous
inhibitors. Nature Protocols 1(2), 550–553 (2006).
[73] Feng, B. Y., Simeonov, A., Jadhav, A., et al. A high-throughput screen for aggregation-
based inhibition in a large compound library. Journal of Medicinal Chemistry 50(10), 2385–
2390 (2007).
[74] Podvinec, M., Lim, S. P., Schmidt, T., et al. Novel inhibitors of dengue virus methyltrans-
ferase: Discovery by in vitro-driven virtual screening on a desktop computer grid. Journal
of Medicinal Chemistry 53(4) (2010).
[75] Babaoglu, K., Simeonov, A., Lrwin, J. J., et al. Comprehensive mechanistic analysis of
hits from high-throughput and docking screens against beta-lactamase. Journal of Medicinal
Chemistry 51(8), 2502–2511 (2008).
[76] Breiman, L. Random forests. Machine Learning 45(1), 5–32 (2001).
[77] Ihaka, R. and Gentleman, R. R: A language for data analysis and graphics. Journal of
Computational and Graphical Statistics 5(3), 299–314 (1996).
[78] Yap, L. J., Luo, D. H., Chung, K. Y., et al. Crystal structure of the dengue virus methyl-
transferase bound to a 5’-capped octameric rna. Plos One 5(9), 9 (2010).
[79] Bollati, M., Alvarez, K., Assenberg, R., et al. Structure and functionality in flavivirus
ns-proteins: Perspectives for drug design. Antiviral Research 87(2), 125–148 (2010).
[80] Phillips, J., Braun, R., Wang, W., et al. Scalable molecular dynamics with namd. J.
Comput. Chem. 26, 1781–1802 (2005).
[81] MacKerell, A. D., Bashford, D., Bellott, M., et al. All-atom empirical potential for molec-
ular modeling and dynamics studies of proteins. Journal of Physical Chemistry B 102(18),
3586–3616 (1998).
162
BIBLIOGRAPHY
[82] MacKerell, A. D., Feig, M., and Brooks, C. L. Extending the treatment of backbone
energetics in protein force fields: Limitations of gas-phase quantum mechanics in repro-
ducing protein conformational distributions in molecular dynamics simulations. Journal of
Computational Chemistry 25(11), 1400–1415 (2004).
[83] Biasini, M., Mariani, V., Haas, J., et al. Openstructure: a flexible software framework for
computational structural biology. Bioinformatics 26(20) (2010).
[84] Frisch, M. J., Trucks, G. W., Schlegel, H. B., et al. Gaussian 03, revision d.02. Gaussian,
Inc., Wallingford CT (2004).
[85] Becke, A. Density-functional thermochemistry. III. the role of exact exchange. J. Chem.
Phys. 7, 5648–5652 (1993).
[86] Ochterski, J., Petersson, G., and Montgomery, J. A complete basis set model chemistry.
V. extensions to six or more heavy atoms. J. Chem. Phys. 104, 2598–2619 (1996).
[87] Cossi, M., Rega, N., Scalmani, G., et al. Energies, structures, and electronic properties
of molecules in solution with the C-PCM solvation model. J. Comput. Chem 24, 669–681
(2003).
[88] Peng, C. Y. and Schlegel, H. B. Combining synchronous transit and quasi-newton methods
to find transition-states. Israel Journal of Chemistry 33(4), 449–454 (1993).
[89] Reed, A. E., Weinstock, R. B., and Weinhold, F. Natural-population analysis. Journal of
Chemical Physics 83(2), 735–746 (1985).
[90] Selisko, B., Peyrane, F. F., Canard, B., et al. Biochemical characterization of the
(nucleoside-2’o)-methyltransferase activity of dengue virus protein ns5 using purified capped
rna oligonucleotides (7me)gpppac(n) and gpppac(n). Journal of General Virology 91, 112–
121 (2010).
[91] Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., et al. Comparison of simple potential
functions for simulating liquid water. Journal of Chemical Physics 79(2), 926–935 (1983).
[92] Foloppe, N. and MacKerell, A. D. All-atom empirical force field for nucleic acids: I. pa-
rameter optimization based on small molecule and condensed phase macromolecular target
data. Journal of Computational Chemistry 21(2), 86–104 (2000).
[93] MacKerell, A. D. and Banavali, N. K. All-atom empirical force field for nucleic acids: II.
application to molecular dynamics simulations of DNA and RNA in solution. Journal of
Computational Chemistry 21(2), 105–120 (2000).
[94] Feng, M. H., Philippopoulos, M., MacKerell, A. D., et al. Structural characterization of
the phosphotyrosine binding region of a high-affinity sh2 domain-phosphopeptide complex
by molecular dynamics simulation and chemical shift calculations. Journal of the American
Chemical Society 118(45), 11265–11277 (1996).
163
BIBLIOGRAPHY
[95] Lee, M. S., Salsbury, F. R., and Brooks, C. L. Novel generalized born methods. Journal
of Chemical Physics 116(24), 10606–10614 (2002).
[96] Lee, M. S., Feig, M., Salsbury, F. R., et al. New analytic approximation to the standard
molecular volume definition and its application to generalized born calculations. Journal of
Computational Chemistry 24(11), 1348–1356 (2003).
[97] Baker, N. A., Sept, D., Joseph, S., et al. Electrostatics of nanosystems: Application to
microtubules and the ribosome. Proceedings of the National Academy of Sciences of the
United States of America 98(18) (2001).
[98] Elstner, M., Porezag, D., Jungnickel, G., et al. Self-consistent-charge density-functional
tight-binding method for simulations of complex materials properties. Physical Review B
58(11), 7260–7268 (1998).
[99] Cui, Q., Elstner, M., Kaxiras, E., et al. A qm/mm implementation of the self-consistent
charge density functional tight binding (scc-dftb) method. Journal of Physical Chemistry B
105(2), 569–585 (2001).
[100] Kumar, S., Bouzida, D., Swendsen, R. H., et al. The weighted histogram analysis method
for free-energy calculations on biomolecules .1. the method. Journal of Computational
Chemistry 13(8), 1011–1021 (1992).
[101] Massova, I. and Kollman, P. A. Computational alanine scanning to probe protein-protein
interactions: A novel approach to evaluate binding free energies. Journal of the American
Chemical Society 121(36), 8133–8143 (1999).
[102] Cunningham, B. C. and Wells, J. A. High-resolution epitope mapping of hgh-receptor
interactions by alanine-scanning mutagenesis. Science 244(4908), 1081–1085 (1989).
[103] Geiss, B. J., Thompson, A. A., Andrews, A. J., et al. Analysis of flavivirus ns5 methyl-
transferase cap binding. Journal of Molecular Biology 385(5), 1643–1654 (2009).
[104] Dong, H., Chang, D. C., Xie, X., et al. Biochemical and genetic characterization of
dengue virus methyltransferase. Virology 405(2), 568–578 (2010).
[105] Dong, H. P., Liu, L. H., Zou, G., et al. Structural and functional analyses of a con-
served hydrophobic pocket of flavivirus methyltransferase. Journal of Biological Chemistry
285(42), 32586–32595 (2010).
[106] Kroschewski, H., Lim, S. P., Butcher, R. E., et al. Mutagenesis of the dengue virus
type 2 ns5 methyltransferase domain. Journal of Biological Chemistry 283(28) (2008).
Kroschewski, Helga Lim, Siew Pheng Butcher, Rebecca E. Yap, Thai Leong Lescar, Julien
Wright, Peter J. Vasudevan, Subhash G. Davidson, Andrew D.
164
BIBLIOGRAPHY
[107] Bradshaw, R. T., Patel, B. H., Tate, E. W., et al. Comparing experimental and compu-
tational alanine scanning techniques for probing a prototypical protein-protein interaction.
Protein Engineering Design and Selection 24(1-2), 197–207 (2011).
[108] Hao, G. F., Yang, G. F., and Zhan, C. G. Computational mutation scanning and drug re-
sistance mechanisms of hiv-1 protease inhibitors. Journal of Physical Chemistry B 114(29),
9663–9676 (2010).
[109] Huo, S., Massova, I., and Kollman, P. A. Computational alanine scanning of the 1 :
1 human growth hormone-receptor complex. Journal of Computational Chemistry 23(1),
15–27 (2002).
[110] Riccardi, D., Schaefer, P., Yang, Y., et al. Development of effective quantum mechani-
cal/molecular mechanical (qm/mm) methods for complex biological processes. Journal of
Physical Chemistry B 110(13), 6458–6469 (2006).
[111] Elstner, M., Frauenheim, T., and Suhai, S. An approximate dft method for qm/mm
simulations of biological structures and processes. Theochem 632, 29–4141 (2003).
[112] Dong, H. P., Ray, D., Ren, S. P., et al. Distinct rna elements confer specificity to flavivirus
rna cap methylation events. Journal of Virology 81(9), 4412–4421 (2007).
[113] Soro, S. and Tramontano, A. The prediction of protein function at CASP6. Proteins-
Structure Function and Bioinformatics 61, 201–213 (2005).
[114] Pellegrini-Calace, M., Soro, S., and Tramontano, A. Revisiting the prediction of protein
function at CASP6. Febs Journal 273(13), 2977–2983 (2006).
[115] Schwede, T., Sali, A., Honig, B., et al. Outcome of a workshop on applications of protein
models in biomedical research. Structure 17(2), 151–159 (2009).
[116] Waterhouse, A., Schmidt, T., Biasini, M., et al. CAMEO Structure Annotation System.
http://www.cameo3d.org/annotation, (2012).
[117] wwPDB. Chemical Component Dictionary. http://www.wwpdb.org/ccd.html, (2012).
[118] Berman, H., Henrick, K., and Nakamura, H. Announcing the worldwide protein data
bank. Nature Structural Biology 10(12) (2003).
[119] Fawcett, T. An introduction to ROC analysis. Pattern Recognition Letters 27(8), 861–
874 (2006).
[120] Spearman, C. The proof and measurement of association between two things. American
Journal of Psychology 15, 72–101 (1904).
[121] Matthews, B. W. Comparison of predicted and observed secondary structure of T4 phage
lysozyme. Biochimica Et Biophysica Acta 405(2), 442–451 (1975).
165
BIBLIOGRAPHY
[122] Altschul, S. F., Gish, W., Miller, W., et al. Basic local alignment search tool. Journal of
Molecular Biology 215(3), 403–410 (1990).
[123] Larkin, M. A., Blackshields, G., Brown, N. P., et al. Clustal W and clustal X version 2.0.
Bioinformatics 23(21), 2947–2948 (2007).
[124] Armon, A., Graur, D., and Ben-Tal, N. ConSurf: An algorithmic tool for the identification
of functional regions in proteins by surface mapping of phylogenetic information. Journal
of Molecular Biology 307(1), 447–463 (2001).
[125] Arnold, K., Bordoli, L., Kopp, J., et al. The SWISS-MODEL workspace: a web-based
environment for protein structure homology modelling. Bioinformatics 22(2), 195–201
(2006).
[126] Peitsch, M. C. Protein modeling by e-mail. Bio-Technology 13(7), 658–660 (1995).
[127] Sanner, M. F., Olson, A. J., and Spehner, J. C. Reduced surface: An efficient way to
compute molecular surfaces. Biopolymers 38(3) (1996).
[128] Prediction Center. Prediction Center. http://www.predictioncenter.org, (2012).
[129] Haas, J. CAMEO. http://www.cameo3d.org, (2012).
[130] Berman, H. M., Westbrook, J., Feng, Z., et al. The protein data bank. Nucleic Acids
Research 28(1) (2000).
[131] Lyne, P. D. Structure-based virtual screening: an overview. Drug Discovery Today 7(20)
(2002).
[132] Deng, Z., Chuaqui, C., and Singh, J. Structural interaction fingerprint (sift): A novel
method for analyzing three-dimensional protein-ligand binding interactions. Journal of
Medicinal Chemistry 47(2) (2004).
[133] Graves, A. P., Shivakumar, D. M., Boyce, S. E., et al. Rescoring docking hit lists for
model cavity sites: Predictions and experimental testing. Journal of Molecular Biology
377(3), 914–934 (2008).
[134] Thompson, D. C., Humblet, C., and Joseph-McCarthy, D. Investigation of mm-pbsa
rescoring of docking poses. Journal of Chemical Information and Modeling 48(5) (2008).
[135] Kroemer, R. T. Structure-based drug design: Docking and scoring. Current Protein and
Peptide Science 8(4) (2007).
[136] Ferrara, P., Gohlke, H., Price, D. J., et al. Assessing scoring functions for protein-ligand
interactions. Journal of Medicinal Chemistry 47(12) (2004).
[137] Friedman, R. and Caflisch, A. Discovery of plasmepsin inhibitors by fragment-based
docking and consensus scoring. Chemmedchem 4(8) (2009).
166
BIBLIOGRAPHY
[138] Doman, T. N., McGovern, S. L., Witherbee, B. J., et al. Molecular docking and high-
throughput screening for novel inhibitors of protein tyrosine phosphatase-1b. Journal of
Medicinal Chemistry 45(11) (2002).
[139] Lyne, P. D., Kenny, P. W., Cosgrove, D. A., et al. Identification of compounds with
nanomolar binding affinity for checkpoint kinase-1 using knowledge-based virtual screening.
Journal of Medicinal Chemistry 47(8) (2004).
[140] Cross, J. B., Thompson, D. C., Rai, B. K., et al. Comparison of several molecular docking
programs: Pose prediction and virtual screening accuracy. Journal of Chemical Information
and Modeling 49(6) (2009).
[141] Gohlke, H. and Klebe, G. Approaches to the description and prediction of the bind-
ing affinity of small-molecule ligands to macromolecular receptors. Angewandte Chemie
(International ed. in English) 41(15) (2002).
[142] Krovat, E. M., Steindl, T., and Langer, T. Recent advances in docking and scoring.
Current Computer-Aided Drug Design 1(1) (2005).
[143] Schulz-Gasch, T. and Stahl, M. Scoring functions for proteinligand interactions: a critical
perspective. Drug Discovery Today: Technologies 1(3), 231–239 (2004).
[144] Warren, G. L., Andrews, C. W., Capelli, A.-M., et al. A critical assessment of docking
programs and scoring functions. Journal of Medicinal Chemistry 49(20) (2006).
[145] Bissantz, C., Folkers, G., and Rognan, D. Protein-based virtual screening of chemical
databases. 1. evaluation of different docking/scoring combinations. Journal of Medicinal
Chemistry 43(25) (2000).
[146] Chen, H. M., Lyne, P. D., Giordanetto, F., et al. Evaluating molecular-docking methods
for pose prediction and enrichment factors. Journal of Chemical Information and Modeling
46(1) (2006). Times Cited: 109 4th Indo-US Workshop on Mathematical Chemistry JAN
08-12, 2005 Pune, INDIA.
[147] Kellenberger, E., Rodrigo, J., Muller, P., et al. Comparative evaluation of eight docking
tools for docking and virtual screening accuracy. Proteins-Structure Function and Bioinfor-
matics 57(2) (2004).
[148] Kontoyianni, M., McClellan, L. M., and Sokol, G. S. Evaluation of docking performance:
Comparative data on docking algorithms. Journal of Medicinal Chemistry 47(3) (2004).
[149] Perola, E., Walters, W. P., and Charifson, P. S. A detailed comparison of current docking
and scoring methods on systems of pharmaceutical relevance. Proteins-Structure Function
and Bioinformatics 56(2) (2004).
[150] Stahl, M. and Rarey, M. Detailed analysis of scoring functions for virtual screening.
Journal of Medicinal Chemistry 44(7) (2001).
167
BIBLIOGRAPHY
[151] Wang, R. X., Lu, Y. P., and Wang, S. M. Comparative evaluation of 11 scoring functions
for molecular docking. Journal of Medicinal Chemistry 46(12) (2003).
[152] Jain, A. N. and Nicholls, A. Recommendations for evaluation of computational methods.
Journal of Computer-Aided Molecular Design 22(3-4) (2008).
[153] Cole, J. C., Murray, C. W., Nissink, J. W. M., et al. Comparing protein-ligand docking
programs is difficult. Proteins-Structure Function and Bioinformatics 60(3) (2005).
[154] Schmitt, S., Kuhn, D., and Klebe, G. A new method to detect related function among
proteins independent of sequence and fold homology. Journal of Molecular Biology 323(2)
(2002).
[155] Halgren, T. A. Merck molecular force field .1. basis, form, scope, parameterization, and
performance of mmff94. Journal of Computational Chemistry 17(5-6) (1996).
[156] Halgren, T. A. Merck molecular force field .2. mmff94 van der waals and electrostatic
parameters for intermolecular interactions. Journal of Computational Chemistry 17(5-6)
(1996).
[157] Halgren, T. A. Merck molecular force field .3. molecular geometries and vibrational
frequencies for mmff94. Journal of Computational Chemistry 17(5-6) (1996).
[158] Halgren, T. A. and Nachbar, R. B. Merck molecular force field .4. conformational energies
and geometries for mmff94. Journal of Computational Chemistry 17(5-6) (1996).
[159] Halgren, T. A. Merck molecular force field .5. extension of mmff94 using experimen-
tal data, additional computational data, and empirical rules. Journal of Computational
Chemistry 17(5-6) (1996).
[160] O’Boyle, N. M., Banck, M., James, C. A., et al. Open babel: An open chemical toolbox.
Journal of Cheminformatics 3 (2011).
[161] Bernstein, F. C., Koetzle, T. F., Williams, G. J. B., et al. Protein data bank - computer-
based archival file for macromolecular structures. Journal of Molecular Biology 112(3)
(1977).
[162] Brandstetter, H., Turk, D., Hoeffken, H. W., et al. Refined 2.3-angstrom x-ray crystal-
structure of bovine thrombin complexes formed with the benzamidine and arginine-based
thrombin inhibitors napap, 4-tapap and mqpa - a starting point for improving antithrom-
botics. Journal of Molecular Biology 226(4) (1992).
[163] Shelley, J. C., Cholleti, A., Frye, L. L., et al. Epik: a software program for pk (a)
prediction and protonation state generation for drug-like molecules. Journal of Computer-
Aided Molecular Design 21, 681–691 (2007).
168
BIBLIOGRAPHY
[164] Graves, A. P., Brenk, R., and Shoichet, B. K. Decoys for docking. Journal of Medicinal
Chemistry 48(11) (2005).
[165] Hartshorn, M. J., Verdonk, M. L., Chessari, G., et al. Diverse, high-quality test set for
the validation of protein-ligand docking performance. Journal of Medicinal Chemistry 50(4)
(2007).
[166] Grosdidier, A., Zoete, V., and Michielin, O. Blind docking of 260 protein-ligand complexes
with eadock 2.0. Journal of Computational Chemistry 30(13) (2009).
[167] Roche, O., Kiyama, R., and Brooks, C. L. Ligand-protein database: Linking protein-ligand
complex structures to binding data. Journal of Medicinal Chemistry 44(22), 3592–3598
(2001).
[168] Wang, R. X., Lai, L. H., and Wang, S. M. Further development and validation of empirical
scoring functions for structure-based binding affinity prediction. Journal of Computer-Aided
Molecular Design 16(1) (2002).
[169] Momany, F. A. and Rone, R. Validation of the general-purpose quanta(r)3.2/charmm(r)
force-field. Journal of Computational Chemistry 13(7) (1992).
[170] Ewing, T. J. A., Makino, S., Skillman, A. G., et al. Dock 4.0: Search strategies for
automated molecular docking of flexible molecule databases. Journal of Computer-Aided
Molecular Design 15(5) (2001).
[171] Brozell, S. R., Mukherjee, S., Balius, T. E., et al. Evaluation of dock 6 as a pose
generation and database enrichment tool. Journal of Computer-Aided Molecular Design
26(6), 749–773 (2012).
[172] Eldridge, M. D., Murray, C. W., Auton, T. R., et al. Empirical scoring functions .1. the
development of a fast empirical scoring function to estimate the binding affinity of ligands
in receptor complexes. Journal of Computer-Aided Molecular Design 11(5) (1997).
[173] Gohlke, H., Hendlich, M., and Klebe, G. Knowledge-based scoring function to predict
protein-ligand interactions. Journal of Molecular Biology 295(2) (2000).
[174] Morris, G. M., Goodsell, D. S., Huey, R., et al. Distributed automated docking of flexible
ligands to proteins: Parallel applications of autodock 2.4. Journal of Computer-Aided
Molecular Design 10(4) (1996).
[175] Zoete, V., Grosdidier, A., Cuendet, M., et al. Use of the facts solvation model for protein-
ligand docking calculations. application to eadock. Journal of Molecular Recognition 23(5),
457–461 (2010).
[176] Novikov, F. N., Stroylov, V. S., Zeifman, A. A., et al. Lead finder docking and virtual
screening evaluation with astex and dud test sets. Journal of Computer-Aided Molecular
Design 26(6), 725–735 (2012).
169
BIBLIOGRAPHY
[177] Muegge, I. and Martin, Y. C. A general and fast scoring function for protein-ligand
interactions: A simplified potential approach. Journal of Medicinal Chemistry 42(5) (1999).
[178] Velec, H. F. G., Gohlke, H., and Klebe, G. Drugscore(csd)-knowledge-based scoring
function derived from small molecule crystal data with superior recognition rate of near-
native ligand poses and better affinity prediction. Journal of Medicinal Chemistry 48(20)
(2005).
[179] Neves, M. A. C., Totrov, M., and Abagyan, R. Docking and scoring with icm: the
benchmarking results and strategies for improvement. Journal of Computer-Aided Molecular
Design 26(6), 675–686 (2012).
[180] Abad-Zapatero, C. and Metz, J. T. Ligand efficiency indices as guideposts for drug
discovery. Drug Discovery Today 10(7) (2005).
[181] Hopkins, A. L., Groom, C. R., and Alex, A. Ligand efficiency: a useful metric for lead
selection. Drug Discovery Today 9(10) (2004).
[182] Baber, J. C., William, A. S., Gao, Y. H., et al. The use of consensus scoring in ligand-
based virtual screening. Journal of Chemical Information and Modeling 46(1) (2006).
[183] Charifson, P. S., Corkery, J. J., Murcko, M. A., et al. Consensus scoring: A method for
obtaining improved hit rates from docking databases of three-dimensional structures into
proteins. Journal of Medicinal Chemistry 42(25) (1999).
[184] Feher, M. Consensus scoring for protein-ligand interactions. Drug Discovery Today 11(9-
10) (2006).
[185] Oda, A., Tsuchida, K., Takakura, T., et al. Comparison of consensus scoring strategies
for evaluating computational models of protein-ligand complexes. Journal of Chemical
Information and Modeling 46(1) (2006).
[186] O’Donoghue, S. I., Gavin, A. C., Gehlenborg, N., et al. Visualizing biological data-now
and in the future. Nature Methods 7(3), S2–S4 (2010).
[187] O’Donoghue, S. I., Goodsell, D. S., Frangakis, A. S., et al. Visualization of macromolec-
ular structures. Nature Methods 7(3), S42–S55 (2010).
[188] Goodsell, D. S. Visual methods from atoms to cells. Structure 13(3), 347–354 (2005).
[189] Ware, C. Using hand position for virtual object placement. Visual Computer 6(5) (1990).
[190] Venolia, D. Facile 3D direct manipulation, (1993).
[191] Balakrishnan, R., Baudel, T., Kurtenbach, G., et al. The Rockin’Mouse: integral 3D
manipulation on a plane, (1997).
170
BIBLIOGRAPHY
[192] Froehlich, B., Hochstrate, J., Skuk, V., et al. The GlobeFish and the GlobeMouse: two
new six degree of freedom input devices for graphics applications, (2006).
[193] 3dconnexion. 3dconnexion. http://www.3dconnexion.com.
[194] Jacob, R. J. K., Sibert, L. E., McFarlane, D. C., et al. Integrality and separability of
input devices. ACM Trans. Comput.-Hum. Interact. 1(1), 3–26 (1994).
[195] Zhai, S., Milgram, P., and Buxton, W. The influence of muscle groups on performance
of multiple degree-of-freedom input, (1996).
[196] Hinckley, K., Pausch, R., Goble, J. C., et al. Passive real-world interface props for
neurosurgical visualization, (1994).
[197] Gillet, A., Sanner, M., Stoffler, D., et al. Tangible interfaces for structural molecular
biology. Structure 13(3), 483–491 (2005).
[198] Gillet, A., Sanner, M., Stoffler, D., et al. Tangible augmented structural molecular
interfaces for biology. Ieee Computer Graphics and Applications 25(2), 13–17 (2005).
[199] Herman, T., Morris, J., Colton, S., et al. Tactile teaching - Exploring protein struc-
ture/function using physical models. Biochemistry and Molecular Biology Education 34(4),
247–254 (2006).
[200] Graham, E. D. and MacKenzie, C. L. Physical versus virtual pointing, 292–299299. Acm
(1996).
[201] Ware, C. and Rose, J. Rotating virtual objects with real handles. ACM Transactions on
Computer-Human Interaction 6(2) (1999).
[202] Bartz, P. and Spors, S. Razor AHRS firmware. http://dev.qu.tu-berlin.de/
projects/sf-razor-9dof-ahrs, (2012).
[203] QExtSerialPort. QExtSerialPort. http://code.google.com/p/qextserialport,
(2011).
[204] OpenNI. OpenNI Framework. http://openni.org, (2011).
[205] PrimeSense. NITE middleware. http://www.primesense.com/nite, (2011).
[206] Surles, M. C., Richardson, J. S., Richardson, D. C., et al. Sculpting proteins interactively
- Continual energy minimization embedded in a graphical modeling system. Protein Science
3(2), 198–210 (1994).
[207] Delalande, O., Ferey, N., Grasseau, G., et al. Complex molecular assemblies at hand via
interactive simulations. Journal of Computational Chemistry 30(15), 2375–2387 (2009).
171

Appendix A
Appendix
A.1 Dengue
A.1.1 Identification and Validation of Novel Dengue Methyltransferase
Inhibitors
Table A.1: Comparison of the decision-tree criteria used by the original work of Seidler et al and by our
work.
Seidler et al. Criterion Criterion, our work
Daylight clogp ≤ 3.633 QikProp clogPow < 3.1
Electrotopological S sssN ≤ 2.287 Max Epik pKa for tertiary N < 7
Max conj path ≤ 18.5 Largest contiguous set of sp2 atoms < 19.5
Contains COOH Contains COOH
Daylight clogP ≥ 5.389 QikProp clogPow ≥ 4.7
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A.1.2 Computational Analysis of the Methyltransferase Reaction
Figure A.1: Differences in RNA-MTase contacts between WT and mutated RNA. Contacts are measured
by their distances observed in MT simulations of the MTase bound to SAM and WT or mutated RNA.
All RNA mutants are shown: (left column) mutants of cap-nucleotide, (middle column) mutants of 1st
nucleotide, (right column) mutants of 2nd nucleotide. Residues with significantly modified distances are
labeled by their number.
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A.2 CAMEO Ligand Binding
A.2.1 CAMEO Ligand Binding Format Examples
Minimum example of ion binding site
Listing A.1 shows an example of the new CAMEO ligand binding site prediction format using
the bare minimum required for a valid prediction that format.
Listing A.1: Example format of a ion (zinc) binding site in structure 3ZTT.
1 r=SER; n=198; | I=0.000; O=0.000; N=0.000; P=0.000; |
2 r=GLU; n=199; | I=1.000; O=0.000; N=0.000; P=0.000; |
3 r=GLY; n=200; | I=0.000; O=0.000; N=0.000; P=0.000; |
4 r=ALA; n=201; | I=0.513; O=0.000; N=0.000; P=0.000; |
Extended example of ATP and Mn binding site
Listing A.2 shows an extended example of the new CAMEO ligand bindings site prediction for-
mat. In addition to the minimum fields required, predictions are given for each atom individually
(key: a=) and predictions for specific compounds are given (keys: ANP= and MN=)
Listing A.2: Example format of an ion (manganese) and an organic ligand (ATP) binding site in structure
3QAM.
1 r=GLU; n=170; a=N; | I=0.000; O=0.000; N=0.000; P=0.000; | ANP =0.000; MN =0.000;
2 r=GLU; n=170; a=CA; | I=0.047; O=0.412; N=0.000; P=0.000; | ANP =0.412; MN =0.047;
3 r=GLU; n=170; a=C; | I=0.337; O=0.668; N=0.000; P=0.000; | ANP =0.668; MN =0.337;
4 r=GLU; n=170; a=O; | I=0.372; O=1.000; N=0.000; P=0.000; | ANP =1.000; MN =0.372;
5 r=GLU; n=170; a=CB; | I=0.249; O=0.424; N=0.000; P=0.000; | ANP =0.424; MN =0.249;
6 r=GLU; n=170; a=CG; | I=0.000; O=0.077; N=0.000; P=0.000; | ANP =0.077; MN =0.000;
7 r=GLU; n=170; a=CD; | I=0.000; O=0.000; N=0.000; P=0.000; | ANP =0.000; MN =0.000;
8 r=GLU; n=170; a=OE1; | I=0.000; O=0.000; N=0.000; P=0.000; | ANP =0.000; MN =0.000;
9 r=GLU; n=170; a=OE2; | I=0.000; O=0.000; N=0.000; P=0.000; | ANP =0.000; MN =0.000;
10 r=ASN; n=171; a=N; | I=0.331; O=0.353; N=0.000; P=0.000; | ANP =0.353; MN =0.331;
11 r=ASN; n=171; a=CA; | I=0.401; O=0.307; N=0.000; P=0.000; | ANP =0.307; MN =0.401;
12 r=ASN; n=171; a=C; | I=0.000; O=0.000; N=0.000; P=0.000; | ANP =0.000; MN =0.000;
13 r=ASN; n=171; a=O; | I=0.000; O=0.000; N=0.000; P=0.000; | ANP =0.000; MN =0.000;
14 r=ASN; n=171; a=CB; | I=0.528; O=0.251; N=0.000; P=0.000; | ANP =0.251; MN =0.528;
15 r=ASN; n=171; a=CG; | I=0.987; O=0.584; N=0.000; P=0.000; | ANP =0.584; MN =0.987;
16 r=ASN; n=171; a=OD1; | I=1.000; O=0.939; N=0.000; P=0.000; | ANP =0.939; MN =1.000;
17 r=ASN; n=171; a=ND2; | I=0.859; O=0.637; N=0.000; P=0.000; | ANP =0.637; MN =0.859;
18 r=LEU; n=173; a=N; | I=0.000; O=0.000; N=0.000; P=0.000; | ANP =0.000; MN =0.000;
19 r=LEU; n=173; a=CA; | I=0.000; O=0.000; N=0.000; P=0.000; | ANP =0.000; MN =0.000;
20 r=LEU; n=173; a=C; | I=0.000; O=0.000; N=0.000; P=0.000; | ANP =0.000; MN =0.000;
21 r=LEU; n=173; a=O; | I=0.000; O=0.000; N=0.000; P=0.000; | ANP =0.000; MN =0.000;
22 r=LEU; n=173; a=CB; | I=0.000; O=0.175; N=0.000; P=0.000; | ANP =0.175; MN =0.000;
23 r=LEU; n=173; a=CG; | I=0.000; O=0.509; N=0.000; P=0.000; | ANP =0.509; MN =0.000;
24 r=LEU; n=173; a=CD1; | I=0.000; O=0.898; N=0.000; P=0.000; | ANP =0.898; MN =0.000;
25 r=LEU; n=173; a=CD2; | I=0.000; O=0.696; N=0.000; P=0.000; | ANP =0.696; MN =0.000;
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A.3 BEscore
Figure A.2: Distributions of surface vertex points around the ligands of the Astex diverse set. Ligands
are categorized into correct and incorrect poses based on their rmsd to the crystal structure. The scaled
distributions are plotted for both categories for different γmax angles: (A) 15°, (B) 30°, (C) 45°, (D) 90°,
(E) 135°, (F) 180°.
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A.3. BESCORE
Figure A.3: Evaluation of the performance of Bscore based on the S3DB test set using (A) retrieval rate,
(B) enrichment AUC, (C) ∆RMSD and (D) Pearson’s correlation coefficient averaged over all complexes in
the test set.
Figure A.4: Evaluation of the performance of Bscoreg based on the S3DB test set using (A) retrieval rate,
(B) enrichment AUC, (C) ∆RMSD and (D) Pearson’s correlation coefficient averaged over all complexes in
the test set.
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Figure A.5: Evaluation of the performance of Escore based on the S3DB set using (A) retrieval rate, (B)
enrichment AUC, (C) ∆RMSD and (D) Pearson’s correlation coefficient averaged over all complexes in the
test set.
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Figure A.6: BEscoreg values (y-axis) plotted against symmetry corrected rmsd for each docked pose
against the respective X-ray ligand conformation (x-axis) for the 85 complex structures in the Astex diverse
set.
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Figure A.7: BEscoreg values (y-axis) plotted against symmetry corrected rmsd for each docked pose
against the respective X-ray ligand conformation (x-axis) for the 145 complex structures in the S3DB set.
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Figure A.8: BEscoreg values (y-axis) plotted against symmetry corrected rmsd for each docked pose
against the respective X-ray ligand conformation (x-axis) for the 66 complex structures in the thrombin set.
181
A.4. HUMAN-COMPUTER INTERFACE SCHEMATICS
A.4 Human-Computer Interface Schematics
Figure A.9: Overview schematic drawing of the rotation input device.
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A.4. HUMAN-COMPUTER INTERFACE SCHEMATICS
Figure A.10: Schematic drawing of the individual building blocks of the rotation input device.
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